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1 Introduction 
 
1.1 The prostate carcinoma – at a glance 
 
In 2008 prostate cancer (PCa) was the second most frequently diagnosed cancer and 
claimed the sixth leading cause of cancer-related death in men worldwide (Global cancer 
Facts & Figures 2ndEdt). A majority of these cases (three-quarters) are diagnosed 
primarily in economically developed countries, but are emerging in developing nations 
as well. In Germany PCa is the most common cancer type with 65830 (26.1 % of total 
cancer burden) diagnosed cases in 2010, followed by lung (13.9 %) and intestinal 
(13.4 %) cancer. With 12676 (10.8 % in 2010) deaths it claims the third leading cause of 
cancer-related death among men in Germany (Krebs in Deutschland 2009/2010, 2013). 
Therefore, PCa is a serious health problem and a disease of increasing significance both, 
in Germany and worldwide. 
Well-established risk factors for the development of PCa are age, race, and family history. 
Age clearly is a risk factor, since the ten-year likelihood for a 75-year old man to get PCa 
is 6 %, whereas a man aged 35 has only a 0.1 % risk to develop PCa. A predisposition 
among close relatives has been documented and might account for 9 % of PCas. 
However, a distinct genetic mutation has not been reported (Krebs in Deutschland 
2009/2010, 2013). In addition, there are some discordant risk factors like diet, 
hormones and environmental cues that have been subject to extensive studies but did 
not reveal trusty evidence yet. 
Within the last years the prostate cancer incidence has increased constantly. This is 
mainly due to prostate specific antigen (PSA) testing. The PSA test measures the blood 
level of PSA, a protein that is exclusively produced in the prostate. These levels can be 
used as a tumor marker as the blood levels of PSA are increasing with increasing size 
and growth of the prostate. Therefore, PSA testing detects clinically important tumors, 
but also those that grow slowly and are not life threatening. However, there are men 
suffering from PCa that do not show elevated PSA levels and additional reasons for a 
high PSA level exist. However, PSA testing has been extensively discussed, since a clear 
correlation of PSA and PCa was not shown so far (Kilpelainen et al. 2011). In addition to 
this, the PSA test cannot distinguish between locally defined and advanced PCa that 
would require different therapies. 
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The prostate tumor starts to develop as a hormone-dependent lesion and usually is 
apparent when men become concerned about urinary and sexual dysfunction. This early 
state tumor is growing slowly and is not life threatening, which is why active 
surveillance, instead of surgery, irradiation or hormone therapy is the favored treatment 
option of these tumors. However, a subset of these lesions will progress and result in an 
advanced setting of prostate cancer, which is characterized by higher invasive and 
metastatic capacities. Until today there is no effective therapy available for the advanced 
state of PCa, which is why it is always attended by a poor prognosis for the patient 
(Trachtenberg, Blackledge 2002; Edwards, Bartlett, John M S 2005). Although many 
genetic and epigenetic alterations for prostate carcinoma have been proposed, the exact 
cellular and molecular mechanisms underlying the progression from a locally defined to 
an advanced prostate carcinoma remain unknown, illustrating the difficulty of diagnosis 
and the need of new improvements in PCa therapy.   
 
1.2 Cancer cell migration 
 
1.2.1 The essential mechanisms of cancer cell migration 
 
Metastatic spread, predominantly to the bone marrow, is the main cause of mortality in 
most prostate cancer patients. This complex process requires a number of genetic 
events in tumor cells that are incompletely understood. Cells have to invade and migrate 
through the surrounding tissue, escape from the primary tumor site to the circulation 
and form metastasis in distant organs. Therefore, a key feature of metastatic spread is 
cancer cell migration. Cancer cells possess a number of migration and invasion 
mechanisms, which mainly rely on the regulation of polarization, membrane extensions 
or protrusions, cell adhesion and cytoskeletal rearrangements (Fig. 1.1). 
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Fig. 1.1: Schematic overview of the processes required for migration. Cell migration relies on several 
components such as cell polarity, protrusion formation, the formation of new adhesions and cytoskeletal 
rearrangements that act all together to enable migration. The regulation of these processes is vital for the 
cell and deregulated in cancer cells. Nuc=Nucleus (Taken and modified from Ridley et al. 2003 and 
http://www.cellmigration.org). 
 
Cell polarity is a major requirement for the determination of the direction of migration. 
Environmental cues like chemoattractants or breakdown of cell-cell contacts (wound 
healing) predetermine this direction of migration and define a cell front and rear. The 
organization of the cytoskeleton finally establishes a stable polarity of the cell. At the 
leading edge of the cell a high frequency of actin reassembly is generating membrane 
protrusions to explore the environment and form focal adhesions. The generation of 
protrusions requires a scaffold of cytoskeletal structures that is supporting the 
expansion of the plasma membrane, as well as a contact to the extracellular matrix to 
provide traction forces for movement. The actin polymerization in these protrusions 
plays a major role for their stability and turnover. The Arp2/3 complex attaches to the 
side of already existing actin filaments and starts to add actin monomers resulting in a 
branched actin network. This actin network connects to the substratum via cell surface 
receptors of the cadherin and integrin family. Integrins consist of an α- and a β-subunit, 
which can form non-covalent heterodimers. They are composed of an extracellular 
ligand-binding site and a cytoplasmic domain linking the cytoskeletal network to the 
signal transduction pathways. Interestingly, integrins can mediate bidirectional 
signaling. On the one hand, intracellular signals can modulate the activity of integrins at 
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the plasma membrane (inside-out signaling). On the other hand, signals coming from the 
cellular environment through ligand-binding of ECM proteins are transmitted to affect 
intracellular processes (outside-in signaling) (Hynes 2002a; Lau et al. 2009). Upon 
integrin ligation downstream signaling pathways are activated and focal complexes of a 
large array of proteins are formed. The mature focal adhesion is composed of kinases 
and adapter proteins that facilitate signaling through their corresponding pathways. 
Adapter proteins like Paxillin, ARA55 and Leupaxin, which belong to the paxillin protein 
family reside at focal adhesion sites and link the cytoskeleton to the extracellular matrix 
(ECM). These proteins are of major importance for the vital processes of migration, as 
the loss of intercellular adhesion is a prerequisite for the development and progression 
of cancer.  
Another group of cell surface proteins involved in cell-cell adhesion is the cadherin 
protein family. Cadherins are trans-membranous proteins composed of an extracellular 
domain that is binding to cadherins of the neighboring cells and an intracellular domain 
that associates with catenins to build the basis for the formation of adhesion complexes. 
Usually cadherins are responsible for cell-cell contacts that are important for 
maintenance of the tissue structure and prevent motility, which is why cadherins are 
known as suppressors of invasion and metastasis of epithelial cells (Paredes et al. 2012). 
Carcinomas derive from epithelial cells and deregulation of E-cadherin is a common 
feature of these tumor cells. 
All these proteins have specific functions in their component processes and act together 
to establish dynamic contacts between the extracellular environment and the 
cytoskeleton to generate contractile forces essential for cell migration. 
 
1.2.2 Cytoskeletal rearrangement during cancer cell migration 
 
Besides cell adhesion the motility of malignant tumor cells is depending on the stability 
and assembly of the cytoskeleton. The dynamics of the actin-cytoskeleton are regulated 
by the small GTPases of the Rho family. These GTPases are known as molecular switches 
in signaling pathways, as they hydrolyze GTP and are cycling between a GTP-bound 
(active) and a GDP-bound (inactive) form. The Rho family is divided into several 
subgroups, among these the Rac, cdc42 and Rho GTPases are the best characterized. 
These GTPases are master regulators of the actin polymerization to generate stress 
fibers, filopodia and lamellipodia, respectively. These cytoskeletal structures are 
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indispensible for migration. The regulation of small Rho GTPases relies on a variety of 
activator and repressor proteins that target GTP-hydrolysis. 
Another group of proteins that directly binds to actin such as cofilin, filamin or 
caldesmon regulates the stabilization of the actin cytoskeleton. These proteins facilitate 
the assembly and disassembly of the cytoskeleton by their affinity to actin. Thus, 
reduced binding of these actin-stabilizing proteins results in dynamic actin structures 
and facilitates cytoskeletal remodeling. 
The investigation of the cellular and molecular mechanisms involved in cell adhesion 
and cytoskeletal rearrangements will add to the understanding of how cancer cells can 
disseminate and will lead to the development of new treatment options. 
 
1.3 Leupaxin (LPXN) - at a glance 
 
1.3.1 LPXN, a member of the paxillin protein family 
 
The LPXN gene is located on chromosome 11q12 and possesses 9 exons, which produces 
a 386 amino acid protein. Leupaxin (LPXN) was originally identified in cells of 
hematopoietic origin in 1998 by Lipsky et al. (Lipsky et al. 1998). Due to its high 
sequence homology to the focal adhesion protein paxillin it was assigned to the paxillin 
protein family. The paxillin protein family consists of the eponymous paxillin, the 
androgen receptor-associated protein 55 (ARA55) formerly known as hydrogen peroxide-
inducible clone 5 (HIC-5) and leupaxin (LPXN). Proteins of the paxillin protein family are 
characterized by their subcellular localization at focal adhesion sites. Focal adhesion 
sites are macromolecular assemblies of a large array of proteins that exhibit multiple 
protein-protein interactions including structural or membrane-spanning proteins that 
bind to their ligands in the extracellular matrix (ECM) as well as signaling proteins that 
mediate regulatory effects of ECM adhesion (Turner 2000).  
Another characteristic of the paxillin protein family is the presence of a multiple of two 
highly conserved domain structures. The four (ARA55 and leupaxin) or rather five 
(paxillin) LD motifs at the N-terminal region of the proteins are composed of a leucine-
rich amino acid sequence with an invariant leucine (L)-aspartic acid (D) pair. The C-
terminal region harbors four approximately 55 amino acid long LIM domains, which 
contain conserved cysteine, histidine and aspartic acid residues. The LIM domain was 
first discovered in the homeobox-transcription factors Lin-11, Isl-1 and Mec-3 (=LIM) in 
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Caenorhabditis elegans (Way, Chalfie 1988). This protein domain displays highly 
conserved residues that guarantee the formation of a tandem zinc finger motif, which 
seems to be essential for secondary structure formation (Kadrmas, Beckerle 2004). 
Usually zinc finger motifs are present in transcription factors and known to facilitate 
DNA binding. However, the function of LIM domains was long time believed to be 
restricted to protein-protein-interactions, but the presence of a LIM domain is emerging 
as a hallmark of proteins that can associate with the actin cytoskeleton, the 
transcriptional machinery or directly with DNA (Nishiya et al. 1998; Muller et al. 2002). 
 
Fig. 1.1: Tandem zinc finger motif of LIM domains. Highly conserved residues generate a tandem zinc 
finger motif with a spacer of two amino acids. The formation of a tandem zinc finger motif seems to be 
essential for proper LIM domain function. Usually, zinc finger motifs are found in DNA binding proteins. 
Taken from (Kadrmas, Beckerle 2004). 
 
For ARA55 DNA binding via its LIM domains was described. This binding turned out to 
require zinc for the proper formation of the LIM domain. Each of the four LIM domains 
contributed to DNA binding of a poly(A) stretch such as those present in the 3’-end of 
mRNAs. Since, a consensus binding sequence was not found and a target gene was not 
described, ARA55 was suggested to associate with secondary DNA structures to exert its 
nuclear function. For paxillin it was shown that LD-motifs as well as LIM domains are 
important for protein-protein-interactions and localization to focal adhesion sites 
(Brown et al. 1996; Brown et al. 1998; Dawid et al. 1998). In addition, the LIM domains 
of LPXN were described to be similar in focal adhesion targeting by tyrosine 
phosphorylation but were distinct from paxillin function in cell adhesion and spreading 
(Chen, Kroog 2010). 
In focal adhesions (FAs) paxillin proteins have various functions. Paxillin for instance 
binds to the cytoplasmic tail of several integrins and is thereby able to mediate signals 
Introduction    7 
from the cellular environment into the cell through direct or indirect interaction with 
structural or signaling molecules like vinculin, PTP-PEST or the focal adhesion kinase 
(FAK) (Shen et al. 1998; Turner 2000). In addition, Paxillin is able to regulate the rho-
family GTPases, which are major players of actin-cytoskeleton and adhesion dynamics 
(Petit et al. 2000).  
 
1.4 The function of LPXN 
 
In contrast to paxillin, there is only little evidence about the function of LPXN today and 
contradictory results are making the situation more complicated. Originally, LPXN was 
found to be expressed in hematopoietic cells (Lipsky et al. 1998). In this publication 
LPXN was described to form a complex with the non-receptor tyrosine kinase PYK2, 
belonging to the FAK family of kinases, to influence cell motility, spreading and 
apoptosis. In osteoclasts, LPXN associates with the sarcoma kinase, SRC, and is involved 
in bone resorption. In addition, LPXN localizes to the podosomal/sealing zone complex, 
which in other cells is known as focal adhesion (Gupta et al. 2003). In B-cells, LPXN plays 
an inhibitory role. Interaction of LPXN and LYN, a critical SRC family tyrosine kinase in 
B-cell receptor (BCR) signaling, is induced by BCR stimulation resulting in a suppression 
of BCR signaling (Chew, Lam 2007). Initially, LPXN was described as a cytoplasmic 
protein residing at focal adhesions. In rodent aortic smooth muscle cells LPXN interacts 
with the (FAK) to form a complex that attenuates nuclear accumulation of LPXN. In the 
nucleus LPXN functions as a serum response factor (SRF) cofactor to induce smooth 
muscle differentiation-marker gene expression (Sundberg-Smith et al. 2008). Obviously, 
LPXN is able to shuttle between the nuclear and cytoplasmic compartment. 
Consequently, LPXN might be more than a focal adhesion protein and takes part in 
processes beyond FA formation. 
The only clinically relevant observation of a LPXN mutation until today was an acute 
myeloid leukemia (AML) patient who was carrying a translocation (t(11;21)(q12;q22)). 
This translocation fused the RUNX1 gene with the LPXN gene, which produced a 
RUNX1/LPXN fusion protein. Both proteins, wild type RUNX1 as well as the 
RUNX1/LPXN fusion protein were present in the nuclei of hematopoietic cells, where 
they were competing for the binding site in the promoter of  colony-stimulating factor 1 
receptor (CSF1R). Consequently, CSF1R expression was reduced, which resulted in 
disturbed proliferation and differentiation of the cells. Interestingly, subcutaneous 
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injection of pEGFP-N1-RUNX1/LPXN stably transfected NIH/3T3 cells into BALB/c nude 
mice resulted in development of carcinomas after 28 days (Dai et al. 2009). This study is 
providing in vitro evidence that LPXN might display a candidate gene associated with 
carcinogenesis. However, despite the functions mentioned above, only little is known 
about the physiological role of LPXN. Especially the molecular mechanisms of LPXN 
mediated processes are incompletely understood. 
 
1.5 The function of LPXN in prostate cancer 
 
First expression of LPXN in PCa was noticed as an Atlas™-array hybridization was 
conducted on micro-dissected human prostate carcinoma specimen in our research 
group (Voigt, 2003). Further studies confirmed focal overexpression exclusively in 
epithelial carcinoma cells in 22 % of prostate carcinomas analyzed and showed that 
LPXN expression was correlating with the gleason score of the corresponding carcinoma 
(Kaulfuss et al. 2008). These findings were supported by western blot analysis of LPXN 
expression in the PCa cell lines PC-3, DU145 and LNCaP, which showed that cell lines 
that represented the advanced setting of PCa (PC-3 and DU145) displayed higher 
expression levels of LPXN than non-invasive and androgen-dependent LNCaP cells 
(Kaulfuss et al. 2008). Moreover, LPXN was influencing the migration and invasion of 
PCa cells, especially of the invasive cell lines PC-3 and DU145. Downregulation of LPXN 
reduced the invasion of these cells and also a significant reduction in migration was 
observed (Kaulfuß, 2006). Overexpression of LPXN had promoting effects on migration 
and invasion in PC-3 cells (Beckemeyer, 2007). Interestingly, we could show that LPXN 
shuttles between the cytoplasm/membrane and the nucleus and is able to transactivate 
the androgen receptor. This activation results in increased transcription of androgen-
responsive genes such as PSA (Kaulfuss et al. 2008). 
The involvement of LPXN in PCa progression was further strengthened by in vivo studies 
using the transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model. 
These TRAMP mice were bred with a mouse model that specifically overexpressed LPXN 
in the prostate. Double transgenic TRAMP/LPXN-mice resulting from this mating 
showed increased numbers of poorly differentiated PCa and distant metastasis as 
compared to control TRAMP mice. Using murine primary tumor cells isolated from the 
prostate of double transgenic TRAMP/LPXN-mice it was shown that LPXN is enhancing 
the invasion and migration abilities of these cells (Kaulfuß et la. 2009, von Hardenberg, 
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2010). In addition, LPXN-mediated invasion of PCa cells was described to involve the cell 
adhesion molecule p120catenin (p120CTN), which displayed negative correlation with 
LPXN expression. p120CTN is a major component of the adhesion complex, which also 
contains β-catenin. The expression of p120CTN has dramatic effects on the stabilization 
of the adhesion complexes. As mentioned earlier cell adhesion is a critical feature of cell 
migration and is severely affected by the stabilization of the adhesion complex. 
Overexpression of LPXN causes p120CTN expression to decrease, leading to a 
destabilization of the adhesion complexes, to the reduction of cell-cell contacts and 
subsequent accumulation of β-catenin in the nucleus. The induction of β-catenin target 
gene expression such as matrix metalloproteases (e.g. MMP-7) finally leads to 
degradation of the extracellular matrix and will enable invasion into the surrounding 
tissue (Kaulfuss et al. 2009). The expression of multiple matrix metalloproteases is a 
known hallmark of tumor cell invasion (Ellerbroek, Stack 1999; Stetler-Stevenson 2001). 
This mechanism is leaving an explanation for the invasive growth of PCa with LPXN 
overexpression. However, the molecular mechanism that drives LPXN-mediated 
migration of PCa cells still remained elusive. 
To investigate how LPXN might influence prostate cancer cell migration, a yeast-2-
hybrid screening was conducted on a prostate specific cDNA library, which identified 
the actin-binding protein caldesmon (CaD) as a putative interaction partner of LPXN 
(von Hardenberg, 2007). CaD was demonstrated to reduce invasion of breast and 
intestinal tumor cells by regulation of podosome and invadopodia formation (Yoshio et 
al. 2007). In addition, CaD was shown to regulate cell growth and survival of vascular 
smooth muscle cells via the cytoskeletal tension-FAK-ERK1/2 axis (Yokouchi et al. 
2006). As a protein that is implicated in cytoskeletal rearrangements CaD might display 
a putative candidate to execute LPXN-associated changes in migration of PCa cells. The 
elucidation of the molecular mechanisms underlying the LPXN-mediated progression of 
PCa might be of great value for patients with advanced prostate carcinoma and might 
also open new avenues for therapeutic intervention. 
 
1.6 Aims of this study 
 
In the present thesis the molecular mechanisms of LPXN-mediated PCa progression are 
investigated. Based on previous findings the underlying mechanism of LPXN-mediated 
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migration of PCa cells is elucidated. In addition, not only the pathological but also the 
physiological role of LPXN is subject of the thesis.  
 
The main aims were: 
 
 Analyses on the putative LPXN interaction partner CaD and its effect on PCa cell 
 migration 
o Confirmation of the interaction of CaD and LPXN in prostate cancer cells 
o Analyses of the interaction of CaD and LPXN by co-immunoprecipitation 
o Analyses of the interaction of CaD and LPXN by in situ proximity ligation 
  assay (PLA) 
 Analyses on the interaction of CaD and LPXN during PCa cell migration 
o Analyses on the putative LPXN interaction partner ERK during PCa cell 
  migration 
 
 Analysis on the influence of LPXN on adhesion of PCa cells 
 Analysis on the influence of LPXN on the expression of the adhesion molecule 
 p120CTN  
o Cloning of p120CTN promoter fragments into the reporter plasmid  
  pGL4.16 luc2CP/Hygro 
o Identify LPXN responsive elements in the p120CTN promoter region using 
  luciferase reporter gene assays  
o Identify LPXN binding sites in the p120CTN promoter region using EMSA 
 
 Analysis on the influence of LPXN on the expression of β1 integrin (ITGB1) 
o Analysis of β1 integrin (ITGB1) expression after LPXN knockdown 
o Analysis of β1 integrin (ITGB1) expression after LPXN overexpression  
 
 Analysis of LPXN-mediated radio-resistance of PCa cells 
o Analysis on the survival of PCa cells after LPXN knockdown and exposure 
  to ionizing irradiation  
o Analysis on the survival of PCa cells after inhibition of β1 integrin (ITGB1) 
  and exposure to ionizing irradiation  
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 Analysis on the effect of ionizing irradiation on LPXN expression 
o Analysis of LPXN expression in PCa cells after exposure to ionizing  
  irradiation 
 
 Analysis on the effect of ionizing irradiation on ITGB1 expression 
o Analysis of β1 integrin (ITGB1) expression in PCa cells after exposure to 
  ionizing irradiation 
 
 Generation of a conditional knockout mouse model for LPXN 
o Purchase of an ES cell clone with a LPXN targeted trap construct 
o Excision of the reporter/selector cassette to generate a conditional allele 
o Blastocyst injection of mutant ES cells  
o Breeding of chimera to establish a conditional knockout mouse model for 
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2 Materials and Methods 
 





Carl Roth GmbH, Karlsruhe, Germany 
Adenosintriphosphate (ATP) Biomol GmbH, Hamburg, Germany 
Agar Carl Roth GmbH, Karlsruhe, Germany 
Agarose Life Technolgies, Darmstadt, Germany 
Ammonium persulfate (APS) Carl Roth GmbH, Karlsruhe, Germany 
Ampicillin Carl Roth GmbH, Karlsruhe, Germany 
Ampuwa Fresenius AG, Bad Homburg, Germany 
Bacto-Trypton Carl Roth GmbH, Karlsruhe, Germany 
Borica cid Scharlau Chemie S.A., Barcelona, Spain 
Cell culture media PAN, Aidenbach, Germany 
Dimethylsulfoxide Carl Roth GmbH, Karlsruhe, Germany 
Dithiotreitol (DTT) Biomol GmbH, Hamburg, Germany 
DNA Stain G Serva GmbH, Heidelberg, Germany 
dNTPs (100 mM) Life Technolgies, Darmstadt, Germany 
Ethanol 
Chemie Vertrieb Hannover, Hannover, 
Germany 
Ethidiumbromid Sigma-Aldrich, Deisenhofen, Germany 
Ethylendiamine-tetraacetic acid (EDTA) ICN, Aurora, USA 
Ethylenglycol-bis(β-aminoethyl)-N,N,N',N'-
tetraacetat (EGTA) 
Carl Roth GmbH, Karlsruhe, Germany 
Ficoll® 400 
AppliChem GmbH, Darmstadt, 
Germany 
Formaldehyde Carl Roth GmbH, Karlsruhe, Germany 
Glycerol Carl Roth GmbH, Karlsruhe, Germany 
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Glycin Carl Roth GmbH, Karlsruhe, Germany 
Igepal CA-630 (NP-40) Sigma-Aldrich, Deisenhofen, Germany 
Isopropanol Carl Roth GmbH, Karlsruhe, Germany 
Kanamycin Sigma-Aldrich, Deisenhofen, Germany 
Magnesium chloride hexahydrate Carl Roth GmbH, Karlsruhe, Germany 
Methanol Carl Roth GmbH, Karlsruhe, Germany 
N,N,N',N'-Tetramethylethylenediamine 
(TEMED) 
Carl Roth GmbH, Karlsruhe, Germany 
NuPAGE™ LDS Sample buffer (4x) Life Technolgies, Darmstadt, Germany 
NuPAGE™ MES Running buffer (20x) Life Technolgies, Darmstadt, Germany 
NuPAGE™ See Blue Plus2 Life Technolgies, Darmstadt, Germany 
Orange G Sigma-Aldrich, Deisenhofen, Germany 
PD98059 (MEK1 Inhibitor) #9900S Cell Signaling, Danvers, MA, USA 
Penicillin/Streptomycin PAN, Aidenbach, Germany 
Phenylmethylsulfonyl flouride (PMSF) Sigma-Aldrich, Deisenhofen, Germany 
Poly(deoxyinosinic-deoxycytidylic) acid 
sodiumsalt 
Sigma-Aldrich, Deisenhofen, Germany 
Potassium chloride Carl Roth GmbH, Karlsruhe, Germany 
RNase inhibitor MBI, St. Leon-Rot, Germany 
Roti®Nanoquant Carl Roth GmbH, Karlsruhe, Germany 
Roti®Phorese (29:1) Carl Roth GmbH, Karlsruhe, Germany 
Simply Blue Safe Stain Life Technolgies, Darmstadt, Germany 
Sodiumdodecylsulfate (SDS) Serva GmbH, Heidelberg, Germany 
Tris 
AppliChem GmbH, Darmstadt, 
Germany 
Triton X-100 Fluka, Deisenhofen, Germany 
Tween 20 Merck, Darmstadt, Germany 
Vectashield with DAPI VectorLab, Burlingame, USA 
Yeast extract Carl Roth GmbH, Karlsruhe, Germany 
α-P33-Deoxyadenosine 5'-triphosphate (dATP) 
Hartmann Analytic GmbH, 
Braunschweig, Germany 
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2.2 Biochemicals and enzymes 
 
Biochemical Manufacturer 
Albumin fraction V Biomol GmbH, Hamburg, Germany 
BigDye® Life Technologies, Darmstadt, Germany 
Complete Mini Protease Inhibitor Cocktail 
Tablets 
Roche, Mannheim, Germany 
Direct PCR Lysis Reagent Peqlab, Erlangen, Germany 
DNAse Sigma-Aldrich, Deisenhofen, Germany 
Fetal bovine serum (SeraPlus) PAN, Aidenbach, Germany 
MangoTaq-DNA-Polymerase Bioline, Luckenwalde, Germany 
MycoZAP™ Spray Lonza, Cologne, Germany 
Phalloidin, FITC-labeled Sigma-Aldrich, Deisenhofen, Germany 
Phosphatase Inhibitor Mix II, solution Serva GmbH, Heidelberg, Germany 
Phusion™ High-Fidelity DNA Polymerase Finnzymes, Espoo, Finland 
Proteinase K Carl Roth GmbH, Karlsruhe, Germany 
Restriction Enzymes New England Biolabs, Ipswich, USA 
Reverse Transcriptase SuperScript II Life Technologies, Darmstadt, Germany 
RNase A AppliChem GmbH, Darmstadt, Germany 
T4 DNA Ligase Life Technologies, Darmstadt, Germany 
Trypsin/EDTA solution PAN, Aidenbach, Germany 
Human Epidermal Growth Factor (EGF) 
#8916SF 
Cell Signaling, Danvers, MA, USA 
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2.3 Usage ware 
 
Usageware Manufacturer 
10, 13, 50 ml Cellstar® Tubes Greiner-bio-one, Kremsmünster, Austria 
384-well plates, white ABgene, Hamburg, Germany 
6-, 24-well cell culture plates 
Sarstedt, Nürnbrecht, Germany 
Corning Inc., New York, USA 
Blotting Paper GB 002, 003, 004 Schleicher &Schnüll, Dassel, Germany 
Cell culture flasks Sarstedt, Nürnbrecht, Germany 
Coverglass 24x60mm Menzel Gläser, Braunschweig, Germany 
FALCON culture slides 
Becton Dickinson GmbH, Heidelberg, 
Germany 
Flat-bottomed Nuclon™ surface 96-well cell 
culture plates 
Nunc A/S, Danmark 
Membrane filter Millipore, Billerica, USA 
Microcentrifuge Tubes Sarstedt, Nürnbrecht, Germany 
NuPAGE™ 4 - 12 % Bis-Tris Gels Life Technologies, Darmstadt 
Petri dishes Greiner Nunc., Nürntingen, Germany 
Pipet tips Sarstedt, Nürnbrecht, Germany 
PVDF-Membrane GE Healthcare, Munich, Germany 
Quarz-Cuvette Hellma, Mühlheim, Germany 
Sterile Single-use filter Minisart Sartorius, Göttingen, Germany 
Nunc® F96 MicroWell™ white Nunc A/S, Danmark 
 
2.4 Technical equipment 
 
Technical equipment Manufacturer 
FluorChem® Q Alpha Innotech, Logan, Utah, USA 
Confocal Laser Scanning Microscope IX81 Olympus, Hamburg, Germany 
SynergyMx Bio Tek, Bad Friedrichshall, Germany 
Irradiation device 225A Gulmaymedical, Camberley, UK 
Fujifilm FLA-5100 Fuji Life Science, Düsseldorf, Germany 
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HT7900 Fast Real-Time PCR System 
Applied Biosystems GmbH, Darmstadt, 
Germany 
 
2.5 Sterilization of solution and equipment 
 
Laboratory equipment, solutions and culture media were autoclaved at 121 °C and 105 
Pa for 60 min or sterilized at 220 °C over night. 
 
2.6 Ready-to-use Reaction systems 
 
Reaction system Manufacturer 
Direct PCR tail reagent Peqlab, Erlangen, Germany 
ECL Prime GE Healthcare, Munich, Germany 
Myco Alert® Mycoplasma Detection Kit Lonza, Cologne, Germany 
peqGold Total RNA Kit Peqlab, Erlangen, Germany 
NucleoSpin® Extract II Macherey & Nagel, Düren, Germany 
Plasmid Midi Kit Life Technologies, Darmstadt, Germany 
Platinum® SYBR®-Green qPCR Super Mix-
UDG Life Technologies, Darmstadt, Germany 
PhosSTOP Phosphatase Inhibitor Roche, Mannheim, Germany 
Duolink® in situ Kit Olink Bioscience, Uppsala, Sweden 
MSB® Spin PCR apace Invitek, Berlin, Germany 




Solutions for routine applications were prepared according to (Maniatis et al. 1982). 
Required chemicals were dissolved in ddH2O and autoclaved or filtered under sterile 
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AP Buffer 100 mM NaCl 
  50 mM MgCl2 
  100 mM Tris/HCl pH 9.5 
AP Staining Solution 45 µl NBT (75 mg/ml in DMF) 
  35 µl BCIP (50 mg/ml in DMF) 
  in 10 ml AP-Buffer 
Blocking Buffer (Western Blot) 1x TBS-Tween 
  5 % low-fat dry milk 
Blocking Buffer (PLA) 1x PBS 
  3 % BSA 
Coomassie Staining Solution 30 % (v/v) Methanol 
  10 % (v/v) Glacialacetic acid 
  0.05 % (w/v) Coomassie Brilliant Blue R250 
Cytoplasmic Extraction Buffer 20 mM HEPES pH 7.4 
 10 mM KCl 
 10 % (v/v) Gylcerol 
 1 mM EDTA 
 0.1 % IGEPAL-CA-360 (NP-40) 
 3 mM DTT 
 
1 Tablet/ 10 ml Complete Mini protease 
inhibitor 
EMSA Shift Buffer 100 mM HEPES, pH 7,9 
  200 mM KCl 
  5 mM MgCl2 
  20 % Ficoll 
  0.5 mM EGTA 
  2.5 mM EDTA 
EMSA Running Buffer Stock Solution 1x TBE 
  88 mM Boric acid 
  2 mM EDTA 
  140 mM Tris pH 8.0 
Lysis Buffer for protein (modified 
RIPA) 
150 mM NaCl 
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  1 mM EDTA 
  50 mM Tris-HCl, pH 7.4 
  1 % IGEPAL-CA-360 (NP-40) 
  0.25 % Natriumdeoxycholat 
  
1 Tablet/10 ml Complete Mini protease 
inhibitor 
  
100 µl /10 ml Phosphatase-Inhibitor-Mix II, 
solution 
Nuclear Extraction Buffer 20 mM HEPES pH 7.4 
 420 mM KCl 
 20 % (v/v) Glycerol 
 1 mM EDTA 
 3 mM DTT 
 
1 Tablet/10 ml Complete Mini protease 
inhibitor 
P1 Buffer (Plasmid Preparation) 50 mM Tris-HCl, pH 8.0 
  10 mM EDTA 
  100µg/ml RNase A 
P2 Buffer (Plasmid Preparation) 200 mM NaOH 
  1 % SDS 
P3 Buffer (Plasmid Preparation) 3 M Potassium acetate (pH 5.5) 
Potassium Phosphate (1M) 0.17 KH2PO4 
  0.72 K2HPO4 
10x PBS 1.37 M NaCl 
  81 mM Na2PO4 
  27 mM KCl 
  14.7 mM KH2PO4 
Stop Mix 1 95 % Formamide 
  20 mM EDTA 
  0.05 % Bromphenolblau 
  0.05 % Xylencyanol 
Stop Mix 2 15 % Ficoll 400 
  200 mM EDTA 
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  0.1 % Orange G 
10x TBS 1.37 M NaCl 
  100 mM Tris 
  Adjusted to pH 7.6 using HCl 
1x TBS-Tween (TBS-T) 1x TBS 
  0.1 % Tween 20 
Transfer Buffer IIa (Western Blot) 25 mM Tris pH 8.3 
  150 mM Glycin 
  20 % Methanol 
5x Tris-Boricacid-EDTA (TBE) Buffer 445 mM Tris/HCl, pH 8.0 
  445 mM Boricacid 
  10 mM EDTA 
20x Turbo Buffer 0.2 M NaOH 
  Adjusted to pH 8.0 using solid H3BO3 
Washing Buffer (Western Blot) 1x TBS-Tween 
  2.5 % low-fat dry milk 
X-Gal Stock solution 20 mg X-Gal/ml N.N.-Dimethyl-foramide 
 
2.8 Culture media, antibiotics, agar plates 
 
2.8.1 Culture media for bacteria 
 
Luria-Bertani medium (LB medium)   
10g/l Bacto-Trypton 
      5g/l Yeast Extract 
      10g/l NaCl 
      pH 7.0 
 
The culture medium was prepared using bi-destilled water, autoclaved and kept at 4 °C. 
For selection ampicillin (50 µg/ml final concentration) or kanamycin (25 µg/ml final 
concentration) were added to the medium, respectively.  
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2.8.2 Agar plates 
 
Before autoclaving 1.5 % (w/v) Agar-Agar was added to the liquid LB medium. After the 
medium was autoclaved it was cooled down to 55°C on a stirring plate before antibiotics 
were added in a corresponding concentration (ampicillin: 50 µg/ml, kanamycin: 
25 µg/ml). Finally, the medium was poured into petri dishes and kept in a sterile plastic 
bag at 4°C. 
 
2.8.3 Culture media for eukaryotic cell cultures  
 
Media used for culture of eukaryotic cells were purchased from PAN, Aidenbach, 
Germany. Before use fetal bovine serum (FBS) and antibiotics (penicillin/streptomycin) 
were added. For cell culture the following media were used: 
 
 Medium for PC-3, DU145 and LNCaP cells:  
  
RPMI 1640 (PAN, Aidenbach, Germany) 
    100 µg/ml Streptomycin 
    100 U/ml Penicillin  
    10 % fetal bovine serum (FBS) 
 
 Medium for HeLa cells: 
    MEM (PAN, Aidenbach, Germany) 
    100 µg/ml Streptomycin 
    100 U/ml Penicillin  
    10 % fetal bovine serum (FBS) 
 
 ES cell medium:   
Dulbecco’s MEM (DMEM) (Life Technologies, Germany)  
   0.1 mM  Non essential amino acids 
    1.0 mM  Sodium pyruvate 
    10.0 µM  β-Mercaptoethanol 
    2.0 mM  L-Glutamine 
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    20 %   Fetal calf serum (FCS) 
    1000 U/ml  Recombinant leukaemia inhibitory factor (LIF) 
 
For cryopreservation of the cells in liquid nitrogen 8 % DMSO have been added to the 
medium. 
 
2.9 Biologic material 
 
2.9.1 Bacterial strains 
 
For the transformation of plasmids into competent bacterial cells, the Escherichia coli 
strain DH5α (Hanahan 1983) was used and purchased from Life Technologies, 
Karlsruhe, Germany. 
 
2.9.2 Eukaryotic cell lines 
 
PC-3 Human prostate adenocarcinoma cell line (bone metastasis), ATCC, 
Rockville, USA, castration resistant cells (Kaighn et al. 1979; Ohnuki 
et al. 1980) 
 
DU145 Human prostate adenocarcinoma cell lines (brain metastasis), 
ATCC, Rockville, USA, castration resistant cells (Stone et al. 1978) 
 
LNCaP Human prostate adenocarcinoma cell line (lymphnode metastasis), 
ATCC, Rockville, USA, androgen dependent (Horoszewicz et al. 
1983) 
 
HeLa  Human cervix adenocarcinoma cell line, ATCC, Rockville, USA 
 
 
2.9.3 Mouse strains 
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All experiments were conducted according to the European and German protection of 
animals act. The number of sacrificed animals and the stress and pain they were 
suffering was kept to the minimum. Euthanasia of mice was performed either by CO2-
asphyxation or cranial dislocation. Mice were kept at a 12 hours light/dark cycle at 22°C 
and 55 ±5 % relative humidity. C57BL/6 wild type mice were obtained from a colony of 
our own department. EIIA-Cre mice (Dooley et al. 1989) were kindly provided by Nils 
Brose and Klaus-Armin Nave (Max Planck Institute of Experimental Medicine, Göttingen, 
Germany)  
 
2.9.4 Synthetic DNA-oligonucleotides 
 
For the generation of PCR products and for quantitative real time PCR analyses as well 
as for the EMSA experiments synthetic oligonucleotides were purchased from Eurofins 
MWG Operon (Ebersberg, Germany). Sequences are listed starting from 5’- to 3’- end. 
 
Primer used for EMSA: 
 
Fragment   Sequence   
8 
Fw 5'- TTTT TATGCCTGGTTCCTATTGGAAGCTCACAGGGGCTG -3' 
Rev 5'- TTTT CAGCCCCTGTGAGCTTCCAATAGGAACCAGGCATA -3' 
9 
Fw 5'- TTTT GGCTGACATCACTTAGGAAAGCGAAGGGGGTAGGG -3' 
Rev 5'- TTTT CCCTACCCCCTTCGCTTTCCTAAGTGATGTCAGCC -3' 
10 
Fw 5'- TTTT TAGGGCTGCCAGATCAGTTTGTCACCACCCAGGCT -3' 
Rev 5'- TTTT AGCCTGGGTGGTGACAAACTGATCTGGCAGCCCTA -3' 
11 
Fw 5'- TTTT AGGCTCCCTTGCCTTTGGCTGGGTGCAACTTCCAT -3' 
Rev 5'- TTTT ATGGAAGTTGCACCCAGCCAAAGGCAAGGGAGCCT -3' 
12 
Fw 5'- TTTT TCCATTTTAGGTGTTGGATCTGAGGGGGAAAAAAA -3' 
Rev 5'- TTTT TTTTTTTCCCCCTCAGATCCAACACCTAAAATGGA -3' 
13 
Fw 5'- TTTT AAAAAAGAGAGAGGGAGAGAGAGAGAAAGAAGAGC -3' 
Rev 5'- TTTT GCTCTTCTTTCTCTCTCTCTCCCTCTCTCTTTTTT -3' 
14 
Fw 5'- TTTT AGAGCAGGAAAGATCCCGAAAGGAGGAAGAGGTGG -3' 
Rev 5'- TTTT CCACCTCTTCCTCCTTTCGGGATCTTTCCTGCTCT -3' 
15 Fw 5'- TTTT GGTGGCGAAAAATCAACTGCCCTGCTGGATTTGTC -3' 
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Rev 5'- TTTT GACAAATCCAGCAGGGCAGTTGATTTTTCGCCACC -3' 
16 
Fw 5'- TTTT TTGTCTTTCTCAGCACCTTGGCGAAGCCTTGGGTT -3' 
Rev 5'- TTTT AACCCAAGGCTTCGCCAAGGTGCTGAGAAAGACAA -3' 
17 
Fw 5'- TTTT GGGTTTCTTTCTTAAAGGACTGATTTTTAGAACTC -3' 
Rev 5'- TTTT GAGTTCTAAAAATCAGTCCTTTAAGAAAGAAACCC -3' 
18 
Fw 5'- TTTT AACTCCACATTTGAGGTGTGTGGCTTTTGAAGAAA -3' 
Rev 5'- TTTT TTTCTTCAAAAGCCACACACCTCAAATGTGGAGTT -3' 
19 
Fw 5'- TTTT AGAAAATGTATGTACTGACGGGAAAAGGAGGATAA -3' 
Rev 5'- TTTT TTATCCTCCTTTTCCCGTCAGTACATACATTTTCT -3' 
1-2 
Fw 5'- TTTT TGTCTCCCTTGCCTCTTCCGCCCCCCTCAGCTCT -3' 
Rev 5'- TTTT AGAGCTGAGGGGGGCGGAAGAGGCAAGGGAGACA -3' 
2-3 Fw 5'- TTTT CAGTAATTCCTCAGAGATTGTACAGTCTCTCCAC -3' 
  Rev 5'- TTTT GTGGAGAGACTGTACAATCTCTGAGGAATTACTG -3' 
3-4 Fw 5'- TTTT TTAAATATAAATATATAAATATAAATATATATAT -3' 
  Rev 5'- TTTT ATATATATATTTATATTTATATATTTATATTTAA -3' 
4-5 Fw 5'- TTTT TATAAACTTCCCCCTGTCTTTCTCTCCTCTCTTT -3' 
  Rev 5'- TTTT AAAGAGAGGAGAGAAAGACAGGGGGAAGTTTATA -3' 
5-6 Fw 5'- TTTT TTTTAATTTTCTATAATAAAGTTTCCTATTGGAT -3' 
  Rev 5'- TTTT ATCCAATAGGAAACTTTATTATAGAAAATTAAAA -3' 
6-7 Fw 5'- TTTT AGGTCAGCTCCCTGATTTATGCCTGGTTCCTATTG -3' 
  Rev 5'- TTTT CAATAGGAACCAGGCATAAATCAGGGAGCTGACCT -3' 
7-8 Fw 5'- TTTT AAGCTCACAGGGGCTGACATCACTTAGGAAAGCG -3' 
  Rev 5'- TTTT CGCTTTCCTAAGTGATGTCAGCCCCTGTGAGCTT -3' 
8-9 Fw 5'- TTTT AGGGGGTAGGGCTGCCAGATCAGTTTGTCACCAC -3' 
  Rev 5'- TTTT GTGGTGACAAACTGATCTGGCAGCCCTACCCCCT -3' 
9-10 Fw 5'- TTTT CAGGCTCCCTTGCCTTTGGCTGGGTGCAACTTCC -3' 
  Rev 5'- TTTT GGAAGTTGCACCCAGCCAAAGGCAAGGGAGCCTG -3' 
10-11 
Fw 5'- TTTT TTTTAGGTGTTGGATCTGAGGGGGAAAAAAAAGA -3' 
Rev 5'- TTTT TCTTTTTTTTCCCCCTCAGATCCAACACCTAAAA -3' 
11-12 
Fw 5'- TTTT AGAGGGAGAGAGAGAGAAAGAAGAGCAGGAAAGA -3' 
Rev 5'- TTTT TCTTTCCTGCTCTTCTTTCTCTCTCTCTCCCTCT -3' 
12-13 
Fw 5'- TTTT CCCGAAAGGAGGAAGAGGTGGCGAAAAATCAACT -3' 
Rev 5'- TTTT AGTTGATTTTTCGCCACCTCTTCCTCCTTTCGGG -3' 
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13-14 
Fw 5'- TTTT CCCTGCTGGATTTGTCTTTCTCAGCACCTTGGCG -3' 
Rev 5'- TTTT CGCCAAGGTGCTGAGAAAGACAAATCCAGCAGGG -3' 
14-15 
Fw 5'- TTTT AGCCTTGGGTTTCTTTCTTAAAGGACTGATTTTT -3' 
Rev 5'- TTTT AAAAATCAGTCCTTTAAGAAAGAAACCCAAGGCT -3' 
15-16 
Fw 5'- TTTT GAACTCCACATTTGAGGTGTGTGGCTTTTGAAGA -3' 
Rev 5'- TTTT TCTTCAAAAGCCACACACCTCAAATGTGGAGTTC -3' 
16-17 
Fw 5'- TTTT AATGTATGTACTGACGGGAAAAGGAGGATAAGCA -3' 





Primer name   Sequence   
Sp6new 5'- TTAGGTGACACTATAGAATACTCAAGC -3' 
T7new 5'- AATACGACTCACTATAGGGCGAATTGG -3' 
pGL3-fw 5'- CTAGCAAAATAGGCTGTCCCCAGTGC  -3' 





Primer name   Sequence   
p120Xho-240fw 5'- CTCGAGTAAAAAGCCCTTGTTCCTTGTCTCCCTTGCC -3' 
p120Xho-508fw 5'- CTCGAGGCTCTAATGCAATTAATCCAAAAC -3' 
p120Xho-1024fw 5'- CTCGAGGGCATAAAATGTTCTTGACATGAGA -3' 
p120Xho-1942fw2 5'- CTCGAGCCTACACTAGAGTGCAATGGCATG -3' 
p120Bgl-TSrev 5'- AGATCTCCTGTGAGCTTCCAATAGGAACCA -3' 
p120Bgl+100rev 5'- AGATCTCTAAAATGGAAGTTGCACCCAGCCAAAG -3' 
p120Bgl+329rev 5'- AGATCTGACAAAAATTCGACTTGCTTATCCT -3' 
 
 
Human-specific primer for quantitative real time PCR: 
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Primer name   Sequence   
TBP-Fw 5'- AGCCTGCCACCTTACGCTCAG -3' 
TBP-Rev 5'- TGCTGCCTTTGTTGCTCTTCCA -3' 
PBGD-Fw 5'- GCAATGCGGCTGCAACGGCGGAAG -3' 
PBGD-Rev 5'- CCTGTGGTGGACATAGCAATGATT -3' 
LPXN-CDS-F1 5'- CCCAGAGCACTTCTTCTGCT -3' 
LPXN-CDS-R1 5'- GCTAAGAAATCCTTTCGGCA -3' 
ITGB1-Q2-Fw 5'- CCCATTGTAAGGAGAAGGATGTTG  -3' 
ITGB1-Q2-Rev 5'- CAAGGCCAATAAGAACAATTCCAG -3' 
 
 






LPXN-5’ 5'- CTCAGGCTGTAATGGGTATGAAG -3' 
LPXN-3’ 5'- GCTATGGCTTTACAGCTCTGTTCT -3' 
LPXN-Fw 5'- AGTTGGATGAGCTCATGGCCCACC -3' 
LoxR 5'- TGAACTGATGGCGAGCTCAGACC -3' 
mLPXN-In-3-4-Fw 5'- AGTTCTCCTTACTTTTGCCAGCA -3' 
mLPXN-In-4-5-Rev 5'- CGGCGTGATCATGCAGAA -3' 
 
 
2.9.5 Synthetic RNA oligonucleotides 
 
The used small interfering RNAs were purchased from Life Technologies (Darmstadt, 
Germany). 
 
Human LPXN “siLPXN” 
 
Target sequence:  5’-GGGGCAGCUCGUGUAUACUACCAAU-3’ 
Sense strand:   5’-GGGGCAGCUCGUGUAUACUACCAAUdTdT-3’ 
Anti-sense strand:  5’-AUUGGUAGUAUACACGAGCUGCGCCdTdT-3’ 
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Luciferase (Photinuspyralis) “siLuc” 
 
Target sequence:  5’-CGUACGCGGAAUACUUCGA-3’ 
Sense strand:   5’-CGUACGCGGAAUACUUCGAdTdT-3’ 




2.9.6.1 Inhibitory antibodies 
 
Antibody Source 
β1-integrin inhibitory antibody, clone 
AIIB2, monoclonal antibody, rat 
Kindly provided by Prof. Dr. Nils Cordes, 
OncoRay, Dresden, Germany 
Rat IgG – Isotype Control (ab37361) Abcam, Cambridge, UK 
 
 
2.9.6.2 Primary antibodies 
 
Primary antibody Manufacturer 
Anti-LPXN (283 G), monoclonal 
antibody, mouse 
ICOS Corp., Bothell, USA 
Anti-Caldesmon (8-L-Caldesmon), 
monoclonal antibody, mouse 
(#610660) 
BD Transduction Laboratories, 
Heidelberg, Germany 
Anti-Integrin β1 (D2E5) monoclonal 
antibody, rabbit (#9699) 
Cell Signaling, Danvers, MA, USA 
Anti-phospho-Caldesmon Ser-789, 
polyclonal antibody, rabbit (sc-12931) 
Santa Cruz Biotechnology, Heidelberg, 
Germany 
Anti-p44/42 MAPK (ERK1/2), 
polyclonal antibody, rabbit 
Cell Signaling, Danvers, MA, USA 
Anti-phospho-p44/42 MAPK 
(ERK1/2) (Thr202/Tyr204) D13.13E4 
Cell Signaling, Danvers, MA, USA 
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Anti-STAT1α p91 (C-24), polyclonal 
antibody, rabbit 
Santa Cruz Biotechnology, Heidelberg, 
Germany 
Anti-α-Tubulin (clone B-5-1-2), 
monoclonal antibody, mouse 
Sigma-Aldrich, Deisenhofen, Germany 
Anti-Leupaxin (N-terminal), polyclonal 
antibody, rabbit (SAB4200010) 
Sigma-Aldrich, Deisenhofen, Germany 
Anti-cmyc Tag (clone 4A6), 
monoclonal antibody, mouse 
Sigma-Aldrich, Deisenhofen, Germany 
 
2.9.6.3  Secondary antibodies 
 
Secondary antibody Manufacturer 
Anti-rabbit IgG, alkaline phosphatase 
conjugated (A-3687), goat 
Sigma-Aldrich, Deisenhofen, Germany 
Anti-rabbit IgG (H+L), HRP (horse 
radish peroxidase) conjugated, goat 
Dianova Jackson ImmunoResearch, 
Hamburg, Germany 
Anti-rabbit IgG, Cy3-conjugated 
(C2306) 
Sigma-Aldrich, Deisenhofen, Germany 
Anti-mouse IgG, alkaline phosphatase-
conjugated (A-3688), rabbit 
Sigma-Aldrich, Deisenhofen, Germany 
Anti-mouse IgG (H+L), HRP-
conjugated, rabbit 
Dianova Jackson ImmunoResearch, 
Hamburg, Germany 
Anti-mouse IgG, Cy3-conjugated 
(C2181) 
Sigma-Aldrich, Deisenhofen, Germany 
 
2.9.7 Plasmids and Vectors 
 
Plasmid/Vector Source 
pGEM-Teasy Promega, Wisconsin, USA 
pGL4.16 luc2CP/Hygro Promega, Wisconsin, USA 
pGL4.50 luc2CP/CMV/Hygro Promega, Wisconsin, USA 
pCAGGS-FLPe kindly provided by Prof. Dr. Ibrahim 
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Adham 
pEGFP-LPXN Dr. S. Kaulfuß, 2006 










pCMV-Myc-LPXN Dr. S. v.Hardenberg, 2010 
pCMV-Myc-Caldesmon Dr. S. v.Hardenberg, 2010 
pRL-Luc Promega, Wisconsin, USA 
 
2.9.8 Used constructs and plasmids 
 

































































pGL4.16-p120CTN- pGL4.16 pBACe.3.6 P120Xho-1048fw / 
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2.10  Databases 
 
Usage Programm 
Restriction site analysis 
NEB Cutter 2.0 
(http://tools.neb.com/NEBcutter2/index.
php) 
WEB Cutter 2.0 
(htp://rna.lundberg.gu.se/cutter2) 
Analysis of DNA- and protein 
sequences 
BLAST-program (Altschulet al. 1990) 
(http://ncbi.nlm.nih.gov) 
Bioinformatics 
Ensembl v32 (http://www.ensembl.org) 






2.11 Isolation and purification of nucleic acids 
 
2.11.1 Minipreparation of plasmid DNA 
 
For rapid isolation of recombinant plasmids, a small amount of plasmid DNA was 
prepared. Therefore, 1 ml of a bacterial overnight-culture was centrifuged at 5000 x g 
and the pellet was resuspended in 250 µl P1 solution. After adding 250 µl of P2 
(modified alkaline lysis) to the suspension, it was incubated at RT for 5 min. Next, 250 µl 
of P3 (neutralization) was pipetted to the sample and centrifuged at 13.000 x g. The 
supernatant was transferred into a reaction tube containing 500 µl of ice cold 0.7 vol 
isopropanol. The plasmid DNA was precipitated and centrifuged at 16.000 x g for 45 min. 
Afterwards, the DNA pellet was washed with 200 µl of 70 % ethanol. Finally, the DNA 
was dried and resolved in 20 – 30 µl ddH2O. 
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2.11.2 Establishment of bacterial glycerol stocks 
 
100 µl sterile glycerol was added to 1 ml of a bacterial suspension, well mixed and 
stored at -80°C. 
 
2.11.3 Midipreparation of plasmid DNA 
 
For isolation of larger amounts of ultra-pure plasmid DNA, the PureLink™ HiPure 
Plasmid Midiprep Kit from Life Technologies (Darmstadt, Germany) was used. This kit 
uses affinity chromatography columns to purify the plasmid DNA. The purification was 
performed according to the manufacturer’s instructions. DNA purified by this method 
can be used for the transfection of cell lines, restriction analysis, subcloning or 
sequencing. 
 
2.11.4 Isolation of total RNA from cell cultures 
 
For isolation of total RNA from cell cultures the pegGOLD Total RNA Kit (Peqlab, 
Erlangen, Germany) was used according to the manufactures instructions.  
 
2.11.5 Determination of nucleic acid concentration 
 
The concentration of nucleic acids was determined by a spectral photometer 
(BioPhotometer, Eppendorf, Hamburg). After the blank value was set, the absorption 
maximum of the nucleic acids (260nm) was measured. Simultaneously, contaminations 
by proteins (280nm) or salts (320nm) were detected. The concentration of nucleic acids 
was calculated according to the Lambert’s law. 
Lower concentrations were determined by agarose gel electrophoresis. A certain 
amount of DNA was loaded onto an agarose gel and run with a DNA standard 
(MassRuler DNA Ladder, Thermo Scientific, Langenselbold, Germany), for which the 
amount of DNA for each band was known. After the gel was run, a photograph of the 
stained DNA was taken and the concentration of the sample was estimated from the 
band intensities. 
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2.12 Cloning techniques 
 
2.12.1 Cleavage of DNA with restriction endonucleases 
 
For enzymatic cleavage of DNA by restriction endonucleases, a restriction reaction in a 
total volume of at least 10 µl was prepared. Per µg DNA 1 U of the respective restriction 
enzyme was used. Together with the corresponding buffer the reaction was incubated at 
37 °C for 1 – 2 hours or overnight. In case the DNA was cleaved by two restriction 
endonucleases, the buffer was chosen for sufficient activity of both enzymes or a 
sequential restriction was performed. 
 
2.12.2 Isolation of DNA fragments from agarose gels 
 
For isolation of DNA fragments from agarose gels, the NucleoSpin™ Extract II Kit 
(Macherey & Nagel, Düren, Germany) was used. After the DNA fragments were 
separated by gel electrophoresis on an agarose gel, they were cut out of the gel using a 
sterile scalpel and dissolved in the corresponding buffer at 50°C. Subsequently, the DNA-
agarose solution was loaded onto the columns and purified according to the 
manufacturer’s instructions. The DNA was eluted in ddH2O. 
 
2.12.3 Dephosphorylation of plasmid DNA 
 
To avoid religation of linearized plasmid DNA, the terminal 5’-phosphate group of the 
vector was removed by alkaline phosphatase. Therefore, the DNA was incubated with 2 
U alkaline phosphatase for 1 hour at 37°C. After dephosphorylation the DNA was 




2.12.4 Ligation of DNA fragments 
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In a ligation reaction, a phosphodiester bond is formed between the 3’-hydroxy- and 5’-
phosphate group of the linearized DNA. This enzymatic reaction is catalyzed by the T4 
DNA ligase leading to the generation of recombinant DNA molecules.  
The following reaction mixture was used: 
 
  25 – 50 ng  vector DNA (digested) 
  30 – 120 ng  insert DNA  
  1 µl  T4 DNA ligase (5 U/µl) 
  1 µl  ligation buffer (10 x) 
  ad 10 µl H2O 
  
The ligation reaction was carried out at RT for 2 hours or at 4°C overnight. 
 
2.12.5 Subcloning of PCR and RT PCR products / TA cloning 
 
(Clark 1988); (Hu 1993) 
 
Taq- and other polymerases possess a terminal transferase activity that results in the 
non-template addition of a single nucleotide to the 3'-ends of PCR products. This 
terminal transferase activity is the basis of the TA cloning strategy. For cloning of PCR 
products, the pGEM-Teasy vector system that has 5‘-dT overhangs was used. For 
products that were amplified with PhusionTM High-Fidelity DNA polymerase (Finnzymes, 
Finland), which does not carry such a terminal transferase activity, the terminal dA had 
to be added before the PCR product could be cloned into the pGEM-Teasy vector. 
Therefore, the following A-tailing reaction was conducted: 
 
  7 µl  PCR product 
  0.7 µl MangoTaq DNA polymerase (1 U/µl) 
  0.3 µl  MgCl2 (50nM) 
  1 µl dATP (2 mM) 
  1 µl 10 x polymerase buffer 
 
The reaction mixture was incubated for 30 min at 70°C.  
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For cloning into the pGEM-Teasy vector 1 – 2 µl of the A-tailing mixture were used in a 
ligation reaction. 
 
  50 ng pGEM-Teasy 
PCR product (3:1, insert : vector ratio) 
1 µl T4 DNA ligase 10 x buffer 
1 µl T4 DNA ligase 
ad 10 µl H2O   
 




For the transformation of competent bacteria a 50 µl aliquot was gently mixed with 3 – 
5 µl of the ligation reaction. After incubation for 20 min on ice, a heat shock was 
performed for 1 min at 42°C. After cooled down on ice for 5 min 200 µl of LB medium 
was added, before the bacteria were incubated on a thermo shaker at 37°C for 45 min. 
Finally, 50 – 200 µl of the transformed bacteria were plated out on LB agar plates 
containing appropriate antibiotics and incubated at 37°C overnight. 
 
2.13  Gel electrophoresis 
 
Gel electrophoresis is a technique that uses an electric field to separate charged 
macromolecules, especially nucleic acids and proteins. The resolution of the separation 
is dependent on the density (percentage) of the gel as well as on the charge to mass ratio 
of the corresponding macromolecule. 
 
2.13.1 Agarose gel electrophoresis of DNA 
 
Agarose gels are used to separate nucleic acid molecules. Depending on the fragment 
size gels with an agarose concentration of 0.5 – 2.0 % (w/v) were prepared. According 
to the gel size the agarose was resolved by boiling in 30 or 60 ml of 1x Turbo buffer. 
DNA Stain G (Serva GmbH, Heidelberg, Germany) was added according to the 
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manufacturer’s instructions, before the agarose gel was poured into a horizontal gel 
chamber. After the gel was completely solidified, gel electrophoresis was performed in 
1x Turbo buffer at a constant voltage between 50 – 200 V. 
 
2.13.2 Length standard 
 
For the determination of DNA fragment length on agarose gels, length standards were 
loaded in parallel. 
 
 1 Kb Plus DNA-ladder  Life Technologies, Darmstadt, Germany 
 
 MassRuler®    MBI Fermentas, St. Leon-Rot, Germany 
 
2.14 Polymerase Chain Reaction (PCR) 
 
(Saiki et al. 1992) 
 
The polymerase chain reaction is an in vitro method to amplify specific DNA fragments. 
This method uses high temperatures to denature double stranded DNA and to allow 
short oligonucleotides (primers) to bind to DNA (annealing). Once bound to single 
stranded DNA these oligonucleotides are extended by the polymerase (elongation). 
These steps of denaturation, annealing and elongation are repeated periodically leading 
to an exponential increase in DNA fragments. Successful amplification can be checked by 
agarose gel electrophoresis. 
 
2.14.1 Amplification of DNA fragments from plasmid DNA 
 
For amplification, a specific pair of primers defined the DNA-region of interest. For the 
amplification of DNA fragments designated for cloning, the Phusion™ High-Fidelity DNA 
polymerase (Finnzymes, Finland), which in addition to its 5’  3’ DNA polymerase 
activity also carries a 3’  5’ exonuclease (proofreading) activity, was used.   
PCR reaction mixture was the following: 
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          Final conc. 
 X µl  template DNA (10 – 50 ng)     
 1 µl   Primer 1 (10pmol/µl, sequence-specific)  0.5 µM 
 1 µl  Primer 2 (10pmol/µl, sequence-specific)  0.5 µM 
 0.4 µl  10 mMdNTPs      200 µM each 
 4 µl   Phusion™ HF Buffer (5 x)    1 x 
 0.2 µl  Phusion™ High-Fidelity DNA Polymerase   0.02 U/µl 
 ad 20 µl ddH2O 
 
25 to 35 amplification cycles were carried out in a Primus 25 advanced Thermocycler 
from Peqlab (Erlangen, Germany) or in a 2720 Thermal Cycler from Applied Biosystems 
(California, USA), respectively. The temperatures, the length of the corresponding PCR 
steps and the number of cycles were accordingly adjusted for every DNA fragment.  
One PCR cycle consisted of: 
 
 Cycle step   Temp. Time   Cycles 
 
Initial denaturation   98°C  30 sec      1 
 
Denaturation   98°C  5 – 10 sec   
Annealing   X°C  10 – 30 sec     25 – 35 
Elongation   72°C  15 – 30 sec /1 Kb  
 
Final elongation  72°C  5 – 10 min 
 
Before the first cycle started there was an initial denaturation of 30 sec at 98°C. After the 
cycles were completed a last elongation step of 7 min at 72°C was ensued. After the run 
was completed, 1 µl of the reaction mixture was mixed with Stop mix and depending on 
the size of the PCR-product loaded onto an 0.5 – 2 % agarose gel. 
 
 
2.14.2 Reverse Transcription 
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The reverse transcription (RT)-PCR is a method that makes use of a reverse 
transcriptase to transcribe RNA into cDNA. The principle of reverse transcription relies 
on the application of an oligo(dT)-primer, which anneals to the poly(A)-sequences of 
mRNAs. Analog to the standard PCR the reverse transcriptase can elongate the strand to 
synthetize cDNA. To generate cDNA from total RNA the SuperScript II (Life Technologies, 
Darmstadt, Germany) was used. Subsequently, the reverse transcribed cDNA was 
subjected to quantitative real time PCR analyses. 
 
The following reaction was performed in three steps: 
 
1.Step:  2 – 5 µg RNA 
   + 0.5 µl oligo(dT)-primer (0.5µg/µl) 
   + 0.5 µl dNTP (10mM) 
   ad 6 µl ddH2O 
   Incubation: 72°C for 10 min  
 
2. Step:  + 2 µl 5x First Strand Buffer 
   + 1 µl DTT (0.1 M) 
   Incubation: 42°C for 2 min 
 
3. Step:  + 0.25 µl SuperScript II 
   + 0.75 µl ddH2O 
   Reverse Transcription: 42°C for 50 min 
   Heat-inactivation: 70°C for 15 min 
   Store at 8°C for ∞ 
 
The synthetized cDNA was checked by PCR using specific primers for the housekeeping-
gene Glyceralaldehyde 3-phosphate dyhydrogenase (GAPDH), before it was subjected to 
quantitative real time PCR analyses. 
 
 
2.14.3 Quantitative real time PCR-analyses 
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The quantitative real time PCR is a method that relies on the basic PCR principle but 
allows the quantification of the PCR product during the PCR. To quantify the DNA a 
fluorescent dye, which is binding unspecifically to double stranded DNA is applied to the 
mixture. In the present study the PCR Mastermix Platinum® SYBR® Green 
qPCRSuperMix-UDG with Rox (Life Technologies, Darmstadt, Germany) was used. The 
rox dye serves as reference to correct for pipetting errors. SYBR® Green, which is bound 
to double stranded DNA can be excited using light of 480 nm wavelength and shows an 
emission spectrum with a maximum at 520 nm. The fluorescent intensity was measured 
after every PCR cycle using the ABI Prism 7900T Sequence Detection System and a 
graph was generated. During the exponential phase of the PCR reaction conditions are 
optimal, meaning that maximum polymerase activity is attained and enough reaction 
materials (Primer, MgCl2) are present. During this phase the threshold value is 
determined, which defines the PCR cycle in which these conditions are met. This value is 
used for further calculations for quantification (Ct value). These data were evaluated 
with the Sequence-detection system software (SDS Version 2.1, PE Applied Biosystems). 
Prior to quantitative real time PCR the cDNA was usually diluted 1:20 in ddH2O.  
The reaction was comprised of the following components: 
 
   2.5 µl cDNA 
   2.5 µl Primer (Fw + Rev 100 pmol/µl) 
   5.0 µl SYBR® Green 
 
The program on the ABI Prism 7900T Sequence Detection System was the following: 
 
   50°C   2 min 
   95°C  3 min  Taq activation 
   94°C  15 sec  Denaturation 
   60°C  30 sec  Annealing 
   72°C  30 sec  Elongation 
   95°C  15 sec 
   60°C  15 sec 
   60°C – 95°C 2°C/min Melting curve 
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After measurement the data was transferred to MS Excel (Microsoft) for further 
calculations. Relative expression was determined by the ΔΔ-Ct-method, which uses the 
following formula: 
 
  ΔCt = Ct (Gene of interest) – Ct (housekeeping gene) 
  ΔΔCt = ΔCt (Control) – ΔCt (Sample of interest) 
Relative expression = 2ΔΔCt 
 
The mRNA expression of the housekeeping genes TATA-binding protein (TBP) and 
Porphobilinogendeaminase (PBGD) was used as a reference. 
 
2.14.4 Sequence analysis / DNA-sequencing after Sanger 
 
The non-radioactive sequencing is based on the principle of chain termination 
developed by (Sanger, Coulson 1975). This method uses four dideoxynucleotides that 
have been labeled with different fluorescent dyes. These dideoxynucleotides do not 
possess a 3’-hydroxy group. In case of incorporation of such a dideoxynucleotide into 
the DNA, this leads to a chain termination. The sequence reaction was performed under 
following conditions: 
 
  1 µl   DNA 
  2 µl  5x Buffer 
1 µl  Sequence-specific Primer (10 pmol/µl) 
1 µl   BigDye® 




Initial denaturation   95°C  1 min    
 
 Denaturation   95°C  30 sec   
         30 cycles 
Annealing   60°C  2.5 min   
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Final elongation  60°C  5 min 
      8°C  ∞ 
 
After completion 10 µl ddH2O were added to the reaction and gel electrophoresis 
through specific capillaries was performed in the automatic sequencer 3500XL (Applied 
Biosystems, Life Technologies, Darmstadt, Germany). 
 
2.15 Protein chemical techniques 
 
2.15.1 Isolation of total protein from cell cultures 
 
For isolation of total protein from cell cultures cultured in 6-well plates or T-25 culture 
flasks, the medium was removed and the cells were washed with ice cold PBS. After 
approx. 150 µl of lysis buffer for protein (modified RIPA) were added the adherent cells 
were scraped off the bottom using a cell scraper or pipet tip and incubated for 5 min on 
ice. The amount of lysis buffer was adjusted to the confluence and size of the culture 
vessel. Next, the lysate was transferred to a microcentrifuge tube and centrifuged at 
16.000 rpm at 4°C for 10 min to pellet cell debris. The supernatant was transferred to a 
new microcentrifuge tube and stored at -20°C after the protein concentration was 
determined. For long-term storage the lysates were kept at -80°C. 
 
2.15.2 Isolation of nuclear extracts 
 
PCa cells were grown on 6-well plates and lysed in 50 µl cytoplasmic extraction buffer 
for 5 min on ice. After centrifugation at 13.000 rpm for 15 sec at 4°C, the supernatants 
were spun again for 5 min at 13.000 rpm and 4°C and the supernatant was collected as 
cytoplasmic extract in a new Microcentrifuge tube. The pellet from the first 
centrifugation was lysed in 50 µl nuclear extraction buffer for 30 min on ice. After 
centrifugation at 13.000 rpm and 4°C for 15 min, the supernatant was collected as 
nuclear extract and either directly used for EMSA or stored at -80°C. 
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Determination of protein concentration was performed using the Roti®-Nanoquant (Carl 
Roth GmbH, Karlsruhe, Germany) according to the method of Bradford. This method is 
suitable for a protein amount ranging from 200 ng to 25 µg and uses the Coomassie 
Brilliant Blue dye. In acidic solution this dye binds unspecifically to cationic and 
hydrophobic site chains of proteins. Upon binding the absorption maximum of this dyeis 
shifted from 495 nm to 595 nm. From measurement of a standard protein concentration 
(bovine serum albumine) a straight calibration line is compiled.  
20 ml of the Roti®-Nanoquant dye (5x) were mixed with 80 ml ddH2O and stored at 4°C. 
Proteins were diluted 1:100 and triplicates of 50 µl of this protein solution were mixed 
with 200 µl 1x Roti®-Nanoquant and incubated for 5 min at RT. Measurement of 
absorption was performed in the SynergyMx plate reader (BioTek, Friedrichshall, 
Germany) and calculated with the appropriate Gene5 software. 
 
2.15.4 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
 
The NuPAGE® Pre-Cast Gel System (Life Technologies, Darmstadt, Germany) was used 
for the separation of proteins. It is a polyacrylamide gel system for high performance gel 
electrophoresis and is based on SDS-PAGE gel chemistry (Laemmli 1970). It consists of 
NuPAGE®Bis-Tris pre-cast gels and specifically optimized buffers which have an 
operating pH of 7.0. This neutral pH increases the stability in both proteins and gels, 
providing increased confidence in electrophoresis results.  
The protein samples, usually 10 – 25 µg were mixed with 0.25 vol sample buffer (LDS 
Sample Buffer (4x), NuPAGE®, Life Technologies, Darmstadt, Germany) and 10 % DTT 
(reducing agent), denatured at 70°C for 10 min, chilled on ice and centrifuged shortly 
before they were loaded onto the gradient gel (NuPAGE®4 – 12 % Bis-Tris Gel, Life 
Technologies, Darmstadt, Germany). Depending on the molecular weight of the proteins, 
gel electrophoresis was performed at 160 V for 1 to 2 hours using the 1 x MES buffer 
(Life Technologies, Darmstadt, Germany). To determine the size of the proteins on a gel, 
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7 µl of a pre-stained molecular weight standard (See Blue® Plus2, Life Technologies, 
Darmstadt, Germany) was loaded. 
 
2.15.5 Transfer of proteins from Polyacrylamide gels to PVDF 
membranes 
 
(Gershoni, Palade 1982); (Gershoni, Palade 1983) 
 
After SDS-PAGE the proteins were transferred to a PVDF membrane using the semi-dry 
blotting technique. Therefore, a PVDF membrane (GE Healthcare, Freiburg, Germany) 
was cut to the size of the polyacrylamide gel and activated by rinsing in 100 % Methanol 
for 5 – 10 sec. Subsequently, the membrane was equilibrated in transfer buffer IIa for 
approx. 10 min. Next, three sheets of Whatman GB003 filter paper (Schleicher & Schull, 
Dassel, Germany) were, as well, cut to the size of the gel and soaked in transfer buffer IIa. 
Finally, three filter papers were placed on the anode (+), followed by the PVDF 
membrane and the gel. The left three filter papers were applied to complete the 
sandwich model and the electro-blotter (Biometra, Göttingen, Germany) was closed, 
putting the cathode (-) on top. The transfer was carried out at 25 V and 220 mA for 30 
min to 1.5 hours at RT, depending on the molecular weight of the proteins. 
 
Fig. 2.1: Schematic overview of a setup of a semi-dry blot. Three sheets of Whatman filter paper are 
placed on the anode (-) followed by the PVDF membrane. The SDS-PAGE gel is placed on top of the 
membrane and covered with three sheets of Whatmann filter paper. The Cathode (-) is completing the 
sandwich model of the semi-dry blot. The applied voltage is forcing the proteins to migrate from the gel 
onto the PVDF-membrane. 
 
Materials and Methods    42 
2.15.6 Staining of polyacrylamide gels 
 
To check for proper protein transfer onto PVDF membranes, SDS-polyacrylamide gels 
were incubated for 1 to 4 hours in Coomassie Brilliant Blue staining solution at RT. 
Afterwards, SDS gels were de-stained in H2O. 
 
2.15.7 Incubation of protein-bound membranes with antibodies 
 
To block unspecific binding sites, the membrane was incubated in blocking buffer 
(Western Blot) for 1 hour at RT. After extensive washing with washing buffer (Western 
Blot), the membrane was incubated with the primary antibody at a recommended 
antibody dilution in TBS-T at 4°C overnight. On the next day, the membrane was washed 
two times for 10 min with washing buffer (Western Blot) to wash off unbound 
antibodies and incubated with the appropriate secondary antibody in blocking solution 
(Western Blot) at RT for approx. 2 hours. After the incubation step, the membrane was 
washed three times for 15 min with washing buffer (Western Blot) and 5 min in TBS/T 
to fully remove any remaining milk. For the detection of the chemi-luminescent signals, 
the ECL Prime detection solution (GE Healthcare, Freiburg, Germany) was used. The 
membrane was placed on a plastic film, the detection solution was pipetted on the 
membrane and incubated for 5 min, before the signals were captured using the Western 
Blot detection system (FlourChem® Q Alpha Innotech, Logan, USA). 
For the detection of proteins using alkaline phosphatase (AP), the secondary antibodies 
were conjugated to alkaline phosphatase. After the membrane was incubated three 
times for 15 min with washing buffer (Western Blot) the membrane was washed with 
AP Buffer at RT for 5 min. Subsequently, the membrane was kept in the dark for the 
incubation in AP Staining solution to visualize protein bands directly on the PVDF 
membrane. The reaction was stopped by washing with washing buffer (Western Blot) 
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Anti-phospho-Caldesmon (Ser-789) 1:2000 1:10000 
Anti-α-Tubulin 1:10000 1:20000 
Anti-Caldesmon 1:1000 1:10000 
Anti-Integrin β1 1:1000 1:10000 




Anti-Leupaxin (N-terminal) 1:1000 1:10000 
 
2.16  Co-Immunoprecipitation 
 
The Co-immunoprecipitation (Co-IP) is a method to study protein-protein interactions. 
A primary antibody directed against the protein of interest is immobilized to e.g. agarose 
or sepharose (beads) through protein A/G. This antibody binds specifically to the 
protein of interest in the protein lysate. In case there is an interaction with another 
protein, it will be co-precipitated during the purification process and can be detected in 
the western blot analyses. To analyze LPXN-CaD interaction, PC-3 cells were plated on T-
75 flasks and transfected with a pCMV-Myc-CaD or pCMV-Myc-LPXN plasmid, 
respectively. 48 hours after transfection the cells were lysed using the lysis buffer for 
protein (modified RIPA) and protein concentration was determined. For Co-IP 2 mg of 
protein lysate were incubated with 10 µg of the cmyc Tag antibody (Sigmal-Aldrich, 
Deisenhofen, Germany) at 4°C over night. On the next day, 20 µl of resuspended protein 
A/G PLUS (Sanat Cruz Biotechnology, Heidelberg, Germany) was added and the mixture 
was incubated for 1 hour at RT to precipitate the cmyc fusion protein from the lysate. 
Centrifugation at 1.000 x g pelleted the beads and the supernatant was removed. Next, 
the beads were washed three times in DPBS (PAN, AIdenbach, Germany) and boiled at 
95°C for 10 min, which reversed the binding of the antibody to the beads. The protein of 
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interest containing supernatant was subjected to western blot analysis. In case of 
interaction, the interacting protein will be co-precipitated and can be detected in the 
subsequent western blot. 
 
2.17  Duolink® II Proximity Ligation Assay (PLA) 
 
The PLA is an immunocytochemical method that enables visualization of protein-
protein-interactions directly (in situ) in the fixed cell. Therefore, specific primary 
antibodies detect both proteins of interest. Importantly, both antibodies need to be 
raised in different species in order for the secondary antibody to bind to only one target. 
Next, specific secondary antibodies labeled with single stranded DNA detect these 
primary antibodies. The conjugated DNA sequences of the secondary antibodies are 
designated as plus (+) and minus (-). Two linker oligonucleotides that are 
complementary to the DNA sequences of the secondary antibodies help to form a 
circular structure. The length of the DNA fragments determines the proximity of the 
interacting proteins. Only when proteins are interacting (<40 nm) a hybridization of the 
DNA sequences is possible. The circular DNA structure is closed by a ligase-reaction. 
Now a DNA-polymerase can amplify the DNA-ring in rolling circle PCR. Finally, a 
fluorescently labeled probe detects the specific DNA sequence, which results in a 
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Fig. 2.2: Schematic overview of the Duolink® II Proximity Ligation Assay. 1) Proteins of interest are 
detected with primary antibodies raised in different species. 2) The primary antibodies are detected by 
specific, DNA-labeled secondary antibodies. 3) The addition of two linker oligonucleotides that are 
complementary to the DNA sequences of the secondary antibodies form a circular DNA structure. 4) The 
circular DNA structure is closed by a ligation-reaction. 5) A DNA-polymerase amplifies the DNA ring in a 
rolling circle PCR. 6) The amplified DNA fragments are detected by a fluorescently labeled DNA probe 
directly at the site of interaction. The fluorescent signal can be detected by fluorescent microscopy. Taken 
and modified from Duolink® II User Manual v. 21 2011, Olink Bioscience, Uppsala, Sweden. 
 
2.17.1 PLA on cells 
 
To simply test for interaction of two proteins, PLA was performed on PC-3 cells. 
Therefore, 4 x 104 cells were plated on a 4-well culture slide (Becton Dickinson GmbH, 
Heidelberg, Germany). After 24 hours cells were washed gently with DPBS (PAN, 
Aidenbach, Germany) and cells were fixed using 3.7 % formaldehyde in DPBS at RT for 
20 min. Next the cells were washed with DPBS at RT for 10 min before the membrane 
was permeabilized with 0.1 % Triton-X-100 solution for 10 min. After this the cells were 
washed in DPBS at RT for 10 min. To block unspecific binding sites for antibodies, the 
cells were incubated in blocking buffer (PLA) for 30 min. Subsequently, the primary 
antibodies were diluted in blocking buffer (PLA) to the corresponding concentration and 
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incubated at 4°C over night. Primary antibodies used for PLA are listed in the following 
table. 
 


















Anti-p44/42 MAPK (ERK1/2), 
rabbit 
1:75 
Cell Signaling, Danvers, MA, 
USA 
Anti-phospho-p44/42 MAPK 
(ERK1/2) (Thr202/Tyr204), rabbit 
1:150 
Cell Signaling, Danvers, MA, 
USA 




The continuous work was performed according to the manufacturer’s instructions. To 
visualize the actin-cytoskeleton of the cells, 0.5 ng/ml FITC-conjugated Phalloidin was 
added to the solution of the secondary antibodies. Finally, the slide was dried at RT and 
kept in the dark until it was mounted in Vectashield/DAPI and sealed using nail polish. 
The slides were stored at -20°C. The pictures were captured using the confocal laser-
scanning microscope FluoView1000 (Olympus, Hamburg, Germany).  
To analyze protein-protein interactions during migration, PLA was combined with a 
scratch assay. Therefore, PC-3 cells were plated to 4-well culture slides (Becton 
Dickinson GmbH, Heidelberg, Germany) and grown to confluence. When confluence was 
reached, a scratch was applied into the cell layer using a yellow pipet tip. After the 
scratch was applied, the cells were incubated for 18 hours until they were fixed in 3.7 % 
formaldehyde. During that time cells were migrating into the scratch and relevant 
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protein-protein interactions during cell migration can be analyzed. The subsequent 
steps followed the protocol of the manufacturer and did not differ from the described 
steps above. 
 
2.18  Electrophoretic mobility shift assay (EMSA) 
 
The EMSA is a method that is mainly used to identify DNA-binding proteins. The 
principle of EMSA uses the cage effect of the gel matrix, which slows down the migration 
speed of large complexes (e.g. DNA-bound proteins) through the gel, whereas small 
fragments (e.g. unbound oligonucleotides) are migrating faster. Usually, radioactively 
labeled DNA probes are used to visualize this gel shift, that’s caused by the different size 
of DNA and DNA-protein complex. 
 
2.18.1 Casting of PAGE gels for EMSA 
 
For the EMSA experiment 4.8 % PAGE gels were casted. Therefore, the following 
reaction was prepared for two gels: 
 
   61 ml ddH2O 
   9.0 ml Rotiphorese® (40, Acrylamide/Bisacrylamide 29:1) 
   3.6 ml 5xTBE 
   1.5 ml 10 % APS 
   75 µl TEMED 
 
After approx. 15 min the polymerization was completed. Next the gels were pre-
equilibrated in 0.25x EMSA Running Buffer at 400 V for 2 hours.  
 
2.18.2 Radioactive labeling using 5’-fill-in reaction 
 
In the present study α-33P dATP was used to label the double stranded oligonucleotides 
in a 5’-fill-in reaction.  
   1µl  Oligonucleotide (1pmol/µl) 
   6µl  α-33PdATP (10mCu/ml) 
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   5µl  10x Klenow Buffer 
   1 µl  Klenow-Polymerase 
   37 µl  ddH2O   
   50 µl 
 
The reaction was incubated at RT for 25 min. After incubation unbound α-33PdATP 
nucleotides were removed from the reaction using the MicroSpin columns (GE 
Healthcare, Munich, Germany) according to the manufacturer’s instructions. 
 
2.18.3 Gelshift reaction 
 
To analyze DNA-binding the following gel shift reaction was prepared in a master mix 
for all protein lysates: 
 
   4 µl ddH2O 
   2.5 µl 5x EMSA Shift Buffer 
   0.5 µl Poly(dIdC) (2mg/ml) 
   1.3 µl 100 mM DTT 
0.2 µl  radioactively labeled DNA probe 
    
The individual gel shift reactions were prepared by adding 4.5 µl of the protein lysate to 
8.5 µl of the Master mix. Depending on whether or not a supershift was induced 1 – 2 µl 
of the corresponding antibody (STAT1-specific antibody C-24, Santa Cruz Biotechnology, 
Heidelberg, Germany) was added to the reaction. The mixture was incubated at RT for 
20 min before it was loaded onto the pre-equilibrated gel and run at 400 V. To estimate 
the migration speed of the complexes a bromphenol blue marker was loaded in parallel 
and the gel was stopped when it reached the end of the gel. Finally, the glass plates that 
held the gel were removed and the gel was placed on Whatman filter paper and vacuum-
dried. Binding activity was visualized with the phosphoimaging system Fujifilm FLA-
5100 (Fuji Life Science, Düsseldorf, Germany) using the computer programs Aida Image 
Analyzer v. 4.06 and TINA version 2.0 (Raytest, Straubhardt, Germany).  
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2.19 Cell biological methods 
 
2.19.1 Cell culture of eukaryotic cells 
 
Adherent growing PC-3, DU145 and LNCaP cells were grown in commercially purchased 
RPMI 1640 medium (PAN-Systems GmbH, Nuremberg, Germany), which was 
supplemented with 1.2 % Penicillin/Streptomycin (PAN-Systems GmbH, Nuremberg, 
Germany) and 10 % fetal bovine serum (PAN-Systems GmbH, Nuremberg, Germany) in 
surface-treated cell culture flasks (Sarstedt, Nümbrecht, Germany). The cells were 
cultured at 37°C in a humidified incubator with 5 % CO2. Depending on the proliferation 
rate, cells were splitted one to two times per week. Therefore, cells were washed with 
DPBS (PAN-Systems GmbH, Nuremberg, Germany) and incubated at 37°C in a minimal 
amount of Trypsin/EDTA (PAN-Systems GmbH, Nuremberg, Germany) until the cells 
detached from the bottom of the culture flask. This process was controlled under an 
inverted microscope. After detachment, the Trypsin-reaction was stopped by the 
addition of growth medium and the cells were diluted in fresh culture medium by 1:5 to 
1:10. 
 
2.19.2 Cryo-preservation and revitalization of eukaryotic cells 
 
Cells were grown to a confluence >80 %, washed with DPBS (PAN) and trypsinized to 
detach cells from the bottom of the culture vessel. Cells were centrifuged at 500 x g for 5 
min to remove remaining trypsin and resuspended in an appropriate amount of culture 
medium containing 10 % DMSO. The cells were then slowly cooled to -80°C (1°C/min) in 
a freezer using the Mr. Frosty (Thermo Scientific, Langenselbold, Germany). After seven 
days at -80°C the cells were transferred to liquid nitrogen for long term storage. For 
revitalization, frozen cells were quickly thawed, spun down at 200 x g for 3 min and the 
supernatant was aspirated. The cells were gently resuspended into pre-warmed culture 
medium, transferred into a culture flask and incubated overnight. On the next day, 
medium was changed in order to fully remove remaining amounts of DMSO. 
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2.19.3 Test for Mycoplasma contamination 
 
Mycoplasma contamination was routinely performed monthly using the MycoAlert® 
Mycoplasma Detection Kit (Lonza, Cologne, Germany) according to the manufacturer’s 
instructions except that only half of the recommended amounts was used. This test is 
based on the measurement of the activity of mycoplasma-specific enzymes before and 
after application of specific substrates. 
 
2.19.4 Transfection of eukaryotic cells 
 
2.19.4.1 Transfection of plasmids into eukaryotic cells 
 
Eukaryotic cells were transfected with plasmids in order to induce an overexpression of 
fusion proteins. The transfection reagent X-tremeGENE HP (Roche, Mannheim, 
Germany) is a unique non-liposomal reagent, free of animal-derived components and is 
able to form reagent-DNA complexes. Upon contact to the cell membrane the cell takes 
up the DNA. Only cells that were in a growth phase were used for transfection 
experiments. Cells were plated out on special 4-well slides and 6- or 96-well culture 
plates in RPMI 1640 medium, supplemented with 10 % FBS, 24 hours before 
transfection. On the following day, when the cells reached a confluence of approx. 70 – 
90 %, DNA and transfection reagent were mixed according to the manufacturer’s 
instructions, incubated for 30 min at RT and gently added directly into the culture 
medium. Afterwards, the cells were incubated for 24 – 72 hours under normal culture 
conditions.  
 
2.19.4.2 Transfection of small interfering RNA (siRNA) into 
eukaryotic cells 
 
siRNAs are small RNA-oligonucleotides that specifically bind to a certain mRNA and 
mark them for degradation resulting in reduced gene expression (gene silencing).  
For transfection of PCa cells with gene-specific siRNA-duplex-oligonucleotides the 
siRNA-transfection reagent OligoFectamine™ (Life Technologies, Darmstadt, Germany) 
was used according to the manufacturer’s instructions with a final concentration of 
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siRNA-duplexes of 80 mM. This reagent forms complexes of lipids and oligonucleotides 
that facilitate uptake of RNA molecules into mammalian cells. As a control PCa cells were 
transfected with siRNA-duplex-oligonucleotides against the luciferase gene of Photinus 
pyralis. 
For the transfection PCa cells were plated either in T-25 or T-75 culture flasks and 
grown to 50 % confluence. On the next day, the reaction was pipetted according to the 
manufacturer’s instructions and incubated for 25 min at RT. During this time the cells 
were washed with DPBS (PAN, Aidenbach, Germany) and OptiMEM I (Life Technologies, 
Darmstadt, Germany) was added to each well before the transfection complexes were 
applied dropwise. Cells were then cultured in an incubator at 37°C and 5 % CO2 for 8 – 
12 hours before the medium was replaced by normal growth medium. At different time 
points after transfection of the cells total protein or total RNA was isolated or cells were 
subjected to colony formation assays. 
 
2.20 Luciferase measurement 
 
For luciferase measurement the P.J.K. luciferase assay system (P.J.K., GmbH, 
Kleinblittersdorf, Germany) was used. To assess transfection efficiency cells were 
transfected with pRL-luc (Promega, Wisconsin, USA), which expresses the renilla 
reniformis luciferase. Before measurement the transfected cells were lysed using 40 µl 
lysis-juice 2 (without detergents) per well. After 10 min incubation on ice 20 µl of each 
well were transferred to two flat-bottomed lightproof (white) 96-well plates. Using the 
SynergyMx plate reader (BioTek, Friedrichshall, Germany) 25 µl of Beetle Juice were 
pipetted to each well and luminosity was measured. For renilla luciferase 25 µl of Renilla 
Juice were used. 
 
2.21 Analysis of reporter gene measurements 
 
The values obtained from the luciferase measurement were transferred to MS Excel 
(Microsoft) to calculate the transfection efficiency (firefly/renilla) and activation of the 
reporter gene. 
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2.22 Specificity protein-1 (Sp1) reporter assay 
 
To assess the activity of the Sp1 protein the Cignal™ Reporter Assay (Qiagen, Hilden, 
Germany) was used. For the reporter assay PC-3, DU145 and LNCaP cells were 
transfected with a combination of the reporter plasmid and the pEGFP-LPXN plasmid to 
assess the function of LPXN overexpression on SP1 activity. To analyze the effect of 
LPXN knockdown, a sequential transfection was performed consisting of a first 
transfection with siRNA against the LPXN gene and a second transfection with the 
reporter plasmid on the next day. All transfection mixtures contained a pCMV-Renilla 
luciferase plasmid to determine the transfection efficiency. Further steps were 
performed according to the manufacturer’s instructions. Luciferase measurement was 
performed like described earlier. 
 
2.23 Functional analysis of eukaryotic cells 
 
2.23.1 Colony formation assay 
 
In the present study colony formation assays were performed to determine the cell 
survival in response to irradiation. Depending on the irradiation dose siRNA-transfected 
or untransfected PC-3, DU145 and LNCaP cells were plated in normal growth medium 
on 6-well plates at the following densities 24 hours before they were exposed to 
different irradiation intensities:  
 
0 Gy  200 cells 
  2 Gy  500 cells 
   4 Gy  750 cells 
   8 Gy  1000 cells 
 
After colony formation after approx. 8 – 10 days the cells were fixed in ethanol for 20 
min and stained using a hematoxylin/eosin staining solution. The colonies were counted 
on a light table. 
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2.24 In vivo-studies 
 
2.24.1 Generation of a conditional LPXN knockout mouse model 
 
Mammalian embryos possess the ability to incorporate cells of foreign origin and 
produce chimeras. This ability has been used in a variety of purposes including the 
generation of knockout mouse models. For the generation of a conditional LPXN 
knockout mouse model, mutant ES cells were purchased from the European Conditional 
Mouse Mutagenesis program (EuCOMM). These ES cells were carrying a targeted trap 
construct in the LPXN gene, leaving the opportunity for the generation of knockout, 
conditional knockout and reporter mouse lines. 
 
2.24.2 FLP recombination of LPXN knockout ES cells 
 
In order to achieve the conditional allele, the reporter/resistance cassette has to be 
removed by FLP recombination. This work was done in close cooperation with Prof. Dr. 
rer. nat. Ibrahim Adham (Department of Human Genetics, Göttingen, Germany). In brief, 
the mouse ES cells were cultured on a feeder layer in normal ES cell medium and 
transfected with the pCAGGS-FLPe plasmid to express the FLP-recombinase. 
Recombination was checked on isolated DNA. In case of positive recombination ES cells 
were used for blastocyst injection. 
 
2.24.3 Blastocyst injection 
 
The injection of the LPXN knockout ES cells was performed in cooperation with Dr. 
Ursula Fünfschilling (Max Planck Institute of Experimental Medicine, Göttingen, 
Germany). For the blastocyst injection wild type C57BL/6 females were sacrificed and 










3.1 The interaction of LPXN with caldesmon and it’s relevance for 
PCa cell migration 
 
In previous studies of our research group the actin-binding protein caldesmon (CaD) 
was identified as an interaction partner of LPXN (von Hardenberg, 2010). In addition, 
we could show that downregulation of LPXN decreased the phosphorylation of CaD at 
S534 corresponding to the low molecular mass isoform of CaD (l-CaD). 
In the present study we were interested in the confirmation of the interaction of LPXN 
and CaD. Furthermore, the relevance of this interaction regarding the de-/stabilization 
of the actin-cytoskeleton was investigated. In addition, we analyzed how the changes in 
CaD phosphorylation status are implicated in this process. 
 
3.2 Confirmation of LPXN-CaD interaction  
 
3.2.1 Co-immunoprecipitation of LPXN and l-CaD 
 
In the aforementioned studies the interaction of LPXN and CaD was detected by a GST-
pulldown experiment. To confirm this interaction in cells a co-immunoprecipitation was 
conducted on whole protein lysate of PC-3 cells, isolated 48 hours after transfection with 
pCMV-myc-CaD or pCMV-myc-LPXN, respectively. Precipitation with a CaD-specific 
antibody followed by immunoblotting using a LPXN-specific antibody showed a specific 
band at 45 kDa, which was not detectable in the pCMV-myc transfected control sample, 
meaning that LPXN was successfully precipitated from the lysate (Fig. 3.1). In addition, 
reciprocal co-immunoprecipitation with a LPXN-specific antibody and immunoblotting 
using a CaD-specific antibody (77kDa) verified the interaction of LPXN and CaD (Fig. 3.1). 
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Fig. 3.1: The actin-binding protein CaD is interacting with LPXN. The interaction was visualized by 
immunoprecipitation of CaD from PC-3 whole protein lysate with a CaD-specific antibody and 
immunoblotting using a LPXN-specific antibody (upper panel). Reciprocal co-immunoprecipitation with a 
LPXN-specific antibody and immunodetection using a CaD-specific antibody confirmed the interaction 
(bottom panel). Antibodies detected specific bands for the low molecular mass isoform of CaD (l-CaD) at 
77 kDa and for LPXN at 45 kDa in the samples as well as in the input controls. As negative control lysate 
from pCMV-myc transfected cells was used (modified from Dierks et al. 2015).   
 
3.2.2 In situ Proximity ligation assay (PLA) of LPXN and CaD 
 
In order to verify LPXN and CaD interaction an in situ proximity ligation assay (PLA) 
using rabbit anti-LPXN and mouse anti-purified-l-CaD antibodies was performed. The in 
situ PLA could confirm the interaction of LPXN and CaD in both PC-3 and DU145 PCa 
cells. Interactions are indicated as red dots, DNA was stained using 4’,6-diamidin-2-
phenylindol (DAPI) and F-actin was visualized by fluorescein isothiocyanate (FITC)-
conjugated phalloidin (Fig. 3.2). PC-3 and DU145 cells were analyzed by confocal laser 
scanning microscopy. Interactions showed a very evenly distributed pattern in non-
stimulated and non-migrating cells. 
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Fig. 3.2: In situ Proximity ligation assay (PLA) of PC-3 cells showing LPXN-CaD interaction. To 
visualize LPXN-CaD interaction, PC-3 cells were plated on glass culture slides, fixed and subjected to in situ 
PLA using polyclonal rabbit anti-LPXN and monoclonal mouse anti-purified l-CaD antibodies. LPXN-CaD 
interactions are visualized as red dots, confirming an interaction of CaD and LPXN. FITC-conjugated 
phalloidin stained F-actin (green), whereas DNA was stained with DAPI (blue). Cells were analyzed by 
confocal laser scanning microscopy using the Olympus FluoView1000 confocal scanning microscope at a 
600-fold magnification. For better visualization, the picture was zoomed in. 
 
 
3.3 Increased interaction of LPXN and CaD during PCa cell 
migration 
 
To further analyze LPXN-CaD interaction in situ, PC-3 and DU145 cells were plated on 4-
well glass culture slides and grown to confluence. For the next steps we combined a 
scratch assay with the PLA technique. Therefore, the confluent cell layer was scratched 
using a yellow pipet tip. After 18 hours of migration into the scratch cells were fixed in 
3.7 % formaldehyde followed by in situ PLA using rabbit anti-leupaxin and mouse anti-
purified l-CaD antibodies. F-actin was stained using FITC-conjugated phalloidin and cells 
were mounted in DAPI-containing medium to visualize nuclei. Confocal laser scanning 
microscopy revealed that by combination of these two methods there were increased 
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interactions of both proteins during cell migration of PCa cells as compared to cells that 




Fig. 3.3: Increased interaction of LPXN and CaD during migration. To investigate LPXN and CaD 
interaction during migration, a combination of scratch assay and in situ PLA was performed. To this end, 
PC-3 cells were plated on glass culture slides, grown to confluence and a scratch was applied into the cell 
layer. Cells were fixed after 18 hours and in situ PLA was performed using specific mouse anti-LPXN and 
rabbit anti-CaD antibodies. Confluent cells did not show high numbers of interaction, whereas cells that 
migrated into the scratch showed increased interactions. Blue arrows indicate the direction of migration, 
the scratch is depicted by the red arrow. Nuclei and F-actin were stained using DAPI and FITC-conjugated 
phalloidin, respectively. Images were captured at a 600-fold magnification using the Olympus 
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3.4 Increased interaction of LPXN and phosphorylated CaD during 
PCa cell migration 
 
After downregulation of LPXN expression we could show diminish phosphorylation of 
CaD pointing towards a regulation of CaD phosphorylation by LPXN (von Hardenberg, 
2010). To this end, we performed in situ PLA using mouse anti-LPXN and a 
phosphorylation site-specific rabbit anti-phospho-CaD S789 antibodies to see if 
phosphorylated CaD shows a different interaction pattern with LPXN than 
unphosphorylated CaD. For this purpose, PC-3 and DU145 cells were plated on 4-well 
glass culture slides and the experiment was performed as described in Materials and 
Methods 2.17. S789-phosphorylated CaD did not display different interaction patterns 
with LPXN during migration of PCa cells compared to unphosphorylated CaD (Fig. 3.4). 
Likewise, migrating cells had increased interactions, whereas confluent and non-
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Fig. 3.4: Increased interaction of LPXN and pCaD during migration. Investigation of LPXN and pCaD 
interaction during migration was carried out by a combination of scratch assay and in situ PLA. Therefore, 
PC-3 cells were plated on glass culture slides, grown to confluence and a scratch was applied into the cell 
layer. Cells were fixed after 18 hours and in situ PLA was performed using specific mouse anti-LPXN and 
rabbit anti-phospho-CaD S534 antibodies. Confluent cells showed only weak interactions, whereas cells 
that migrated into the scratch showed increased interactions. Blue arrows indicate direction of migration, 
the scratch is depicted by the red arrow. Nuclei and F-actin were stained using DAPI and FITC-conjugated 
phalloidin, respectively. Images were captured at a 600-fold magnification using the Olympus 
FluoView1000 confocal scanning microscope (modified from Dierks et al. 2015). 
 
3.5 Localization of pCaD-LPXN interaction during migration of PCa 
cells 
 
In order to analyze the subcellular localization of the CaD/pCaD-LPXN interactions 
during PCa cell migration, PC-3 and DU145 cells were plated on glass culture slides and 
a scratch was applied into the confluent cell layer. After 18 hours cells were fixed and 
the in situ PLA was performed. Migrating cells clearly showed interactions of LPXN and 
pCaD in areas of dynamic actin structures, whereas they were nearly absent from the 
leading edge of the migrating cell, where the actin-cytoskeleton needs to be stabilized 
(Fig. 3.5). 
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Fig. 3.5: In situ PLA visualized the localization of pCaD-LPXN interactions in migrating PC-3 cells. 
pCaD interaction with LPXN on celllular level was analyzed by in situ PLA on migrating PC-3 cells. Cells 
were grown on glass culture slides to about 50 % confluence. On the next day the cells were fixed and in 
situ PLA was performed using specific mouse anti-LPXN and rabbit anti-phospho-CaD S534 antibodies. 
As indicated by red dots, interactions of pCaD and LPXN during migration are located to regions of 
dynamic actin structures. At the leading edge of the cells as well as at stabilized actin filaments there were 
no interactions detectable (red dots). Nuclei were visualized by DAPI staining. F-actin was stained using 
FITC-conjugated phalloidin. The arrow indicates direction of migration. Images were captured using the 
Olympus FluoView1000 confocal scanning microscope at a 600-fold magnification and zoomed to 
visualize migrating cells (modified from Dierks et al. 2015). 
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3.6 LPXN interacts with the extracellular signal-regulated kinase 
(ERK) 
 
F-actin-binding of l-CaD in non-muscle cells is mainly regulated in a phosphorylation-
dependent manner. Since LPXN does not carry any kinase activity, phosphorylation of 
CaD has to be carried out by a kinase that is recruited to phosphorylate CaD during cell 
migration.  
From the literature there are several kinases known to phosphorylate CaD specifically 
on the phosphorylation site S789 of h-CaD / S534 of l-CaD responsible for actin affinity. 
Among these kinases are the p38 mitogen-activated protein kinase (MAPK) and the 
extracellular signal-regulated kinase (ERK) (Jeon 2009). From previous experiments 
including the antibody array KAM 850 (Kinexus, Canada) we know that TGF-beta 
activated kinase 1 (TAK1) is downregulated after LPXN knockdown (von Hardenberg, 
2010). TAK1 was shown to activate JNK and p38 MAPK through phosphorylation. 
However, only JNK and ERK showed reduced phosphorylation after LPXN knockdown, 
and ERK was already described to be associated with migration-dependent 
phosphorylation at the actin binding sites of CaD (D'Angelo et al. 1999, Roman et al. 
2014). In addition, previous experiments in our research group found that LPXN 
knockdown resulted in reduced phosphorylation of ERK (Kaulfuß, 2006). Therefore, we 
hypothesize that ERK is the kinase responsible for LPXN-mediated phosphorylation of 
CaD during cell migration. To test our hypothesis we investigated a putative interaction 
of ERK and LPXN in both PC-3 and DU145 cells using in situ PLA. Therefore, PC-3 and 
DU145 cells were plated on 4-well glass culture slides and fixed in 3.7 % formaldehyde 
after 24 hours of culture in normal culture medium. Figure 3.6 clearly shows the 
interactions of LPXN and ERK, as indicated by the red dots.  
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Fig. 3.6: In situ PLA of PC-3 cells showing interaction of ERK and LPXN. To test whether ERK is the 
kinase that is mediating the phosphorylation of CaD an in situ PLA was performed using polyclonal rabbit 
anti-ERK1/2 and mouse anti-LPXN antibodies. PC-3 and DU145 cells were plated on glass culture slides, 
fixed in 3.7 % formaldehyde and in situ PLA was performed. Red dots clearly indicate interaction of ERK 
and LPXN. F-actin was stained using FITC-conjugated phalloidin (green). DAPI visualized the nucleus 
(blue). Images were captured at a 600-fold magnification using the Olympus FluoView1000 confocal 
scanning microscope and zoomed in for better visualization. 
 
3.7 Basal expression of ERK in PCa cell lines PC-3, DU145 and 
LNCaP 
 
The deregulation of the MAP kinase pathway is a common feature in a wide variety of 
cancers. As ERK is a major component of this pathway and seems to be involved in the 
LPXN-mediated phosphorylation of CaD, the expression and activation status of ERK 
was analyzed in PCa cell lines. Therefore, whole protein lysates of PC-3, DU145 and 
Results    63 
LNCaP cells were immunoblotted using specific anti-ERK and anti-pERK antibodies. 
Among all cell lines, there was a quite equal expression of ERK, whereas only DU145 
showed activated levels of ERK (pERK) (Fig. 3.7). 
 
Fig. 3.7: Basal ERK expression and activation status in PCa cells. Immunoblotting of whole protein 
lysate of PC-3, DU145 and LNCaP cells using specific-ERK and pERK antibodies revealed equal levels of 
ERK in all cell lines. Among the PCa cell lines tested only DU145 cells showed activated ERK (pERK).  
Immunostaining of α-tubulin ensured equal protein loading. 
 
3.8 Increased interaction of LPXN and ERK during PCa cell 
migration 
 
Having shown a clear interaction of LPXN and phospho-CaD and of LPXN and ERK 
during migration of PC-3 cells, we analyzed whether LPXN-ERK interaction is also 
induced by and relevant for migration. Therefore, cells were plated on 4-well glass 
culture slides and scratches were applied into a confluent PC-3 cell layer. After 18 hours, 
cells were fixed and in situ PLA was carried out using specific mouse anti-LPXN and 
rabbit anti-ERK antibodies. Similar to the pattern of LPXN-CaD/pCaD interactions an 
increased interaction of LPXN and ERK in migrating cells compared to confluent or non-
migrating cells (Fig. 3.8) was observed. Interestingly, we also found the same interaction 
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Fig. 3.8: In situ PLA of migrating PC-3 cells showing ERK-LPXN interactions during PCa cell 
migration. To analyze ERK-LPXN interaction during migration of PC-3 cells, a combination of a scratch 
assay and in situ PLA was performed. Therefore, PC-3 cells were plated on glass culture slides, grown to 
confluence and a scratch was applied into the cell layer. After 18 hours, cells were fixed and an in situ PLA 
was performed using specific mouse anti-LPXN and polyclonal rabbit anti-ERK1/2 antibodies. Migrating 
cells showed increased interactions compared to non-migrating and confluent cells indicated by red dots. 
Nuclei (blue) and F-actin (green) were visualized using DAPI and FITC-conjugated phalloidin, respectively. 
Images were captured at a 600-fold magnification using the Olympus FluoView1000 confocal scanning 
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Fig. 3.9: In situ PLA of migrating PC-3 cells showing increased interaction of LPXN and pERK. LPXN 
and pERK interaction was analyzed by a combination of a scratch assay and in situ PLA. PC-3 cells were 
plated on glass culture slides and grown to confluence before a scratch was applied into the cell layer. 
After 18 hours, cells were fixed and an in situ PLA was performed using specific anti-LPXN and anti-
pERK1/2 antibodies. Migrating cells showed increased interactions compared to non-migrating and 
confluent cells indicated by red dots. Nuclei (blue) and F-actin (green) were visualized using DAPI and 
FITC-conjugated phalloidin, respectively. Images were captured at a 600-fold magnification using the 
Olympus FluoView1000 confocal scanning microscope (modified from Dierks et al. 2015).  
 
3.9 LPXN mediates phosphorylation status of CaD through 
interaction with ERK 
 
To further investigate if ERK is the kinase that is recruited to phosphorylate CaD during 
migration, PC-3 cells were treated with a combination of the MEK1 (mitogen-activated 
protein kinase kinase 1)-specific inhibitor PD98059, which blocks activation of ERK by 
its upstream kinase MEK1 and the epidermal growth factor (EGF) to induce ERK 
activation. In the subsequent western blot analysis of the protein lysates using a 
phosphorylation site-specific anti-phospho-CaDS789 antibody reduced levels of pCaD in 
Results    66 
PD98059 treated cells were observed, which could not be prevented or attenuated by 
EGF stimulation (Fig. 3.10). Notably, reduction of CaD phosphorylation could not be 
further enhanced by a downregulation of LPXN expression. Levels of unphosphorylated 
CaD remained equal. Reduced pERK levels in PD98059 treated cells indicated the 
functionality of the inhibitor. It is worth to note that ERK activation was reduced after 
LPXN knockdown, which underlines the hypothesis that ERK is mediating the 




Fig. 3.10: Phosphorylation status of CaD in PC-3 cells after LPXN knockdown and MEK-1 inhibition. 
PC-3 cells plated on 6-well paltes and transfected with siRNA against the LPXN (siLPXN) or luciferase 
(siLuc) gene as a control. On the next day the cells were treated with the MEK1-specific inhibitor PD98059 
for 1 hour, or EGF or a combination of both. Protein lysates were isolated 20 min after EGF stimulation 
and subjected to western blot analyses using specific antibodies for phospho-CaD S789, phospho-ERK1/2 
and α-tubulin. Knockdown of LPXN reduced phosphorylation levels of CaD and notably of ERK. Prevention 
of CaD-phosphorylation by inhibition of MEK-1 using the PD98059 inhibitor also showed reduced 
phosphorylation of CaD, but had no additional effect to LPXN knockdown (modified from Dierks et al. 
2015). 
 
3.10  The influence of LPXN on PCa cell adhesion 
 
In previous studies from our research group LPXN was shown to exert dramatic effects 
on the adhesion of PCa cells (von Hardenberg, 2010). Integrins are major components of 
the adhesion process. Therefore, the expression levels of several integrins were 
investigated. Out of this analyses the deregulation of several integrins was observed, 
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especially the expression of the integrin β1 gene (ITGB1), a major player of cell adhesion 
was correlating with LPXN expression (Hitzing, 2010). 
 
3.10.1 Expression of ITGB1 in the established PCa cell lines PC-3, 
DU145 and LNCaP 
 
The expression of ITGB1 was analyzed in the established PCa cell lines PC-3 DU145 and 
LNCaP using real time RT-PCR as well as western blot analysis. These analyses revealed 
that on the RNA as well as on the protein level the androgen-independent and highly 
invasive cell lines PC-3 and DU145 showed the highest expression of ITGB1. Whereas, 
androgen-dependent and non-invasive LNCaP cells showed rather weak expression 
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Fig. 3.11: Basal β1 integrin expression in the PCa cell lines PC-3, DU145 and LNCaP. (A) PC-3, DU145 
and LNCaP cells were plated on 6-well plates and total RNA was isolated, reverse transcribed and 
subjected to qRT-PCR. PC-3 and DU145 showed an approx. 12-fold increase of β1 integrin expression 
compared to LNCaP cells. (B) Western blot analysis was performed on whole protein lysates from 
untreated PC-3, DU145 and LNCaP cells with specific β1 integrin antibody. α-tubulin served as a protein 
loading control. The highly invasive and androgen-independent cell lines PC-3 and DU145 showed the 
highest β1 integrin expression, whereas the non-invasive and androgen-dependent LNCaP cells showed 
only a moderate expression of β1 integrin. 
 
3.10.2 Leupaxin influences ITGB1 expression 
 
To further investigate the influence of LPXN on ITGB1 expression, LPXN expression was 
downregulated in PC-3 and DU145 cells by RNA interference. Protein and RNA was 
isolated 48 hours after transfection. Luciferase siRNA transfected cells served as a 
control. Quantitative real time PCR (qRT-PCR) was performed using specific primer 
pairs for LPXN (LPXN-CDS-F1 and LPXN-CDS-R1) and ITGB1 (ITGB1-Q2-Fw and ITGB1-
Q2-Rev), respectively. A reduced expression of ITGB1 in PC-3 and DU145 cells was 
shown (Fig. 3.12A). This reduction of ITGB1 expression was also observed on the 
protein level (Fig. 3.13B). 
 
 




Fig. 3.12: Integrin β1 expression after down regulation of LPXN expression. (A) To analyze ITGB1 
expression after LPXN knockdown, PC-3 and DU145 cells were transfected with siRNA against the LPXN 
gene (siLPXN) and the luciferase gene as a control (siLuc). 48 hours after transfection total RNA was 
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isolated and subsequently subjected to qRT-PCR using the specific primer pairs LPXN-CDS-F1 and LPXN-
CDS-R1 as well as ITGB1-Q2-Fw and ITGB1-Q2-Rev. ITGB1 expression is reduced after LPXN knockdown 
in all PCa cell lines. The illustrated values represent an average of three independent experiments, which 
were measured in duplicate. * are indicating statistical significance as judged by students t-test (p≤0.05 
(*); p≤0.001 (**); p≤0.0001 (***); n.s.= not significant. (B) Western blot analysis of the PCa cell lines PC-3, 
DU145 and LNCaP showing reduced β1integrin expression after LPXN knockdown. All cell lines showed 
decreased levels of β1 integrin after LPXN knockdown, with the most prominent effect in PC-3 cells. This 
down regulation of β1 integrin was not observed in control siLuc-transfected cells. α-tubulin served as a 
loading control. 
 
Likewise, overexpression of an EGFP-LPXN fusion construct caused a slight increase of 
ITGB1 expression in DU145 cells in comparison to EGFP control transfected cells. In PC-
3 cells the EGFP-LPXN induced ITGB1 expression was not detectable (Fig. 3.13). 
Although the effect of EGFP-LPXN overexpression on ITBG1 expression was not very 
strong, there is a significant correlation between LPXN and ITGB1 expression.  
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Fig. 3.13: β1 integrin expression after EGFP-LPXN overexpression in PCa cell lines. The indicated 
PCa cells were transfected with an EGFP-LPXN fusion construct and with EGFP alone as a control. To 
analyze correlation of LPXN and ITGB1 expression RNA was isolated 48 hours after transfection, reverse 
transcribed and subjected to qRT-PCR. LPXN CDS F1R1 primer confirmed successful transfection and 
overexpression of EGFP-LPXN. DU145 showed a significant 1.2-fold upregulation of ITGB1 after EGFP-
LPXN overexpression, which was not present in PC-3. Stars indicate statistical significance as calculated by 
students t-test (*=0.01≤p≤0.05; **=0.001=p≤0.01; ***=0.0001≤p≤0.001; n.s.= not significant) 
 
Western blot experiments also showed an upregulation of ITGB1 expression in PC-3 and 
DU145 cells upon EGFP-LPXN transfection in comparison to EGFP control transfected 
cells. This induction of ITGB1 expression was not present in LNCaP cells (Fig. 3.14). Thus, 
the LPXN-mediated effects on ITGB1 expression might account for the reduced adhesion 
of PCa cells after LPXN knockdown. 
 






Fig. 3.14: Overexpression of LPXN results in increased β1 integrin expression. To analyze the effect 
of LPXN overexpression on β1 integrin, the PCa cell lines PC-3, DU145 and LNCaP were transfected with 
an EGFP-LPXN construct or EGFP as a control, respectively. 24 hours after transfection whole protein was 
isolated and subjected to western blot analyses. Specific detection of β1 integrin showed elevated levels of 
β1 integrin expression after LPXN overexpression. This effect was most prominent in PC-3 and DU145 
cells. α-tubulin served as a protein loading control. 
 
3.10.3 LPXN influences activity of the specificity protein 1 (Sp1) 
 
From the literature it is known that integrins, especially α6 integrin harbor binding sites 
for the transcription factor specificity protein 1 (Sp1) in their promoter region and that 
Sp1 is able to positively influence α6 promoter activity (Gaudreault et al. 2007). We 
therefore tested whether LPXN can influence the transcriptional activity of Sp1 by a 
reporter gene assay. This assay contains a firefly luciferase gene under the control of a 
minimal CMV promoter and tandem repeats of the Sp1 transcriptional response element 
(TRE). On the one hand PC-3, DU145 and LNCaP cells were plated on 96-well plates and 
double transfected with either pEGFP-C1-LPXN or pEGFP-C1 and the Cignal™ reporter 
plasmid. On the other hand, cells were transfected with either siLPXN or siLuc siRNA. 
After 24 hours the Cignal™ reporter plasmid was transfected separately. Measurement 
of the luciferase activity revealed that overexpression of LPXN induced a significant 
increase in Sp1 activity in DU145 and LNCaP cells. This increase was also visible in PC-3, 
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but not statistically significant. On the other hand, knockdown of LPXN did also display 
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Fig. 3.15 Sp1 activity in PC-3, DU145 and LNCaP cells after modulation of LPXN expression. To 
analyze Sp1 activity the Cignal™ Sp1 activity assay was used. PC-3, DU145 and LNCaP cells were plated on 
96-well plates and transfected with a pEGFP-LPXN fusion construct and the reporter plasmid (Cignal™) to 
check the effect of LPXN overexpression on Sp1 activity. Likewise, for LPXN knockdown, the cells were 
plated on 96-well plates and transfected with siRNA against the LPXN and luciferase gene, respectively. 
On the next day, the cells were transfected with the reporter plasmid. Sp1 activity was determined by 
measurement of luciferase activity 24 hours after transfection. Values displayed are normalized to siLuc 
or EGFP, respectively and represent relative values averaged from triplicates from three independent 
experiments. Stars indicate statistical significance as calculated by students t-test (*=0.01≤p≤0.05; 
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3.11  LPXN affects radio-resistance of PCa cells 
 
Cellular adhesion is a process that is also implicated in the acquisition of radio- and 
chemo-resistances of several cancer entities. It was already shown for head and neck 
cancer that targeting the β1 integrin is beneficial for tumor cell radiotherapy (Eke et al. 
2012). Integrins are a major mediator of cellular adhesion and their deregulation is a 
common feature of the aggressive and metastatic phenotype in several types of cancer, 
including PCa. 
To analyze if the ITGB1-regulating effects that LPXN exerts on cell adhesion do also 
affect the resistance to ionizing radiation, PC-3, DU145 and LNCaP cells were transfected 
with siRNA against LPXN, whereas siRNA against the luciferase gene (Luc) served as a 
control. After transfection a defined cell number was plated on to 6-well plates and 
exposed to single dose ionizing irradiation of 0, 2, 4 and 8 Gy, respectively, on the next 
day. Subsequently, the clonogenic cell survival was evaluated by a colony formation 
assay. The assay clearly showed a sensitization of PCa cells against ionizing radiation 
after LPXN knockdown. With increasing irradiation intensity this effect was significantly 
detectable in all cell lines. LNCaP cells showed the highest sensitivity to irradiation, e.g. 
after a single dose of 2 Gy the sensitizing effect of LPXN knockdown was already visible. 
However, DU145 and PC-3 cells were quite resistant to low doses of irradiation and 
started to show significant sensitizing effects from doses of 4 Gy on (Fig. 3.16). 
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Fig. 3.16: Response of PCa cells to ionizing radiation after downregulation of LPXN expression. PC-3, 
DU145 and LNCaP cells were transfected with siRNA against the LPXN (siLPXN) or luciferase (siLuc) gene. 
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After transfection a defined number of cells was plated on 6-well plates and exposed to single dose 
ionizing irradiation of 0, 2, 4, and 8 Gy on the next day. Cells were incubated until colonies formed and 
colonies were stained and counted. Survival fraction was calculated. Data represents means ±s.d. from 
three experiments. All PCa cell lines showed a significant radio-sensitization upon knockdown of LPXN 
expression, which was highest in the LNCaP cell line. Stars represent statistical significance as calculated 
by students t-test (*=0.01≤p≤0.05; **=0.001=p≤0.01; ***=0.0001≤p≤0.001). 
 
Next we assessed if inhibition of β1 integrin is able to show the same effect upon 
irradiation that we observed for LPXN knockdown. Since Cordes et al. already described 
sensitization to irradiation by the inhibition of β1 integrin in head and neck squamous 
cell carcinoma cells and proposed that β1 integrin could be used as a molecular target in 
combination with radiotherapy to sensitize tumor cells and increase survival of patients 
(Cordes, Park 2007), we used the inhibitory monoclonal anti-β1 integrin antibody 
(AIIB2, kindly provided by Prof. Dr. med. Nils Cordes, Oncoray, Dresden, Germany) to 
block β1 integrin activity of our PCa cell lines PC-3, DU145 and LNCaP. To test 
clonogenic cell survival a defined number of cells was plated on 6-well plates. One hour 
before the cells were exposed to different doses of irradiation (0, 2, 4, 8 Gy), the 
inhibitory anti-β1 antibody as well as a control rat IgG were added to the growth 
medium at a final concentration of 1 µg/ml. Clonogenic cell survival was evaluated and 
revealed that also inhibition of β1 integrin significantly sensitized PCa cells to ionizing 
irradiation. As it was observed for sensitization by LPXN knockdown, LNCaP cells 
showed the highest amount of sensitization by AIIB2-mediated β1 integrin inhibition. 
Whereas, PC-3 and DU145 cells were quite resistant to low doses of irradiation and the 
sensitizing effect of AIIB2 to irradiation was only observed at doses higher than 4 Gy 
(Fig. 3.17). 
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Fig. 3.17: Radio-sensitization of PC-3, DU145 and LNCaP cells after inhibition of β1 integrin. To 
evaluate clonogenic cell survival after β1 integrin inhibition, PC-3, DU145 and LNCaP cells were plated on 
6-well plates at a defined cell number. One hour before cells were exposed to different doses of irradiation 
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(0, 2, 4, 8 Gy) the inhibitory anti-β1 integrin antibody (AIIB2), as well as a control rat IgG were applied to 
the growth medium of the cells at a final concentration of 1 µg/ml. Colony formation assay was performed 
as described in Material and Methods. Cell colonies were stained, counted and survival fraction was 
calculated. The inhibition of the β1 integrin significantly sensitized the PCa cells to irradiation. Data 
represent means ±s.d. from three experiments. Stars represent statistical significance as calculated by 
students t-test (*=0.01≤p≤0.05; **=0.001=p≤0.01; ***=0.0001≤p≤0.001). 
 
Having shown a sensitization of PCa cells to ionizing irradiation after LPXN knockdown 
or β1 integrin blockade, we wondered if both treatments might have a synergistic effect 
and could even enhance sensitization to ionizing irradiation. 
Therefore, PCa cells were transfected with siRNA against the LPXN and luciferase gene, 
respectively. After 24 hours, the cells were plated on a 6-well plate at a defined cell 
number. On the next day, one hour before irradiation cells were treated with the 
inhibitory AIIB2 antibody at a final concentration of 1 µg/ml. Analyses of the 
corresponding colony formation assays revealed that the LPXN-induced radio-
sensitization of PC-3 and DU145 cells could not be further enhanced by the blockade of  
β1 integrin (Fig. 3.18). Thus, these results show that simultaneous knockdown of LPXN 
and β1 integrin blockade do not have a synergistic effect on radio-sensitization of PCa 
cells. Furthermore, this result indicates that LPXN might influence radio-resistance 
mechanisms by regulation of ITGB1 expression. 
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Fig. 3.18: Colony formation assay of irradiated PCa cells after simultaneous knockdown of LPXN 
and β1 integrin blockade. Clonogenic cell survival of PC-3 and DU145 was evaluated to determine a 
synergistic effect of simultaneous downregulation of LPXN and blockade of β1 integrin on radio-
sensitization of PCa cells. Cells transfected with siRNA against the LPXN gene were plated on 6-well plates 
at a defined cell number. One hour before cells were exposed to different doses of irradiation (0, 2, 4, 8 Gy) 
the inhibitory anti-β1 integrin antibody (AIIB2) were applied to the growth medium of the cells at a final 
concentration of 1µg/ml. Colony formation assay was performed as described in Material and Methods. 
Cell colonies were stained, counted and survival fraction was calculated. Simultaneous knockdown of 
LPXN and blockade of β1 integrin do not have a synergistic effect on radio-sensitization of PCa cells. Data 
represent means ±s.d. from three experiments. Stars represent statistical significance as calculated by 
students t-test (*=0.01≤p≤0.05; **=0.001=p≤0.01; ***=0.0001≤p≤0.001; n.s.=not significant). 
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3.11.1 LPXN expression is enhanced upon ionizing radiation 
 
As we were able to sensitize PCa cells to radiation by downregulation of LPXN 
expression, LPXN might be involved in these resistance mechanisms. In order to test if 
the cells rely on LPXN expression to acquire radio-resistance we exposed PC-3, DU145 
and LNCaP cells to a single dose irradiation of 4 Gy. Total RNA was isolated 1, 2, 24 and 
48 hours after irradiation. Un-irradiated cells were taken as a control (0h). The 
following qRT-PCR analysis demonstrated that during the early time points of 1 and 2 
hours after irradiation a decrease in LPXN expression for PC-3, DU145 and LNCaP cells 





Fig. 3.19: Irradiation-induced expression of LPXN in DU145 and LNCaP cells. DU145 and LNCaP cells 
were plated on 6-well plates to analyze irradiation-induced expression of LPXN.Total RNA was isolated 1, 
2, 24, and 48 hours after exposure to a single dose irradiation of 4 Gy, reverse transcribed and subjected 
to qRT-PCR. Un-irradiated cells (0h) were used as a control. LPXN-specific primers showed an increasing 
LPXN expression after single dose irradiation in DU145 and LNCaP cells. The illustrated values represent 
an average of three independent experiments, which were measured in duplicate and normalized to the 
LPXN expression in control cells (0h). Stars indicate statistical significance as judged by students t-test 
(p≤0.05 (*); p≤0.001 (**): p≤0.0001 (***). 
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3.11.2 ITGB1 expression is enhanced upon ionizing radiation 
 
In order to analyze ITGB1 expression after ionizing radiation, DU145 and LNCaP cells 
were exposed to a single dose irradiation of 4 Gy. Total RNA and protein was isolated at 
0, 1, 2, 24 and 48 hours after irradiation, whereas cells from 0 hours time point were not 
irradiated and served as a control. Total RNA was isolated, reverse transcribed and 
subjected to qRT-PCR. Subsequent analysis revealed that directly after irradiation ITGB1 
expression decreased in DU145, but started to rise again already two hours after 
irradiation. Although this increase is not statistically significant in DU145 cells, there is a 
clear trend noticeable. In LNCaP cells expression levels of ITGB1 did not decline after 
irradiation but were steadily increasing and significantly upregulated 1.4-fold at 24 and 
1.7-fold at 48 hours after exposure to single dose irradiation (Fig. 3.20). 
 
 
Fig. 3.20: Irradiation-induced upregulation of ITGB1 in DU145 and LNCaP cells. DU145 and LNCaP 
cells were plated on 6-well plates to analyze irradiation-induced expression of ITGB1. Cells were exposed 
to a single dose irradiation of 4 Gy and total RNA was isolated at 1, 2, 24, and 48 hours after irradiation, 
reverse transcribed and subjected to qRT-PCR. Un-irradiated cells (0h) were used as a control. The qRT-
PCR analysis using ITGB1-specific primers showed that 24 hours after irradiation ITGB1 expression is 
significantly increased in LNCaP cells (1.4-fold), whereas in DU145 ITGB1 expression declines 
immediately after irradiation and steadily rises until it reaches a peak at 48 hours (1.2-fold). The 
illustrated values represent an average of three independent experiments, which were measured in 
duplicate and normalized to the ITGB1 expression in control cells (0h). Stars are indicating statistical 
significance as judged by students t-test (p≤0.05 (*); p≤0.001 (**): p≤0.0001 (***). 
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Western blot analysis also showed an increased β1 integrin expression over time with a 
peak at 48 hours in DU145 and LNCaP cell lines. α-tubulin bands indicate equal protein 





Fig. 3.21: Expression of β1 integrin in DU145 and LNCaP at different time points after irradiation. 
DU145 and LNCaP cells were plated on 6-well plates to analyze irradiation-induced expression of ITGB1. 
Cells were exposed to a single dose irradiation of 4 Gy and total protein was isolated at 1, 2, 24, and 48 
hours after irradiation and subjected to western blot analysis. Non-irradiated cells (0h) were used as a 
control. Western blot analysis was performed using a β1 integrin-specific antibody. α-tubulin ensured 
equal protein loading. The PCa cell lines showed an upregulation of ITGB1 expression with proceeding 
time and a peak at 48 hours after irradiation. 
 
3.11.3 LPXN knockdown prevents radiation-induced upregulation of 
ITGB1 expression 
 
Having shown a clear correlation of LPXN and ITGB1 expression we were wondering if 
knockdown of LPXN could prevent radiation-induced upregulation of ITGB1. Therefore, 
LPXN expression was downregulated in PC-3 and DU145 cells 48 hours before they 
were exposed to a single dose irradiation of 4 Gy. Total RNA was isolated at 1, 2, 24, and 
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48 hours after irradiation. Cells transfected with siRNA against the luciferase gene 
(siLuc) and non-irradiated cells (0h) served as a control. qRT-PCR of control transfected 
cells (siLuc) showed radiation-dependent increases of ITGB1 expression. Reduction of 
LPXN expression by RNA interference (siLPXN) could prevent this radiation-induced 
upregulation of ITGB1 even after 48 hours. Compared to siLuc-transfected cells, which 
showed the characteristic increases in ITGB1 expression levels, ITGB1 stayed at a quite 
equal expression level of approximately 60 % in siLPXN-transfected cells over the time 
course of the experiment (Fig. 3.22). This indicates an involvement of LPXN in ITGB1 
regulation and points towards a putative mechanism of LPXN-induced radio-resistance 
of PCa cells. 
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Fig. 3.22: LPXN knockdown in PC-3 and DU145 cells prevents irradiation-induced upregulation of 
ITGB1. PC-3 and DU145 cells were plated on 6-well plates and transfected with siRNA against the LPXN or 
luciferase gene, respectively. 24 hours after transfection, cells were exposed to a single dose irradiation of 
4 Gy and total RNA was isolated at 1, 2, 24, and 48 hours after irradiation, reverse transcribed and 
subjected to qRT-PCR. Non-irradiated cells (0h) were used as a control.  
The qRT-PCR analysis clearly shows a radiation induced increase in ITGB1 expression in control (siLuc) 
transfected cells. This irradiation-induced upregulation of ITGB1 was significantly reduced by knockdown 
of LPXN. Thus, LPXN knockdown prevented irradiation-induced expression of ITGB1. Furthermore, ITGB1 
expression levels stayed at approximately 60 % in siLPXN-transfected cells, even after irradiation. The 
illustrated values represent an average of three independent experiments, which were measured in 
duplicate and normalized to the ITGB1 expression in control cells (0h). Stars are indicating statistical 
significance as judged by students t-test (p≤0.05 (*); p≤0.001 (**): p≤0.0001 (***). 
 
3.12  The interaction of LPXN and the adhesion molecule p120CTN 
 
Previous experiments from our research group showed that the expression of the 
adhesion molecule p120 catenin (p120CTN) negatively correlates with the expression of 
LPXN. In addition, LPXN was reported to localize to the nucleus and mediate the 
transcriptional activity of the androgen receptor (AR) in PCa cells by direct binding to 
the AR. However, if LPXN is able to bind directly or indirectly to promoter sequences of 
the p120 catenin gene, CTNND1, remained unclear. 
In order to investigate the nuclear mechanisms of LPXNs influence on p120CTN, the 
promoter region of the CTNND1 gene was fragmented and cloned in front of the 
luciferase gene. Promoter fragments were chosen according to the findings from 
Mortazavi et al. (2010), who described several activating as well as repressing elements 
in close proximity to the transcriptional start site of CTNND1. Interestingly, this group 
also reported a SP1 binding site in the promoter region of the CTNND1 gene. This work 
was already started during my master thesis (Dierks, 2011). A total of ten fragments of 
the CTNND1 promoter region were generated, starting from 2 kb upstream to 300 bp 
downstream of the transcriptional start site (TS) (Fig. 3.23).  
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Fig. 3.23: Overview of the CTNND1 (p120CTN) promoter fragments. To analyze the CTNND1 
promoter for LPXN responsive regions, a total of ten fragments were generated ranging from 2 kb 
upstream to 329 bp downstream of the transcriptional start site (TS). The fragments were defined 
according to the findings from Mortazavi et al., who already reported activating elements and SP1 binding 
sites in the region around the TS of the p120CTN gene (CTNND1). The scheme displays the positions of the 
corresponding fragments. 
 
Fig. 3.24 displays a restriction analysis using the XhoI and BglII restriction enzymes to 
check for successful integration of the corresponding promoter fragments into the 
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Fig. 3.24: Restriction analysis to show successful integration of the p120CTN promoter constructs 
into the pGL4.16 luc2CP/Hygro plasmid. The restriction enzymes XhoI and BglII were used to cut the 
promoter fragments out of the luciferase reporter plasmid pGL4.16 luc2CP/Hygro to show successful 
integration. The agarose gel shows the estimated size of the fragments excised.  
 
3.12.1 The CTNND1 promoter is influenced by LPXN 
 
To analyze the activity of the CTNND1 promoter fragments, PC-3 cells were transfected 
with siRNA against the LPXN and luciferase gene, respectively. Since, LPXN and 
p120CTN expression are negatively correlating, this should reveal LPXN-responsive 
fragments of the CTNND1 promoter region in the subsequent luciferase reporter assays. 
The fragment ranging from -200 bp upstream to 100 bp downstream of the 
transcriptional start site (TS) turned out to generate the highest difference in luciferase 
activity between siLPXN and control transfected cells. Interestingly, the fragments that 
were including downstream sequences to 100 bp showed the highest promoter activity 
compared to fragments ranging to 300 bp downstream, whereas constructs ending at 
the TS only showed activity comparable to background levels. In addition, promoter 
activity increased with increasing size of the fragments, but LPXN seems to have 
repressive influence on the more distant regions upstream of the TS (Fig. 3.25). 
 
 
Fig. 3.25: Luciferase reporter gene assay of CTNND1 promoter fragments. For the identification of a 
LPXN responsive region in the CTNND1 promoter, the reporter plasmids containing the corresponding 
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fragments were transfected into PC-3 cells that have been transfected with siRNA against the LPXN gene 
(siLPXN). SiRNA against the luciferase gene served as a control. Measurements of luciferase activity 
revealed that fragments including larger regions showed higher promoter activity, whereas the fragment 
ranging from 200 bp upstream to 100 bp downstream of the transcriptional start site (TS) showed the 
highest response to LPXN knockdown, which was not visible in control transfected cells. Therefore, this 
fragment was chosen for further analysis. Interestingly, fragments that did not include downstream 
sequences of the TS, showed only weak activity that was comparable to background levels. The illustrated 
values represent an average of three independent experiments. RLU = relative light units 
 
3.12.2 LPXN does not directly bind to promoter sequences of the 
CTNND1 gene 
 
In previous studies we could show that LPXN expression is negatively correlating with 
p120CTN expression (Kaulfuss et al. 2009). However, a regulatory mechanism was not 
purposed. ARA55, a protein family member of LPXN, was described to bind directly to 
DNA sequences (Nishiya et al. 1998). Zyxin, another focal adhesion-associated LIM-
domain containing protein, was also reported to do the same (Nix, Beckerle 1997). This 
and the fact that LPXN is able to shuttle between the nucleus and the cytoplasm 
(Sundberg-Smith et al. 2008) were raising the hypothesis of a nuclear function of LPXN.  
To identify potential binding sites for LPXN in the promoter region of the CTNND1 gene 
the CTNND1 promoter construct that showed the highest reporter activity (-240 to +329 
bp relative to transcriptional start site) was divided into fragments of 35 bp in length 
(Fig. 3.26). Fragments were overlapping 5 bp on 5’ and 3’ ends. To exclude binding 
between two fragments another fragment was spanning the 5’-3’ connections.  
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Fig. 3.26: Scheme of the fragment of the CTNND1 promoter region for EMSA. The CTNND1 promoter 
construct reaching from 240 bp upstream to 329 downstream of the transcriptional start site was 
fragmented into 35 bp fragments for an EMSA. The fragments were overlapping 5 bp on both 5' and 3' 
ends (black). In addition, fragments spanning the overlapping region (blue) were generated to exclude 
possible binding sites in this region. Fragments are numbered beginning with fragment one at -240 bp and 
ending with fragment 19. First overlapping fragment was numbered 1-2 ending with 16-17. TS = 
transcriptional start site; SP1 = Specificity protein 1 binding sites are indicated in red.  
 
These fragments were subjected to an electrophoretic mobility shift assay (EMSA), 
starting with fragments around the transcriptional start site (Fig. 3.26). For this 
experiment PC-3 cells, which show the highest LPXN expression among our PCa cell 
lines, were used. To even enhance the presence of LPXN in the nucleus, an EGFP-LPXN-
NLS fusion protein was expressed in the PC-3 cells, whereas an EGFP protein served as a 
control. Functionality of the fusion protein was not changed as evidenced by androgen 
receptor transactivation assay (Dierks, 2011). Nuclear protein extracts were incubated 
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with 33P–labeled oligonucleotides and run on a native gel. As a positive control 33P-
labeled oligonucleotides containing either one or two gamma activated sites (GAS, 
2xGAS) were incubated with protein lysates from HeLa cells that were stimulated for 45 
min with 5 ng/ml interferon gamma (IFNγ) to induce STAT1 activation. Supershifts 
were induced by the addition of anti-LPXN or anti-STAT1 antibody, respectively. The 
EMSA experiments were performed in close cooperation with Prof. Dr. mult. Thomas 
Meyer (Department of Psychosomatic Medicine and Psychotherapy; Molecular Psycho-
cardiology, University Medical Center Göttingen). LPXN did not bind to any of the 
fragments 8 to 19, which harbored sequences close to the transcriptional start site and 
further downstream sequences (Fig. 3.27B). However, binding of the STAT1-GFP control 
protein to the GAS (M67) was clearly visible. The 2xGAS oligonucleotides carried two 
binding sites for STAT1, consequently a larger band was visible which could be 
supershifted and confirmed the identity of the STAT1-GFP protein (Fig. 3.27A). In 
addition, an oligonucleotide with the Sp1 consensus sequence was designed and used in 
the EMSA. Incubation with the protein lysates from EGFP and EGFP-LPXN transfected 
PC-3 cells, did not show any differences in the band pattern of the EMSA. Thus, LPXN is 
not directly binding to this promoter region of the CTNND1 gene. 
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Fig. 3.27: CTNND1 promoter sequence-binding analysis of LPXN using EMSA. To investigate if LPXN is 
directly binding to the CTNND1 promoter region, whole protein lysate from PC-3 cells that were 
transfected with either EGFP or EGFP-LPXN-NLS constructs was incubated with 33P-labeled 35 bp 
oligonucleotides from the CTNND1 promoter. (A) As a positive controls a STAT1 binding site probes were 
incubated with protein lysates from HeLa cells that were stimulated with IFNγ. Probe M 67 contained one 
STAT1 binding site, probe 2xGAS contained two STAT1 binding sites. Supershift was induced by the 
addition of a STAT1-specific antibody. Likewise, a Sp1 consensus probe was incubated with lysates from 
PC-3 cells, but did not show any binding nor a supershift. Overlapping oligonucleotides from 7 to 12 were 
incubated with the above mentioned protein lysates, but did not show binding of EGFP-LPXN. (B) 33P-
labled oligonucleotides 8 to 19 were also incubated with protein lysate from EGFP or EGFP-LPXN 
transfected PC-3 cells, respectively. As observed for the overlapping fragments these oligonucleotides did 
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3.13 Generation of a LPXN gene trap conditional knockout mouse 
model 
 
3.13.1 The LPXN targeted trap construct 
 
To investigate the function of LPXN in mammals a LPXN gene trap mouse line was 
generated in our laboratory. Since the induced phenotype by LPXN knockout cannot be 
predicted, a conditional knockout model was chosen. For the generation of this 
conditional knockout mouse model of LPXN, a mouse embryonic stem cell (mES) clone 
with a target trap construct was purchased from the European Conditional Mouse 
Mutagenesis Program (EuCOMM) (HEPD0688_2_D07). These cells are carrying the 
EuCOMM gene trap construct, which targeted the critical fourth exon 
(ENSMUSE00000445728), present in all transcript variants of the LPXN gene. The 
location of the loxP sites in this construct is leading to an excision of exon four after cre-
recombination and consequently to a loss of function of the LPXN gene. In addition, the 
cells carry a reporter cassette with a splice acceptor (SA) site that is flanked by FRT-sites 
and driven by the endogenous LPXN promoter, meaning that the endogenous expression 
of LPXN can be easily visualized by lacZ staining when the reporter cassette is not 




Fig. 3.28: Scheme of the LPXN gene trap construct. Showing the typical elements of the gene trap 
construct: A 5’-splice acceptor sequence, an internal ribosomal entry site (IRES), the reporter gene, lacZ, 
and a neomycin resistance gene, FRT-sites to remove the reporter/selector cassette to create the 
conditional allele, as well as loxP-sites flanking the neomycin-resistance gene and the critical exon. Picture 
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3.13.2 Excision of reporter/selector cassette 
 
The typical gene trap construct consists of a splice acceptor (SA) sequence, a “trap” 
cassette, which includes the reporter gene (lacZ) as well as a selection marker (NeoR) 
and a polyadenylation (polyA) signal. Consequently, the translated mRNA will generate a 
truncated protein consisting of the endogenous N-terminal protein sequence lacking the 
exons downstream of the insertion site and the reporter protein.   
For the generation of a conditional knockout the reporter/selector gene cassette has to 
be removed. In order to excise this cassette, mES cell clone HEPD0688_2_D07 was 
transfected with a pCAGGS-FLPe vector (Schaft et al. 2001) to express the FLP-
recombinase, which excised the FRT-site flanked reporter/selector cassette. The 
transfection of the mES cells with the FLP-recombinase construct was done in 
cooperation with Prof. Dr. Ibrahim Adham (Department of Human Genetics, Göttingen). 
Genotyping of transfected mES cell clones was conducted using specific primers LPXN-5’ 
and LPXN-3’ that flanked the reporter cassette. PCR conditions were chosen in a way 
that the reporter cassette could not be amplified when no recombination took place. 
Only when the FLP-recombinase excised the reporter cassette a 304 bp product was 
amplified from the mutant sequence displayed in the scheme in Fig. 3.29 (mut). A 220 bp 
fragment was amplied from the wild type sequence (wt). Fig. 3.29 illustrates the band 
pattern of the pCAGGS-FLPe transfected clone 19 with a 304 bp fragment from the 
mutant allele (reporter cassette excised) and a 220 bp fragment amplified from the wild 
type allele (wt).  
Clone 46, which was not transfected with the pCAGGS-FLPe vector, only showed the 
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Fig. 3.29: Genotyping PCR of FLP-recombinase transfected and un-transfected mouse embryonic 
stem cells (mES). The numbers are indicating the clone number. Clone 19 was transfected with a 
pCAGGS-FLPe vector to express FLP-recombinase, whereas clone 46 served as an un-transfected control. 
Gene-specific primers LPXN-5’ and LPXN-3’ were used on gDNA isolated from the mES cell clones. 
Excision of the reporter/selector cassette is visible in the band pattern of clone 19, a wild type band at 220 
bp and a mutant band at 304 bp, whereas clone 46 (un-transfected) only showed a wild type band at 220 
bp. The scheme shows the corresponding alleles after FLP-recombination and the location of the primer 
pair. PCR conditions were chosen in a way that the reporter cassette could not be amplified from the 
mutant allele without recombination.  
 
3.13.3 First blastocyst injection of mouse embryonic stem cells 
 
In order to generate chimeric mice with the conditional LPXN allele, mES cells were 
injected into C57/BL6 wildtype blastocysts and transferred into C57/BL6 wildtype 
foster mothers. The purchased parental mouse embryonic stem cell line JM8A3.N1, 
derived from C57/BL6 with agouti fur color provided the advantage of easy 
identification of chimeric animals by coat color. The blastocyst injection and transfer 
were performed in cooperation with Dr. Ursula Fünfschilling (Max-Planck-Institute of 
Experimental Medicine, Göttingen). 
Out of 5 blastocyst transfers we obtained only one chimera, which presented a low 
degree (0-10 %) of chimerism estimated from coat color. Mice born from this chimera, 
which was bred with C57/BL6 wild type mice, did not show the specific band pattern for 
the conditional allele as tested by genotyping. Therefore, no knockout mice were 
obtained indicating that there was no germline contribution in the chimeric mouse.  
 
3.13.4 Cytogenetic analysis of mouse embryonic stem cells for 
blastocyst injection 
 
Since trisomy, especially the trisomy of chromosome 8, is one of the most common 
aneuploidies that counteracts successful generation of transgenic mice from mES cells 
(Sugawara et al. 2006), the clones were subjected to a cytogenetic analysis including 
chromosome counting. Both, Flp-recombinase treated (LPXN19) and non-treated 
(LPXN) mES cells were tested. Chromosome counting on metaphases of 20 cells of each 
cell population revealed 40 chromosomes (2n) in the majority of cells meaning that no 
significant numerical aberrations were present in both cell populations (Table 3.1).  
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Table 3.1: Cytogenetic analysis of the mES cells after Flp-recombinase treatment. 
 
  
Chromosome number (2n) 
    43 42 41 40 39 
Flp LPXN (clone 19) 0 0 1 16 3 
non-Flp LPXN (clone 46) 2 0 0 17 1 
 
 
3.13.5 Rescue of differentiated mES cells by RESGRO® culture 
medium 
 
Apart from aneuploidy, differentiation of ES cell lines is another cause for low 
percentage chimeras or poor germline transmission rates. Since cytogenetic analysis did 
not reveal any aneuploidies that could account for the low-percentage chimerism we 
observed from our first blastocyst injections, mES cells were cultured over two passages 
in the RESGRO® culture medium. With this special culture medium differentiated mES 
cells become distinguishable from undifferentiated mES cells. Culture and sub-cloning of 
undifferentiated mES cells were carried out in cooperation with Prof. Dr. Ibrahim 
Adham (Department of Human Genetics, Göttingen). 
 
3.13.6 Second blastocyst injection of mouse embryonic stem cells  
 
After mES cells were sub-cloned in RESGRO® culture medium, a second blastocyst 
injection was performed in cooperation with Dr. Ursula Fünfschilling (Max-Planck-
Institute of Experimental Medicine, Göttingen, Germany). This time, out of six blastocyst 
transfers a total number of three chimeras were obtained. One of them presented a high 
degree of chimerism, approximately 90 %, while the others were showing about 60 % 
and 10 % chimerism as estimated from coat color. All chimeric mice were male, reached 
sexual maturity and were mated with C57/BL6 wild type mice. The progeny was 
analyzed by genotype PCR for the presence of the 3’-loxP site. From the three chimeras 
only the one with the highest degree of chimerism (90 %) showed germline contribution 
and produced a total of 12 LPXNflox/+-pups. The 10 % chimera produced 2 litters without 
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germline contribution, whereas the 60 % chimera did not generate any offspring. Table 
3.2 summarizes the offspring of the three chimeras. 
 
Table 3.2: Table of chimera progeny 
 
Chimerism Gender Litter positive total pups 
10 % ♂ 2 0 16 
60 % ♂ 0 0 0 
90 % ♂ 4 12 25 
 
 
3.13.7 Genotyping of LPXN19 chimera offspring 
 
To check for the presence of the 3’-loxP-site, a prerequisite for the conditionality of the 
allele (see Fig. 3.28) and for genotyping of the pups born from the chimeras, a pair of 
primers was designed. The forward primer LPXN-F was located in the critical exon 4 and 
the reverse primer (loxR) adjacent to the 3’-loxP-site. This will only produce a 343bp 
fragment from the mutant sequence, whereas no product is generated from the wild 
type sequence (Fig. 3.30). In addition, the presence of the 5’- and 3’-loxP-sites was 
confirmed by sequencing of the PCR products. 
From all chimeric mice only the mouse with the highest degree of chimerism showed 
germline transmission. Genotyping of the pups of this litter showed one animal (27) that 
carried the specific band pattern for the conditional allele and the presence of the 
3’loxP-site (Fig. 3.30). Mouse 27, as well as the positive tested candidates that were 
obtained from the following matings of this chimera, were used to establish a colony of 
the LPXN conditional knockout mouse line (LPXN19flox/flox).  
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Fig. 3.30: Result of the genotyping PCR of LPXN19 F1 generation born from chimeric mice. The 
agarose gel shows the specific band patterns for both, the presence of the 3’-loxP-site using the LPXN-Fw 
and loxR primer pair. Only mouse 27 showed a specific band, whereas mouse 30 and 31 did not carry the 
mutant allele. The gDNA from mES cells served as positive control (+). For the negative control PCR  
ddH20 was used instead of DNA. M = Marker 
 
3.13.8 Establishment of a homozygous LPXNflox/flox conditional 
knockout mouse model 
 
To establish a LPXNflox/flox conditional knockout mouse line, heterozygous animals from 
the F1 generation of the chimera (LPXN19+/flox) were mated either inbred with their 
LPXN19+/flox siblings or with wild type C57/BL6 mice. For further breeding only the 
resulting homozygous LPXNflox/flox animals were used to ensure a pure homozygous 
mouse line. Since the parental mES cells were also derived from the C57/BL6 mouse 
strain no backcrossing was required. 
 
3.13.9 Complete knockout of LPXN using the EIIA-Cre-loxP-system 
 
Since prediction of the phenotype of LPXN-/--animals is very difficult and it may also end 
in embryonic lethality, a conditional knockout model was chosen to keep the possibility 
of a tissue- and time-specific knockout of LPXN. To analyze LPXN function we aimed to 
disturb the LPXN gene very early in embryonic development. Therefore, LPXN19flox/flox 
mice were mated with EIIA-Cre+/+mice on a C57/BL6 background. The EIIA-Cre-mouse 
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line expresses the bacteriophage P1 cre-recombinase under the control of an adenoviral 
promoter, which is already active before implantation of the oocyte into the uterus 
(Dooley et al. 1989). This early activity of the cre-recombinase excises the critical exon 4 
of the LPXN gene very early in embryonic development. This gives rise to 
LPXN19+/flox/Cre+/- mice in the F1 generation that carry the heterozygous knockout only 
in those cells that expressed the cre-recombinase. Consequently, these mice are a mosaic 
for LPXN heterozygous knockout. Only when the recombination also reached the 
germline cells the knockout allele can be passed on to the F2 generation. To select for 
the LPXN+/--mice, the mosaic mice were bred to C57/BL6 wild type mice. These 
LPXN19+/- mice of the F2 generation are used to establish the homozygous LPXN19 




Fig. 3.31: Mating scheme to produce a LPXN-/- mouse line. To knockout LPXN very early in 
development LPXNflox/flox-mice were mated with EIIA-Cre-mice. Due to EIIA-Cre promoter activity this will 
give rise to mosaic mice. These animals were bred with C57/BL6 mice to select for germline transmission 
of the knockout allele in the F2 generation. Finally, LPXN-/- animals were obtained in the F3 generation. 
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3.13.10 Genotyping of LPXN19 knockout mice 
 
To genotype putative LPXN conditional knockout mice, another pair of primers was 
designed. The specific primers mLPXN-In-3-4 & mLPXN-In-4-5 amplified a 1114 bp 
product from the wild type sequence, approximately 1250 bp from the LPXN19flox/flox -
allele and an approximately 500 bp fragment from the knockout allele (Fig. 3.32). The 
LPXNΔ/- Crepos mice show three bands because of the EIIA promoter activity, which leads 
to mosaicism in these mice. 
 
 
Fig. 3.32: Results of genotyping PCR of LPXN19 conditional knockout mice. Specific mLPXN-In-3-4 & 
mLPXN-In-4-5 primers amplified an approx. 500 bp product from the knockout allele, an approx. 1250 bp 
product from the floxed-allele and a 1114 bp fragment from the wild type sequence. Due to the EIIA-
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3.13.11 Phenotypic analysis of LPXN19 knockout mice 
 
Macroscopic analysis of born LPXN-/- mice did not exhibit any morphologic 




Fig. 3.33: Phenotypic comparison of a wild type C57BL/6 and a LPXN-/- mouse. Comparison of 9 
weeks old mice showed no obvious phenotype of LPXN-/- mice recognizable.  
 
This result indicates that LPXN might not be essential during development. However, 
detailed studies have not been conducted so far and might reveal a certain phenotype 
later on. 
 




4.1 Summary of results 
 
In previous studies the actin-binding protein CaD was identified as a putative interaction 
partner of LPXN by a yeast-2-hybrid screening on a prostate cDNA library. In the present 
study this interaction was confirmed using co-immunoprecipitation and proximity 
ligation assays (PLA). Furthermore, this interaction was shown to be relevant for cancer 
cell migration. Using a combination of scratch and PLA assays, we detected increased 
interactions of LPXN and CaD in migrating PCa cells compared to non-migrating or 
confluent cells. In addition, the same experiments using an antibody that specifically 
detected the phosphorylated form of CaD showed similar results. Phosphorylated CaD 
detaches from actin leading to more dynamic actin structures. A specific localization 
pattern of LPXN and phospho-CaD interactions could be detected in migrating PCa cells. 
These interactions were located to the sub-membranous compartment, where the actin 
cytoskeleton needs to be more dynamic for cytoskeletal remodeling and were absent 
from the leading edge or stabilized actin structures of the migrating cell. Furthermore, 
we analyzed how LPXN influences the phosphorylation status of CaD. As it was shown 
that the activity of the extracellular signal-regulated kinase (ERK) was reduced after 
LPXN knockdown, we tested whether ERK is interacting with LPXN. A PLA was 
performed and revealed interaction of both proteins is present and enhanced in 
migrating cells. Moreover, the interaction pattern was resembling the pattern observed 
for pCaD and LPXN interactions. Interestingly, basal expression of ERK was equal among 
the PCa cell lines PC-3, DU145 and LNCaP, whereas activated ERK was only detectable in 
DU145 cells. Using the specific ERK inhibitor, PD98059, we identified the extracellular 
signal-regulated kinase (ERK) to be responsible for CaD phosphorylation. However, a 
simultaneous inhibition of ERK and siRNA-mediated downregulation of LPXN had no 
synergistic effect. 
Previous studies showed that LPXN, as a focal adhesion protein, has great impact on cell 
adhesion. In the present study LPXN was shown to influence the expression level of a 
group of major adhesion molecules, the integrins. Especially, β1 integrin expression was 
correlating with the expression of LPXN. In highly invasive PC-3 and DU145 cells β1 
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integrin expression was high in comparison to the non-invasive LNCaP cell line. 
Downregulation of LPXN using siRNA reduced expression of β1 integrin both on RNA 
and protein level, whereas overexpression of an EGFP-LPXN fusion protein in the PCa 
cell lines PC-3 and DU145, respectively, increased β1 integrin expression. To analyze the 
basis for the LPXN-dependent expression of β1 integrin, a Sp1 transcription factor (SP1) 
activity assay was performed and revealed that overexpression of an EGFP-LPXN fusion 
protein resulted in an increased activity of Sp1, whereas knockdown of LPXN expression 
did not show any significant changes in Sp1 activity. 
LPXN expression of PCa cells was found to be inducible by ionizing irradiation. 
Expression levels started to increase at 2 hours and reached a peak at 48 hours after 
exposure to ionizing irradiation. Likewise β1 integrin expression did also show a similar 
response to ionizing radiation. This effect was detectable both at RNA and protein levels. 
Downregulation of LPXN prevented an irradiation-induced upregulation of β1 integrin 
and kept β1 integrin expression levels at approximately 60 % in comparison to un-
irradiated cells, which illustrates the influence of LPXN on β1 expression. Furthermore, a 
downregulation of LPXN expression using siRNA resulted in a radiosensitization of the 
PCa cell lines PC-3, DU145 and LNCaP. In addition, blockade of β1 integrin using the β1 
integrin inhibitory AIIB2 antibody resulted in the same radiosensitive response of the 
PCa cells. A simultaneous downregulation of LPXN and blockade of β1 integrin did not 
reveal an additional or synergistic effect on the radiosensitization of the PCa cells. 
In our research group the expression of the adhesion molecule p120CTN (CTNND1) was 
recently described to negatively correlate with LPXN expression. In the present study 
reporter gene assays using different fragments of the CTNND1 promoter showed that 
activating as well as repressing elements are present in the CTNND1 promoter and 
finally revealed a putative region for LPXN-mediated expression of p120CTN, ranging 
from 240 bp upstream to 340 bp downstream relative to the transcriptional start site of 
the CTNND1 promoter. For the subsequent EMSA, this region was further fragmented 
into 35 bp oligonucleotides. Nuclear extracts of PC-3 cells, which were additionally 
transfected with an EGFP-LPXN-NLS construct to enrich LPXN in the nucleus were used. 
The EMSA did not reveal any direct binding sites for LPXN in this CTNND1 promoter 
region. 
The physiological role of LPXN in the organism is not clear and a knockout model for 
LPXN has not been reported. In this study a conditional LPXN knockout mouse model 
was generated. Therefore, mutant C57BL6 ES cells were purchased from EuCOMM that 
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carried a targeted trap construct. After excision of the resistance/reporter cassette, 
these cells were injected into C57/BL6 blastocysts of agouti coat color to generate 
chimera. The first blastocyst injection only produced one chimera with low percentage 
chimerism and without germline transmission. Culture of the ES cells in RESGRO 
medium helped to remove differentiating ES cells from the culture. The second 
blastocyst injection generated three chimeras from which one displayed high percentage 
chimerism and germline transmission. The established LPXN conditional knockout 
mouse line was bred with the EIIA-Cre mouse model to mimic a loss of LPXN function 
very early in development. To date, LPXN/EIIA-Cre mice are viable, fertile and do not 
display any abnormalities during development.    
 
4.2 Paxillin proteins in cytoskeletal rearrangements and migration 
 
Tumorigenesis is a multi-step process starting with genetic changes that lead to the 
transformation of normal cells to tumor cells. These tumor cells will progress and end 
up in highly invasive and metastatic cells. The underlying molecular mechanisms that 
drive tumorigenesis and tumor progression are incompletely understood. However, 
these mechanisms might involve a variety of proteins such as CaD and small GTPases 
that facilitate actin-cytoskeletal remodeling or proteins of the integrin, paxillin and 
cadherin families that play a major role in the establishment and dynamics of focal 
contacts during cell adhesion.  
Paxillin family proteins are predominantly localized to focal adhesion sites and share a 
characteristic domain structure, which grants them their roles as molecular adapter 
proteins (Schaller 2001). They overtake important cellular functions as they recruit a 
variety of proteins implicated in signal transduction or cytoskeletal rearrangement to 
focal adhesions. The regulation of these processes is essential for cell migration, which 
in turn is required for vital mechanisms like wound healing, immune response or 
embryogenesis. Actin-cytoskeletal dynamics during cell migration are tightly regulated 
by the Rho family of small GTPases (Jaffe, Hall 2005). Upon integrin ligation, paxillin 
becomes phosphorylated by SRC or FAK and regulates the activity of Rho GTPases by the 
recruitment of various guanosine exchange factors (GEFs), GTPase-activating proteins 
(GAPs) or effector proteins (Bellis et al. 1997; Burridge et al. 1992; Petit et al. 2000; 
Schaller, Parsons 1995). In addition, the CrkII-DOCK180-ELMO complex interacts with 
Y31 and Y118 phoshorylated paxillin to regulate signaling of the Rho family GTPase 
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Rac1 during cell migration (Grimsley et al. 2004; Birge et al. 1993; Petit et al. 2000; 
Valles et al. 2004). On the other hand, phosphorylation of paxillin at the same residue 
was shown to regulate RhoA activity by binding to p120RasGAP (RASA1). This 
interaction reduces the affinity of p120RasGAP to p190RhoGAP (ARHGAP5) at the 
plasma membrane, which suppresses RhoA activity (Tsubouchi et al. 2002). Therefore, 
paxillin carries a major function during cytoskeletal rearrangements and largely affects 
the formation of protrusion at the leading edge of migrating cells (Fig. 4.1). Via its LD 
motifs paxillin binds to p95PKL (95-kDa paxillin-kinase linker), which mediates 
association of paxillin with another complex of the p21 GTPase-activated kinase (PAK), 
Nck and the guanosine exchange factor, PIX (Turner et al. 1999). Moreover, the same 
study showed interaction of this complex with the paxillin family protein ARA55. This 
protein was also described to co-localize with paxillin and α-actinin at the ends of actin 
filaments of neonatal cardiac myocytes to regulate fetal gene expression and 
cytoskeletal organization (Yund et al. 2009). Another study showed that ARA55 reduced 
integrin-mediated cell spreading on fibronectin through competition with paxillin for 
FAK, which was reported as a novel mechanism of integrin-mediated signal transduction 
(Nishiya et al. 2001). Obviously, paxillin family proteins are involved in the regulation of 
cytoskeletal dynamics and provide a link between extracellular cues and intracellular 
response. Figure 4.1 summarizes the functions of the paxillin protein family members in 
cytoskeletal remodeling. Besides its indirect activation or inhibition of the Rho family 
GTPases Rac1 and RhoA, respectively, further associations and regulating functions of 
paxillin proteins have been reported, e.g. in cell spreading but these are not subject of 
the present study. 
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Fig. 4.1: Schematic overview of paxillin family members and their implications in cytoskeletal 
remodeling. The scheme shows a broad overview of how the paxillin proteins, ARA55 and paxillin are 
implicated in cytoskeletal rearrangements. Paxillin is acting on the family of small Rho GTPases via 
association with the GTPase activating protein p120RasGAP and the DOCK180/CRKII/ELMO protein 
complex. Small GTPases of the Rho family are important mediators of actin filament assembly and exhibit 
an essential role in cell migration. Furthermore, paxillin family proteins display a link between the tails of 
integrins and the actin cytoskeleton. Therefore, they include further structural proteins like talin or α-
actinin. For all paxillin proteins an interaction with FAK has been reported. As a protein predominantly 
localized at focal adhesions, FAK is of major importance for cell migration. 
 
Paxillin’s interaction with the focal adhesion kinase (FAK) and the structural adhesion 
protein vinculin are reported to be important for phosphorylation of paxillin and its 
subsequent localization to nascent focal adhesions. In addition, studies on the survival 
and motility of vinculin-/- cells showed that vinculin is modulating the interaction of 
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paxillin and FAK and that this interaction in the absence of vinculin is up-regulating the 
activity of the extracellular signal-regulated kinase (ERK) (Subauste et al. 2004). The 
transforming oncoprotein bovine papilloma virus type 1 (BPV-1) E6 was demonstrated 
to interact with paxillin. Moreover, it was shown to disrupt actin stress fibers by 
blockade of paxillin interaction with vinculin and FAK at its LD motifs ((Tong et al. 1997). 
The human papilloma virus type 16 (HPV-16) E6 protein also interacts with paxillin at 
the same site of the LD motifs and additionally targets degradation of the tumor 
suppressor protein p53 together with the ubiquitin-protein ligase E6-AP (Vande Pol, S B 
et al. 1998). In addition, paxillin was demonstrated to interact with actopaxin, a protein 
that is directly binding to F-actin. This interaction was suggested to be important for 
integrin-dependent remodeling of the actin cytoskeleton during cell motility and cell 
adhesion. However, the exact nature of this interaction is still elusive (Nikolopoulos, 
Turner 2000). Interestingly, actopaxin was reported to influence cell invasiveness and 
motility by regulating the expression of focal adhesion proteins, including paxillin, in 
hepatocellular carcinomas (Ng et al. 2013). Thus, paxillin binds to a variety of proteins 
involved in changes in the organization of the actin cytoskeleton. For LPXN it is not 
much known about its associations with cytoskeletal proteins. The only reported 
association was found in murine osteoclasts, where LPXN binds to the paxillin-kinase 
linker, p95PKL, an ARF-GTPase-activating protein (Gupta et al. 2003). 
LPXN was found to interact with other focal adhesion proteins like the focal adhesion 
kinase pp125FAK, the protein tyrosine kinase PYK2 or the protein phosphatase PTP-
PEST that take part in signal transduction (Gupta et al. 2003; Sahu et al. 2007b). In 
contrast, LPXN was shown to bind and co-activate the androgen receptor as well as the 
sarcoma tyrosine kinase, SRC (Kaulfuss et al. 2008; Sahu et al. 2007a). However, these 
interactions had no effect on cytoskeletal rearrangements. Since proteins of the paxillin 
protein family share great homology especially in their protein domains, it seems likely 
that LPXN is able to interact with several other interactions partners that have not been 
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4.3 Interaction of LPXN and CaD and its implications in prostate 
cancer 
 
4.3.1 Caldesmon and its role in cytoskeletal rearrangements 
 
Caldesmon (CaD) is a myosin-, actin-, tropomyosin-, and Ca2+-calmodulin-binding 
protein involved in the regulation of contractility and actin cytoskeleton remodeling in 
smooth muscle and non-muscle cells. The CALD1 gene is alternatively spliced to 
generate two major isoforms of the CaD protein (Haruna et al. 1993). A high molecular 
mass CaD (h-CaD), which is almost exclusively expressed in smooth muscle cells and a 
low molecular mass CaD (l-CaD), which is ubiquitously expressed in nearly all cell types 
(Hayashi et al. 1992). Most evidence today is based on findings from h-CaD and only 
little is known about l-CaD. Since both isoforms are generated from the same gene, 
domain sequences are identical and their biochemical characteristics are expected to be 
quite similar. CaD stabilizes the actin cytoskeleton by binding to tropomyosin-
containing actin filaments, which leads to effective inhibition of the actomyosin ATPase 
activity, the driving force in filament-contraction and -motility. Furthermore, CaD is 
known to regulate multiple actin-associated proteins. The actin-binding activity of the 
actin-bundling protein fascin is mediated by the association of CaD with tropomyosin in 
a Ca2+-calmodulin and phosphorylation-dependent manner (Ishikawa et al. 1998). 
Likewise, the affinity of filamin to F-Actin, a protein important for orthogonal 
crosslinking of actin filaments at the cortical cytoplasm, is regulated in a similar fashion 
(Nomura et al. 1987). In addition, CaD was shown to act on actin polymerization. During 
the nucleation process CaD is preventing F-actin-binding of the Arp2/3 complex, 
whereas Ca2+-calmodulin-binding and/or phosphorylation of CaD diminished this 
inhibitory effect (Yamakita et al. 2003). This actin polymerization process plays an 
important role in the regulation of motile structures like membrane ruffles and 
lamellipodia (Lin et al. 2009). Thus, CaD might display two opposing functions. On the 
one hand CaD stabilizes the filamentous actin structures by direct binding along with 
tropomyosin, on the other hand CaD prevents the assembly of new actin filaments by 
competition for F-actin structures with the Arp2/3 complex and other actin-binding 
proteins like filamin and fascin. 
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Controlling actomyosin ATPase activity and actin cytoskeleton remodeling is important 
for normal cell function. Therefore, the regulation of CaD activity is of fundamental 
interest for the cell. However, the essential functions of CaD are tightly associated with 
its affinity for actin. This affinity for actin is affected by the presence of Ca2+-calmodulin 
and by phosphorylation of a number of residues by various kinases. In smooth muscle 
cells contraction requires Ca2+. High levels of Ca2+ will lead to the activation of Ca2+-
calmodulin, which directly binds to and releases CaD from actin. In non-muscle cells 
actin binding of CaD is predominantly regulated by phosphorylation. Both isoforms h-
CaD and l-CaD are reported to be phosphorylated during a variety of cellular processes 
like smooth muscle contraction, migration, non-muscle cell division or cell 
transformation by oncogenic v-erbB (Adam et al. 1992; Kordowska et al. 2006; Cuomo et 
al. 2005; Matsumura, Yamashiro 1993). The phosphorylation of CaD results in reduction 
of its binding properties to its binding partners depending on the phosphorylation sites 
(Fig. 4.2A). Thus, upon phosphorylation the inhibition of the actomyosin ATPase activity 
is released. There are various phosphorylation sites found in the CaD protein and a 
number of kinases have been identified to specifically phosphorylate these residues. 
Hence, phosphorylation sites important for actin binding are located in the actin-binding 
domain (Foster et al. 2000). Kinases that are known to phosphorylate Serine 789 of h-
CaD or Serine 534 of l-CaD are the cdc2 kinase, the p38 mitogen-activated protein kinase 
(MAPK) and the extracellular signal-regulated kinase (ERK), whereas, cdc2 is associated 
with CaD phosphorylation during mitosis (Li et al. 2003; Mak et al. 1991). Another study 
showed that activation of p38 MAPK and phosphorylation of l-CaD is fundamental for 
migration of tracheal smooth muscle cells in response to urokinase type plasminogen 
activator (Goncharova et al. 2002). In pulmonary artery smooth muscle cells, which 
express high levels of l-CaD rather than h-CaD, the activation of ERK and subsequent 
phosphorylation of l-CaD is required for platelet derived growth factor (PDGF)-
stimulated cell migration (Yamboliev, Gerthoffer 2001).  
l-CaD associates with actin stress fibers in non-muscle cells and is an essential 
component of podosomes, highly dynamic and actin-based structures in highly motile 
cells (Eves et al. 2006; Gu et al. 2007). Loss of l-CaD results in reduced stress fibers and 
focal adhesions and is found in many transformed and cancer cells including gastric 
cancer (Fig. 4.2B) (Novy et al. 1991; Owada et al. 1984; Ross et al. 2000; Tanaka et al. 
1993). In diagnostics, h-CaD is used as a specific tumor marker to distinguish smooth 
muscle tumors from bone tumors with myeloid differentiation (Watanabe et al. 2000). 
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However, the pathological role of CaD is not exactly clear. There are a number of 
conflicting results suggesting l-CaD to have a tumor-supporting as well as –suppressive 
role. Primary colon cancer and liver metastasis tissue showed increased expression 
levels of l-CaD, which was correlating with a poor response to chemoradiotherapy of 
these patients. Interestingly, suppression of l-CaD in human colon cancer cell lines 
increased the susceptibility to 5-fluorouracil (5-FU) (Kim et al. 2012). In contrast, 
podosome formation, a cellular structure that is formed during cell invasion, in 
transformed and cancer cells is affected by CaD expression. Ectopic expression of CaD 
showed a decreased ECM degradation and subsequently suppressed invasion. 
Furthermore, depletion of CaD facilitated podosome formation and enhanced cell 
invasion (Yoshio et al. 2007). 
 
Fig. 4.2: Simplified schematic overview of CaD in actin stabilization in non-muscle cells. CaD binds 
to F-actin and stabilizes stress fibers. The activity of CaD and affinity for actin is mostly regulated through 
phosphorylation (A). Upon phosphorylation CaD reduces its affinity and detaches from actin stress fibers. 
As a result actin stress fibers are disassembled. (B) CaD binds and stabilizes actin and loss of CaD leads to 
the destabilization of actin stress fibers (Lin et al. 2009). 
 
As revealed by siRNA-mediated knockdown of CaD in smooth muscle cells, CaD might 
not only play a role in the rearrangement of the actin cytoskeleton but also showed to 
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have a regulatory function on other cytoskeletal structures. Knockdown of CaD 
decreased the amount of F-actin, whereas the expression of actin was not changed 
(Dierks et al. 2015). Interestingly, CaD might interact with intermediate filament 
components such as vimentin and desmin as evidenced by in vitro binding assays. 
Electronmicroscopic analyses of these cells showed that the distribution of the 
microfilaments was disturbed after CaD knockdown. The same study further showed 
that there were no alterations in expression or distribution of microtubules detectable 
in these cells (Deng et al. 2007). Furthermore, Ishikawa et al. found that non-muscle CaD 
from bovine brain is associating with microtubules and that this binding, similar to actin 
binding, is inhibited by the presence of Ca2+-calmodulin and/or the phosphorylation of 
CaD (Ishikawa et al. 1992a; Ishikawa et al. 1992b). Thus, CaD, as a mediator of 
cytoskeletal rearrangements, displays an important protein in many cellular processes 
such as cell shape, cell division, invasion and migration. 
 
4.3.2 LPXN modulates cytoskeletal rearrangements through 
interaction with CaD  
 
In our research group, LPXN was identified as a protein, which regulates the invasion of 
PCa cells and as an interaction partner of CaD. In the present study, this interaction was 
confirmed by co-immunoprecipitation and PLA. LPXN has a number of interaction 
partners, but has not been shown to directly interact with any cytoskeleton-associated 
protein. Therefore, CaD displays a putative candidate, which controls actin-cytoskeleton 
stabilization during invasion and migration of PCa cells downstream of LPXN. 
Investigations from our research group showed that the phosphorylation status of CaD 
is extenuated by LPXN knockdown. In addition, we observed that the activity of TGF-β-
activated kinase 1 (TAK-1) is also reduced after LPXN knockdown. However, this had no 
effect on its downstream targets JNK and p38 MAPK (von Hardenberg, 2010). Thus, ERK 
became the candidate kinase for LPXN-mediated phosphorylation of CaD during 
migration of PCa cells. Using a MEK1-specific inhibitor that blocks activation of ERK 
reduced phosphorylation of CaD and identified ERK to be responsible for CaD 
phosphorylation (Dierks et al. 2015). These results supported our hypothesis, which 
emphasizes LPXN as a mediator of CaD phosphorylation during PCa cell migration. In 
this hypothesis LPXN is recruiting ERK to phosphorylate l-CaD at S534, a 
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phosphorylation site important for actin affinity. Once phosphorylated CaD detaches 
from actin, which leads to highly dynamic actin structures (Fig. 4.3). The major 
phosphorylation sites in h- and l-CaD are ERK-specific sites and are phosphorylated in 
response to migrative stimuli. The modulatory role of ERK-dependent phosphorylation 
of CaD in cell motility and migration has already been reported (Ishikawa et al. 1998). 
By this mechanism we could explain the pathological overexpression of LPXN, which is 
resulting in the aggressive growth and enhanced motility of metastatic prostate tumor 
cells (Dierks et al. 2015).  
 
 
Fig. 4.3: Scheme of LPXN-mediated phosphorylation of CaD through the ERK kinase. In our 
hypothesis LPXN acts as a mediator of CaD phosphorylation during PCa cell migration. LPXN is recruiting 
the ERK kinase to phosphorylate CaD at places of pre-dynamic actin-cytoskeleton. Upon phosphorylation 
CaD detaches from actin leading to highly dynamic actin structures, which enables actin-cytoskeletal 
remodeling and consequently migration. This hypothesis could explain the pathological overexpression of 
LPXN in advanced PCa cells that may be responsible for their aggressive growth (Modified according to 
Matsumura et al. 1993, Wang 2008 and Dierks et al. 2015).  
 
Using in situ PLA technique we could visualize the subcellular localization of the 
interactions of LPXN with CaD or ERK, respectively. In migrating cells the interaction 
pattern of LPXN and ERK was similar to that of LPXN and CaD. This pattern showed 
interactions mainly in the sub-cellular compartment, whereas they were absent from the 
membrane or leading edges of the cell. Thus the localization of the interactions can be 
divided into two major zones. On the one hand, a "pCaD-zone", where CaD is 
phosphorylated in order to achieve dynamic actin structures for the disassembly and 
break down of old actin fibers and a "CaD-zone", where CaD is not phosphorylated and 
has a high affinity for actin, thereby stabilizing the actin-cytoskeleton for proper 
lamellipodia formation (Fig. 4.4). 




Fig. 4.4: Sub-cellular interaction pattern of LPXN and pCaD during cell migration. The interaction 
pattern of LPXN and pCaD during migration of PCa cells is generating two zones. A sub-cellular zone, 
where CaD is phosphorylated (pCaD-zone) in order to achieve dynamic actin structures and a "CaD-zone" 
at the leading edge of the migrating cell. In the "CaD-zone" CaD is present in an unphosphorylated state 
showing high affinity for actin and thereby stabilizing the actin-cytoskeleton for proper assembly of new 
actin-cytoskeletal structures. 
 
However, how LPXN is recruited to pCaD-zones and excluded from CaD-zones in 
lamellipodia and how LPXN recruits ERK to places of pre-dynamic cytoskeletal 
structures is unclear and requires further investigations. Also the stimuli in that 
response LPXN might be recruited to these places remains an open question. 
Localization of LPXN itself to these places could involve its phosphorylation, which was 
shown to be responsible for sub-cellular localization, e.g. for focal adhesion targeting 
upon stimulation of the gastrin-releasing peptide receptor (GRPr) (Chen, Kroog 2010). 
As mentioned above, although CaD is able to modulate actin-cytoskeleton stability it was 
reported to bind to intermediate filaments, leaving the possibility that LPXN might 
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4.4 The role of integrin family proteins in cell adhesion 
 
4.4.1 Integrin signaling 
 
Cell migration affects a variety of cellular processes during development, immune 
response or tumor metastasis. Usually cell migration starts by sending out new 
protrusions at the leading edge of the cell. The formation of new adhesions at these 
protrusions is of major importance to link the actin-cytoskeleton to the substratum to 
enable cell movement. Integrins are essential adhesion proteins for the connection of 
the extracellular and intracellular environment and are also crucial for signal 
transduction. This protein family consists of transmembrane receptors that form 
heterodimers composed of α- and β-subunits. Today in mammals there are 18 α- and 8 
β-subunits known that, depending on their composition, define the specificity for ligands 
in the extracellular matrix like collagens, fibronectins or laminins (Hynes 2002b). 
Integrin activation is regulating the affinity for the corresponding ligands through 
inside-out signaling, where intracellular activators, e.g. talin or kindlins, bind to the 
cytoplasmic tail of β integrins leading to conformational changes that increase ligand 
affinity. Therefore, integrin activation via inside-out signaling keeps the strength of 
connections between integrins and the ECM, required for proper cell migration (Fig. 4.5). 
Activated integrins can then act as cell surface receptors. Upon ligand binding to their 
extracellular domain, the integrins form clusters at the plasma membrane. The 
intracellular signals that are generated (outside-in signaling) lead to the formation of a 
large protein complex, the focal adhesion (FA) (Zaidel-Bar et al. 2007). Adapter proteins 
of these multi-protein FA complexes, like the paxillin protein family, allow the assembly 
of actin filaments and link integrins to the actin cytoskeleton (Giancotti, Ruoslahti 1999). 
The generation of this linkage is a fundamental step for the regulation of cell shape 
changes at the leading or trailing edges during cell migration. Thus, integrin-mediated 
adhesion is a critical regulator of cell migration.  
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Fig. 4.5: Scheme of bidirectional integrin signaling. Integrins can signal in two directions leading to 
different cellular responses. During inside-out signaling integrins are activated by intracellular activators, 
e.g. talin, which bind to the cytoplasmic tail of β integrins. Subsequent conformational changes increase 
ligand affinity and contribute to cell adhesion and migration. Ligand binding triggers integrin clustering 
and formation of a multiprotein complex that forms the focal adhesion. This outside-in signaling will affect 
cell polarity, proliferation, survival and cytoskeletal structure. Scheme was taken and modified from 
Shattil et al. 2010. 
 
4.4.2 Integrins and their implications in radio- and chemo-resistance 
 
A number of human diseases including immunodeficiency disorders and cancer are 
linked to altered integrin-mediated adhesion and migration (Allende et al. 2000; 
Ghevaert et al. 2008; Ruzzi et al. 1997). Additionally, deregulation of integrin expression 
is often linked to poor patient outcome. For prostate cancer treatment increased α3β1 
levels were shown to be associated with tumor recurrence after radical prostatectomy 
(Pontes-Junior et al. 2010). Likewise, β3 integrin expression correlated with the clinical 
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outcome of cervical cancer patients, who had undergone radiotherapy (Gruber et al. 
2005). During cancer progression the regulation of integrin-mediated cell adhesion has 
to be tightly regulated. Whereas, adhesion needs to be reduced in order to leave the 
primary tumor and enter the circulation for extravasation and metastasis formation the 
adhesion, e.g. to the endothelium, needs to be reestablished. All these modulations have 
to happen, while avoiding defensive mechanisms like anoikis. A mechanism that shows 
how integrin-mediated adhesion regulates migration was suggested by Cox et al., who 
showed that binding of the α5β1 heterodimer to its ligand fibronectin (FN) stopped cell 
migration by inhibition of cell polarization and protrusion through the Rho family of 
GTPases (Cox et al. 2001). In addition, the adhesion to FN was shown to offer a survival 
benefit for human myeloma cells (8226) after exposure to the cytotoxic drugs 
doxorubicin and/or melphalan (Damiano et al. 1999). Moreover, a significant increase in 
α4-mediated cell adhesion was detected in these cells. This phenomenon was observed 
in a variety of tumors in chemo- as well as radiation therapy and was termed cell 
adhesion-mediated drug- (CAM-DR) or radio-resistance (CAM-RR), respectively. ECM 
adhesion and the constitutive activation of AKT and MAP kinase pathways are common 
mechanisms that correlate with the acquisition of radioresistance of tumor cells (Cordes, 
Meineke 2003; Kraus et al. 2002; Sandfort et al. 2007). Recently, the β1 integrin, which 
is involved in several signaling pathways that control proliferation, apoptosis and 
survival, was shown to be associated with resistance to several chemotherapeutics 
(Hodkinson et al. 2006; Sethi et al. 1999). Moreover, β1 integrin was upregulated in the 
two lung cancer cell lines A549 and SKMES1 in response to ionizing radiation (Cordes et 
al. 2002). Another study revealed that β1 integrin-stimulated tyrosine kinase activation 
results in a microenvironment that inhibits chemotherapy-induced apoptosis (Sethi et al. 
1999). In addition, adhesion of myeloma cells to FN was observed to be implicated in 
drug resistance. FN-adhesion leads to an accumulation of these cells in G1 phase, which 
was quickly released upon adhesion disruption (Hazlehurst et al. 2000). Taken together, 
it is not surprising that new therapy options are targeting adhesion molecules to reduce 
radioresistance (Cordes, Park 2007; Kiziltepe et al. 2012; Ni et al. 2013). 
The sequence of events that follows ionizing irradiation to acquire resistance is a great 
challenge in therapeutic research and is incompletely understood. Certainly, focal 
adhesion-associated proteins are playing an essential role in this process. A well-known 
feature of resistance mechanisms is the induction of survival and apoptosis-related 
genes such as those of the Bcl-2 family. The adhesion of Chinese hamster ovary cells to 
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FN through α5β1 integrin was shown to induce Bcl-2 expression and thereby 
suppressing apoptosis (Paoli et al. 2013). The process that is facilitating anchorage-
independent growth of cells exhibiting malignant potential is known as anoikis. Thus, it 
was not surprising that Bcl-xl, a member of the Bcl-2 anti-apoptotic protein family, was 
induced in murine prostatic tumor tissue upon ionizing radiation (Zhu et al. 2014). 
Paxillin family proteins have already been observed to be involved in resistance 
mechanisms of tumor cells. Paxillin phosphorylation was linked to an increase in the 
expression of the anti-apoptotic protein Bcl-2. Moreover, paxillin phosphorylation was 
correlating with resistance to cisplatin treatment of non-small cell lung cancer (Wu et al. 
2014). Interestingly, ionizing irradiation induced phosphorylation of paxillin and 
p130Cas in response to β1 integrin activation and resulted in pro-survival effects in 
GD25 mouse fibroblasts (Seidler et al. 2005).  
 
4.4.3 LPXN influences radio-resistance through regulation of integrin 
expression 
 
As adapter proteins at focal adhesion sites and their recruitment to β-integrin tails, 
paxillin protein family members take part in signal transduction and the acquisition of 
radioresistance. In the present study we showed that β1 integrin expression is 
associated with LPXN expression and that both, LPXN as well as β1 integrin expression 
were induced by ionizing irradiation. Downregulation of LPXN by RNA interference 
clearly sensitized the PCa cells to irradiation, which was also observed when β1 integrin 
activity was blocked by the AIIB2 inhibitory antibody. In addition, the irradiation-
induced expression of β1 integrin was prevented by LPXN knockdown, suggesting that 
LPXN is involved in the acquisition of radioresistance and might act upstream of β1 
integrin in irradiation-responsive signaling of the PCa cell lines PC-3, DU145 and LNCaP. 
Cordes et al. observed that after irradiation of human lung tumor cells the expression of 
β1 integrin was increased, which did also enhance cell adhesion. In the following studies 
they were detecting a prolongation and increased accumulation of cells in G2 phase after 
exposure to ionizing irradiation (Cordes et al. 2002; Cordes, van Beuningen 2004). 
However, the induction of adhesion-associated genes by ionizing irradiation seems to be 
a common feature not only of tumor cells (Nübel et al. 2004, Hallahan, Virudachalam 
1997). Interestingly, the expression and phosphorylation of the focal adhesion-
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associated proteins p130cas, FAK and paxillin were shown to be induced by ionizing 
irradiation in A549 human lung carcinoma cells (Beinke et al. 2003). These results 
indicate that these genes are likely to play a role in the cellular response to ionizing 
irradiation. Most likely the microenvironment of the cells is altered by irradiation, which 
might explain why primarily adhesion-associated genes are affected by this process. 
LPXN might exert its function in radioresistance by two possible mechanisms. The first 
mechanism is suggesting LPXN to influence β1 integrin expression directly, leading to a 
mediation of the cellular responses downstream of β1 integrin. This mechanism could 
further involve ERK1/2, which was already shown to be influenced by LPXN (Kaulfuss 
2006) to act as a regulator of the DNA binding ability of the transcription factor SP1 
(Merchant et al. 1999; Milanini-Mongiat et al. 2002) (Fig. 4.6). This way is further 
strengthened by the fact that we could observe an upregulation of Sp1 activity by 
overexpression of LPXN. However, LPXN knockdown also resulted in an upregulation of 
Sp1 activity that was not significant. This contradiction could be based on the fact that 
the downregulation of LPXN was not strong enough and that remaining LPXN levels 
were sufficient to induce Sp1 activity. Nevertheless, our results are suggesting a 
mechanism for the LPXN-mediated expression of β1 integrin that could have influence 
on cell adhesion and promote the acquisition of radioresistance. In addition to our 
studies, Sp1 was also shown to bind to several integrin promoters, like the human α6 
subunit gene in response to the ECM protein laminin, the α2 subunit gene or the α5 
subunit gene in breast tumor cells and rabbit corneal epithelial cells (Gingras et al. 2003; 
Zutter et al. 1997; Sisci et al. 2010; Gaudreault et al. 2007). Interestingly, it was shown 
for the PCa cell lines PC-3 and LNCaP that Sp1 is necessary for basal promoter activity of 
the α6 integrin (Onishi et al. 2001). 
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Fig. 4.6: Overview of how LPXN might regulate integrin expression in the acquisition of 
radioresistance. LPXN might exert its influence on β1 integrin expression directly or via ERK1/2 and Sp1. 
LPXN knockdown was reported to reduce ERK1/2 activity. ERK1/2 in turn is able to modulate DNA-
binding activity of Sp1, which was reported to bind to several integrin promoters. The depicted 
mechanism displays a possible way of LPXN-mediated integrin expression. Nuc=Nucleus; Sp1 = Specificity 
protein 1; ERK1/2 = Extracellular signal-regulated kinase 1/2. Modified from Gauldreault et al. 2007 and 
Merchant et al. 1999. 
 
According to what is known from the literature LPXN could also mediate radioresistance 
by interaction with its binding partners FAK or SRC, which are located downstream in 
the integrin-signaling pathway and have already been reported to interact with paxillin. 
Phosphorylation of FAK upon β1 integrin inhibition resulted in a dissociation of the 
FAK/cortactin protein complex, which reduced JNK signaling and induced cell rounding 
and radiosensitization (Eke et al. 2012). Possibly, LPXN might influence the 
phosphorylation status of FAK and control downstream signaling. A depletion of FAK 
from mouse squamous cell carcinoma (SCC) was associated with increased 
radioresistance in advanced SCC. Re-expression of FAK in these cells induced 
upregulation of p53 target genes involved in DNA repair like p21, in response to ionizing 
radiation, suggesting a role of FAK in radioresistance (Graham et al. 2011). FAK has also 
been described to mediate drug resistance, because the circumvention of docetaxel-
induced cleavage of FAK was suggested to contribute to the resistance of taxane-
resistant ovarian cancer cell lines. Reduction of FAK expression by RNAi-mediated 
knockdown promoted sensitization of these cells to docetaxel (Halder et al. 2005). A 
summary of the radioresistance mechanisms that are based on the findings of this study 
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as well as other possible mechanisms of how paxillin proteins might regulate 




Fig. 4.7: Schematic overview of signaling pathways associated with β1 integrin after exposure of 
cells to ionizing irradiation and how LPXN might interfere in these pathways to modulate 
radioresistance. LPXN might affect several mechanisms to mediate radioresistance. It could control ERK 
1/2 activity, which controls Sp1 DNA-binding to regulate integrin expression. β1 integrin signaling 
involves several pathways including caspases, Akt, and GSK3β to modulate cellular responses like 
apoptosis, survival or proliferation that play a role in the acquisition of radioresistance. LPXN might exert 
its radio-sensitizing function in several ways. It might directly act on β1 integrin expression via 
association with transcription factors like Sp1 or it might mediate radioresistance by interaction with its 
binding partners FAK or SRC. Binding partners that have also been reported to associate with paxillin. 
Nuc=Nucleus; ILK = Integrin-linked kinase; GSK3β = Glycogensynthase-kinase 3 β; JNK = c-Jun-N-terminal 
kinase; Src = sarcoma kinase; Cas = Crk-associated substrate. Scheme was taken and modified from Cordes, 
Park 2007 and Merchant et al. 1999. 
 
Cell adhesion displays an essential process for normal cell function. Its importance 
becomes illustrated by its deregulation resulting in tumor development or cell death. As 
mentioned earlier cell adhesion has also influence on the acquisition of resistance to 
radiation. Besides radioresistance cell adhesion is also affecting a phenomenon known 
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as anoikis, a programmed cell death that is autonomously initiated upon loss of adhesion 
to the ECM. Anoikis is a protective mechanism of the organism to prevent adhesion-
independent growth that might end in colonization of distant organs. Tumor cells need 
to circumvent this programmed cell death upon ECM detachment to survive during their 
life-threatening journey. Integrin composition and expression severely affect anoikis 
and contribute to anoikis resistance. In the present study LPXN was shown to regulate 
β1 integrin expression. Thus, LPXN might not only mediate radioresistance but could 
also affect the resistance to anoikis. Although this mechanism was not studied in the 
present thesis, previous studies in our research group showed that downregulation of 
LPXN in PC-3 and DU145 cells resulted in a sensitization of these cells to anoikis (Hitzing, 
2010). Therefore, LPXN could be assumed to contribute to anoikis resistance by either 
regulating integrin expression or interfere with downstream effector protein of the 
integrin signaling pathway. This hypothesis could explain the resistance to anoikis of PC-
3 and DU145 cells. However, these cells have been isolated from bone metastasis and 
have been through the process of metastasis including epithelial to mesenchymal 
transition (EMT), invasion of the surrounding tissue, entering the lymph or blood 
stream and exiting the circulation at a distant site. This is a sequence of events that 
requires modulation of cell adhesion throughout the whole process. Therefore, the 
anoikis-resistance of these cells might not be critically for their survival anymore and 
might be a beneficial remain from the pre-metastatic stages. 
Taken together, focal adhesion-associated proteins have an important role in the 
acquisition of resistance mechanisms by governing cell adhesion and cell adhesion-
induced signaling. Hence, LPXN displays a fundamental part to regulate a complex 
interplay of an enormous array of proteins and contributes to radioresistance of PCa 
cells. This study identified LPXN to regulate the expression of β1 integrin through Sp1. 
By this mechanism LPXN was suggested to mediate the adhesion and radioresistance of 
PCa cells. However, if this mechanism involves other proteins and what underlies the 
irradiation-induced expression of LPXN requires further investigations and might also 
elucidate the acquisition of anoikis-resistance and contribute to the development of new 
therapeutic strategies. 
From the findings of this study the therapy of LPXN positive tumors using irradiation 
might quickly result in an acquisition of radioresistance and would reduce therapy 
effectiveness. Therefore, LPXN could be used as a biomarker for PCas that are likely to 
develop radioresistance and would contribute to individualize PCa therapy for 
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maximum outcome. To sensitize PCa cells to radiation LPXN itself could display a 
putative target to improve the effectiveness of radiotherapy of PCa. How exactly LPXN 
can be targeted requires further research. In addition, the investigation of integrin-
mediated cell adhesion mechanism of PCa could reveal additional targets that could 
imply new therapeutic targets in PCa therapy.  
 
4.5 How does LPXN regulate the expression of the adhesion protein 
p120-catenin? 
 
4.5.1 The implications of the cell adhesion molecule p120CTN in 
LPXN-mediated PCa progression 
 
Cell adhesion is a fundamental process for the growth, migration and differentiation of 
cells. Cell adhesion molecules (CAMs) are proteins important for cell-cell and cell-matrix 
interaction (Cohen et al. 1997). Basically, CAMs are categorized into four groups, the 
immune globulins, selectins, intergrins and cadherines (Okegawa et al. 2002). Defects in 
cadherin expression are linked to tumor progression and are known to function as a 
tumor suppressor during cell invasion and metastasis (Herzig et al. 2007; Perl et al. 
1998; Jeanes et al. 2008). Cadherins do not possess an intrinsic catalytic activity. 
Therefore, their cytoplasmic domains associate with the group of catenin proteins, 
which facilitate signal transduction and link the cadherins to the actin cytoskeleton 
(Mege et al. 2006; Behrens 1999). The interaction of cadherins with catenins is essential 
for the formation of the adhesion complex and important for proper cell adhesion and 
the maintenance of the tissue architecture. Disruption of these contacts will end up in an 
aggressive and invasive growth of tumor cells (Wijnhoven et al. 2000). The adhesion 
complex consists of β-catenin, α-catenin, γ-catenin and p120-catenin (p120CTN). For β-
catenin a tumor promoting function was described and also an abnormal expression of 
p120CTN was detected in different tumor entities (Kallakury et al. 2001; Chetty et al. 
2008; Perez-Moreno et al. 2008; Liu et al. 2009). Predominantly in colorectal cancer a 
mutation in the APC gene, a component of the Wnt signaling pathway, results in an 
impaired degradation of β-catenin and subsequent accumulation in the nucleus 
(Schneikert, Behrens 2007). In the nucleus β-catenin is binding to the transcription 
complex of TCF/LEF (t-cell-factor/lymphoid enhancer factor) leading to the activation of 
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Wnt-β-catenin target genes implicated in cell proliferation and cell migration such as the 
group of matrix metalloproteinases or cyclins (Fig. 4.8) (Friedrich, Kullmann 2003). 
 
 
Fig. 4.8: Scheme of APC-mediated degradation of β-catenin. Under normal conditions the adhesion 
complex is stabilized and connects the cadherins to the actin cytoskeleton. Cytoplasmic β-catenin is 
primed for degradation via the proteasome (ubiquitin) by the destruction complex, containing the 
adenomatous polyposis coli (APC) protein. APC is an important component of the Wnt signaling pathway. 
Upon APC mutation, cytoplasmic β-catenin degradation is impaired and subsequently accumulates in the 
cytoplasm and the nucleus. Once in the nucleus β-catenin associates with TCF/LEF to activate target genes. 
Nuc=Nucleus. Modified according to Morin et al. 1997. 
 
The catenin p120, which is encoded by the CTNND1 gene, is part of the p120 armadillo 
protein family. Originally, in 1989 p120CTN was described as a substrate of tyrosine 
kinases (Reynolds et al. 1989). New evidence is suggesting p120CTN to have multiple 
functions. On the one hand it takes part in the dynamic regulation of the actin 
cytoskeleton and cadherin transport to the membrane. On the other hand it binds to the 
cytoplasmic domain of cadherins at the plasma membrane and stabilizes the cell-cell 
adhesion complexes. A nuclear localization of p120CTN has also been described, but 
except for its association with the transcription factor kaiso, the nuclear function of 
p120CTN remains largely unsolved. As mentioned above, changes in expression levels of 
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p120ctn are detected in a number of tumor types. A disturbed expression of p120CTN 
caused a destabilization of the adhesion complexes and a degradation of cadherins in the 
colorectal cell line SW48 (Davis et al. 2003). In the majority of carcinomas, which derive 
from epithelial cells, the dysfunction, degradation or loss of cadherin expression is a 
common finding (Onder et al. 2008; Birchmeier, Behrens 1994; Thiery 2002; Yap 1998). 
The loss of p120CTN was associated with metastatic progression and anoikis resistance 
in breast cancer cells and a complete p120CTN knockout results in tumor development 
in mice (Schackmann, Ron C J et al. 2013; Stairs et al. 2011). Accordingly, these studies 
establish p120CTN as a tumor suppressor gene. 
The transcriptional regulation of the p120CTN gene is incompletely defined. In non-
small cell lung cancer (NSCLC) the Sp1 transcriptional factor was shown to act as a 
transcriptional repressor of p120CTN. Furthermore, Sp1 was suggested to be a possible 
mediator of p120CTN repression by the proto-oncogene cellular-CT10 Regulator of 
Kinase (c-Crk). However, this hypothesis was not confirmed in this study (Mortazavi et 
al. 2011). In addition, the same research group showed that p120CTN is 
transcriptionally downregulated by the forkhead box C2 (FOXC2) transcription factor 
(Mortazavi et al. 2010).  
Recently, our lab could identify p120CTN as a mediator of LPXN-induced invasion and 
progression of PCa (Kaulfuss et al. 2009). In our studies p120CTN expression was 
negatively correlated with LPXN expression. Downregulation of LPXN resulted in 
increased p120CTN expression and a membranous localization of β-catenin. In contrast, 
overexpression of LPXN caused a decrease in p120CTN expression and subsequent 
destabilization of the adhesion complexes. Following adhesion complex destabilization, 
β-catenin was accumulating in the nucleus leading to activation of the β-catenin target 
gene matrix metalloprotease-7 (MMP-7) important for degradation of the extracellular 
matrix (Fig. 4.9). However, how LPXN might regulate the expression of p120CTN is 
unknown. 
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Fig. 4.9: Overview how LPXN overexpression of PCa cells leads to adhesion complex destabilization 
and nuclear accumulation of β-catenin. Under normal conditions the adhesion complex composed of β-
catenin, γ-catenin, α-catenin and p120-catenin is formed and stabilized at the cytoplasmic tail of the 
cadherin and linked to the actin cytoskeleton. In PC-3 and DU145 cells LPXN is overexpressed and causes 
p120ctn expression levels to decrease. Upon p120CTN reduction the adhesion complex is destabilized. 
Subsequently, β-catenin is released from the adhesion complex to the cytoplasm, where it is primed for 
degradation via the destruction complex containing APC. However, β-catenin will also accumulate in the 
nucleus and associate with TCF/LEF transcription factors leading to β-catenin target gene transcription. 
Modified according to Morin et al. 1997 
 
4.5.2 The nuclear function of paxillin family proteins 
 
Recent investigations have shown that paxillin and its protein family members take 
functions beyond their main roles as molecular adapter proteins located at adhesion 
plaques. They were described to mediate extra- as well as intra-nuclear signaling, the 
latter being poorly understood. Within the nucleus, proteins of the paxillin family were 
described to act as steroid hormone nuclear receptor coactivators. In our studies, we 
could identify LPXN to play a role in adhesion and invasion of prostate carcinoma cells 
by coactivation of the androgen receptor (Kaulfuss et al. 2008). In addition, LPXN was 
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shown to form a complex with the transcription factor, serum response factor (SRF), in 
human and mouse vascular smooth muscle cells, driving SRF-responsive gene 
expression (Sundberg-Smith et al. 2008). Likewise, paxillin was shown to be involved in 
the progression of castration-sensitive to castration-resistant PCa by association with 
the androgen receptor (AR) (Sen et al. 2012). For ARA55 association with the androgen 
receptor, the glucocorticoid receptor and the peroxisome proliferator-activated receptor 
gamma (PPARγ) was shown (Yang et al. 2000; Fujimoto et al. 1999; Heitzer, Defranco 
2006). Thus, paxillin family proteins clearly have a nuclear function. However, it is not 
much known about the mechanism of nuclear/cytoplasmic shuttling and only a few 
suggestions have been proposed. Paxillin proteins do not possess a nuclear localization 
signal (NLS) and might therefore enter the nucleus with the help of other proteins. The 
nuclear import of LPXN has not been elucidated today. For paxillin, phosphorylation of 
the LD4 motif was described to regulate nuclear localization, which was correlating with 
cell proliferation (Dong et al. 2009). In contrast, nuclear accumulation of ARA55, another 
paxillin family protein, turned out to be regulated by reactive oxygen species (ROS), 
which is why it was originally named hypoxia-inducible clone 5 (Hic-5) (Shibanuma et al. 
2003). The nuclear export of paxillin family proteins is facilitated by a leucine-rich 
nuclear export signal (NES) (Wang, Gilmore 2003). Especially for LPXN our research 
group identified NES in the LD3 and LD4 motifs in the N-terminal region of the protein 
(Kaulfuss et al. 2008). 
Undoubtedly, paxillin family proteins are able to shuttle between the cytoplasm and the 
nucleus. Localization to the nucleus and their association and co-activation of nuclear 
steroid hormone receptors like the androgen receptor or glucocorticoid receptor clearly 
grants them nuclear functions. A direct DNA binding was only described for ARA55 
(Nishiya et al. 1998). Neither paxillin nor LPXN were shown to bind directly to DNA 
sequences.  
In the present study the DNA binding of LPXN to the p120CTN promoter region was 
analyzed to elucidate the negative correlation of both proteins. Fragmentation of the 
p120CTN promoter region and subsequent analysis indeed identified a LPXN responsive 
region. Using luciferase reporter gene assays the region from 240 bp upstream to 349 bp 
downstream relative to the transcriptional start site was identified to show the highest 
activity upon LPXN knockdown in comparison to control transfected cells. Larger 
promoter fragments also showed increased activity but this increase was not caused by 
LPXN, as it was also detectable in control-transfected cells. Further investigation of this 
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LPXN-responsive region using EMSA, showed no direct binding of LPXN to the p120CTN 
promoter region. Even an enrichment of an EGFP-LPXN fusion protein in the nucleus, 
did not shown any differences in the band pattern compared to EGFP control transfected 
cells. Also we did neither detect binding of the Sp1 transcription factor to the proposed 
binding sites in the p120CTN promoter region by Mortazavi et al. nor did we observe 
Sp1 binding to a consensus sequence (Kadonaga et al. 1988). However, with the EMSA 
we were only able to analyze a small isolated section of the p120CTN promoter region, 
which is composed of a variety of promoting and repressing sequences (Mortazavi et al. 
2010; Mortazavi et al. 2011). Therefore, we focused on the proximal promoter region 
around the transcriptional start site. Possibly, we cannot exclude that we might have 
missed other important regions with this decision.  
Since a negative correlation of LPXN and p120CTN expression was reported in previous 
studies of our research group, it is likely that LPXN is involved in the regulation of 
p120CTN expression. Certainly a direct binding of LPXN to the proximal p120CTN 
promoter region could not be demonstrated. Apart from this, only for the paxillin 
protein family member, ARA55, a direct, zinc-dependent binding to an adenine-rich DNA 
sequence via its LIM domains was reported (Nishiya et al. 1998). Usually LIM domains 
were thought to be restricted to protein-protein interactions, but as mentioned earlier, 
the LIM domains of paxillin family proteins might be potentially DNA binding interfaces. 
Interestingly, LIM domains were originally discovered in the three transcription factors 
lin 11, isl-1 and mec-3 and accordingly named after them. These LIM domains are highly 
conserved residues that form a tandem zinc finger motif. The fact that zinc fingers are 
important structures in DNA binding proteins such as transcription factors, called the 
attention that also LIM domain-containing proteins are capable of DNA binding 
(Kadrmas, Beckerle 2004). ARA55 was the first LIM domain-containing protein that was 
observed to bind to DNA. In addition, this research group was not successful in 
discovering a consensus sequence for ARA55. Rather it was suggested to bind to a 
poly(A) DNA sequence such as those present in the 3’-end of mRNAs (Nishiya et al. 
1998). A similar mechanism was proposed for paxillin, which interacts with the poly(A)-
binding protein and thereby transports certain mRNAs to the leading edge of migrating 
cells (Woods et al. 2002). Interestingly, there seem to be certain types of protein-DNA 
complexes that are not stable when subjected to conventional gel shift assays (von Kries, 
J P et al. 1991; Romig et al. 1992). The authors suggested that these proteins do not 
recognize a specific DNA sequence but the secondary structure within those sequences. 
Discussion    128 
In contrast, these secondary DNA-structure-binding proteins were successfully 
precipitated in a DNA binding protein blot assay. Thus, LPXN might also bind to a 
secondary DNA structure rather than to a specific DNA sequence and this might account 
for the negative EMSA results obtained. On the other hand DNA binding of LPXN was not 
detected in a DNA cellulose pulldown in previous experiments (Dierks, 2011). Therefore, 
DNA binding of LPXN might be restricted to sequences that escaped our analyses or the 
binding to secondary DNA structures required other conditions than those used in our 
binding assays. Further analysis of the human p120CTN promoter showed the presence 
of putative steroid hormone receptor binding sites, which are known to be activated by 
LPXN, but remain inconclusive. Possibly, LPXN is not directly binding to DNA sequences 
but executes its regulatory function through other transcription factors that negatively 
influence p120CTN expression. Hence, LPXN might influence p120CTN expression 
through other, yet unknown mechanisms. 
 
4.6 The physiological role of LPXN 
 
Paxillin proteins are effectors of integrin signals and play major roles in cell adhesion 
and signal transduction. Their predominant localization at focal adhesion sites and 
domain structure of multiple protein-protein interaction interfaces grants them their 
primary role as molecular adapter proteins, which orchestrate the complex dynamics of 
signaling and structural proteins. 
Whether paxillin family proteins can compensate for the loss of other protein family 
members is not completely known. The role of paxillin and leupaxin in cell adhesion and 
spreading of MDA-MB231 breast cancer cells found that both proteins are similar in 
focal adhesion targeting and tyrosine phosphorylation but each protein has distinct 
functions (Chen, Kroog 2010). Since paxillin protein family members share a number of 
interaction partners it is likely that they might compensate for the loss of other paxillin 
proteins. Nevertheless, there are unique interaction partners for each protein within the 
paxillin protein family, which suggests that they could modulate each other’s functions 
(Turner et al. 1990; Thomas et al. 1999). However, if paxillin proteins have an inhibitory 
effect on each other’s functions needs to be determined. The fact that paxillin deficiency 
results in embryonic lethality suggests that neither LPXN, nor ARA55 can substitute the 
functions of paxillin and further strengthen the hypothesis that each protein has its 
specific functions. 
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The function of LPXN in the organism is not clear and a knockout of LPXN has not been 
reported. In our research group a mouse model was generated that specifically 
expressed LPXN under the control of the prostate-specific rat probasin promoter. This 
leads to an overexpression of LPXN in the prostate and resembles the clinical situation 
found in approximately 20 % of the PCa patients. Prostate-specific overexpression of 
LPXN showed that it is not involved in tumor initiation. Further investigations included 
breeding of these mice to the TRAMP mouse model (transgenic adenocarcinoma of the 
mouse prostate), which specifically expresses the simian virus 40 (SV40) large T antigen 
in the prostate inducing tumor development. Double transgenic TRAMP/LPXN mice 
showed enhanced tumor progression in comparison to single transgenic TRAMP mice 
(Kaulfuss et al. 2009), suggesting LPXN to play a role in cell invasion and migration. 
These results are consistent with the findings that the highly invasive PCa cell lines PC-3 
and DU145 show high LPXN expression and that LPXN knockdown leads to reduced 
migration and invasion of these cells (Kaulfuss et al. 2009). 
To understand the physiological role of LPXN a targeted trap of the LPXN gene was 
generated. Mice carrying the conditional LPXN allele were then bred to mice that 
express the cre-recombinase under the control of the adenoviral EIIa promoter, which 
targets cre expression to the early embryo. Like observed for ARA55 knockout mice, 
LPXN-/- mice are viable and fertile, which suggests that LPXNs function is not important 
during embryonic development. Loss of LPXN function may also be compensated by one 
of its protein family members. However, a detailed analyses of LPXN-/-mice concerning 
tissue structure and especially the immune system is needed. Since LPXN was initially 
reported to be expressed in motile cells of hematopoietic origin analyses of these tissues 
seems promising to uncover a phenotype of these mice.  
Paxillin knockout results in embryonic lethality at E9.5. Until this stage paxillin was 
expressed in extraembryonic structures such as parietal endoderm, ectoplacental cone 
and extraembryonic mesodermal structures like the chorion, amnion and allantois 
(Hagel et al. 2002). Thus paxillin is essential for proper embryonic development. 
Noteworthy, the phenotype of the paxillin knockout mouse model is closely reflecting 
the phenotype of fibronectin-/- mice (George et al. 1993; Watt, Hodivala 1994). 
Fibronectin is a major component of the extracellular matrix and ligand of a number of 
integrin heterodimers, which suggests paxillin to be an effector of integrin signaling 
during early embryonic development. This fact is further strengthened by paxillin null 
embryonic stem cells that display delayed spreading on fibronectin and laminin and 
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reduced phosphorylation of attachment-dependent FAK phosphorylation (Wade et al. 
2002). 
ARA55 knockout mice are viable and fertile and do not show any abnormalities in 
development and tissue homeostasis. However, ARA55 may have a role in vascular 
remodeling because recovery of injured arteries was delayed in ARA55 deficient mice 
(Kim-Kaneyama et al. 2011). In addition, ARA55 expression is induced by the 
transforming growth factor-β (TGFβ), a well-known promoter of fibrosis, which involves 
ARA55 in a number of fibrotic disorders such as glomerulosclerosis (Border, Noble 
1993). 
In conclusion, the LPXN knockout mouse model does not show an obvious phenotype or 
embryonic lethality. The phenotypes of ARA55 and paxillin knockout mice suggest that 
each protein has its particular function. Detailed studies of the LPXN knockout mice, 
especially on cells of hematopoietic origin, are thought to give promising results and are 
required to contribute to the understanding of LPXNs physiologic function. This 
knowledge can then be transferred to uncover its pathologic function and help to 




In the present study LPXN was identified to exert its pro-migratory function on PCa by 
directly affecting the actin cytoskeleton through modulation of the phosphorylation 
status of the actin-binding protein CaD. Out of these studies LPXN was released from its 
classical role as a molecular adapter protein at focal adhesions and hypothesized to 
recruit the extracellular signal-regulated kinase 1/2 (ERK1/2) in order to facilitate CaD 
phosphorylation. Undoubtly, CaD phosphorylation alone is not sufficient for actin 
cytoskeletal remodeling and migration of PCa cells. Thus, LPXN might facilitate 
migration by other mechanisms that remain unknown so far. The fixation of migrating 
cells for microscopic analysis has been a major obstacle in the study of migrating 
mechanisms that are often spatially and temporally restricted. Therefore, life cell 
microscopy might display a suitable opportunity to study the LPXN-dependent 
processes during migration of PCa cells. In addition, in vivo studies should confirm the 
relevance of LPXN-mediated phosphorylation of CaD through ERK1/2. For this purpose 
the phosphorylation status of ERK1/2 and CaD of prostate tumors isolated from double 
transgenic LPXN/TRAMP-mice should be analyzed by western blot. Furthermore, it has 
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to be assumed that LPXN has influence on other processes and signaling pathways that 
promote tumor progression. For instance, LPXN might be implicated in ERK1/2 
downstream signaling, since LPXN knockdown was affecting ERK1/2 activity. However, 
the fact that paxillin family proteins carry functions beyond their original role as 
molecular adapters suggests that these proteins may be involved in other processes as 
well. These processes might also have promoting influence on cancer progression and 
should be subject to further investigations to identify LPXNs function in more detail. In 
addition, these studies could help to establish LPXN as a putative progression marker 
and to develop new therapeutic treatment options. Obviously, reduction of LPXN 
expression would display such a treatment possibility to reduce CaD phosphorylation, 
stabilize the actin cytoskeleton and hamper PCa cell migration. Since modern cancer 
treatment will be more and more individualized for each patient to decrease site effects 
and yield maximum therapeutic response, further investigations that uncover the 
physiologic role of LPXN may be the key to understand the pathologic function of LPXN 
and will also contribute to the development of new therapeutic approaches for PCa 
therapy. Targeting LPXN overexpression in PCa itself would require siRNA-based 
treatment approaches. These RNAi techniques have been shown to successfully reduce 
expression of targeted genes in cancer therapy. However, the main challenge of this 
method is its efficacy and the delivery of nucleic acids specifically to tumor cells after 
intravenous application. In addition, many siRNAs display off target gene modulation, 
which may result in additional site effects. Nevertheless, latest studies that were able to 
specifically target mutant oncogenic ras but were not affecting wild type ras show 
promising results and would revolutionize the field of RNAi in cancer therapeutics (Lois 
et al. 2001). According to the findings from this study and the complexity of PCa, it 
seems unlikely that LPXN has such strong influence on the tumor progression to be 
considered as a single target. Rather LPXN should be noticed as a protein that is 
integrated in a complex network of genes, which need to be included in the development 
of therapeutic approaches.  
In the present study LPXN was emphasized to play a role in the acquisition of 
radioresistance. LPXN expression was found to be inducible by ionizing irradiation and 
further shown to regulate the expression of β1 integrin. By this mechanism LPXN might 
affect cell adhesion, which is a common feature of cells after exposure to ionizing 
irradiation. Knockdown of LPXN resulted in radio-sensitization of PCa cells, a finding 
that might also be relevant for radiotherapy of e.g. PCa. Resistance mechanisms are 
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mostly regulated through the expression of genes that are important for apoptosis or 
survival. The analysis of these genes (e.g. Bcl-2 family genes) after exposure to ionizing 
irradiation and their response to LPXN overexpression or knockdown could reveal how 
LPXN exactly mediates radioresistance. These experiments might also add to the 
understanding of general radioresistance mechanisms and how to circumvent 
radioresistance during radiotherapy. 
As mentioned above LPXN should not be considered as a pure focal adhesion adapter 
protein. Especially the nuclear presence and the coactivation of the androgen receptor 
point towards a broader function of LPXN in a variety of processes. The negative 
correlation of LPXN and p120CTN expression and their suggested implications in PCa 
cell invasion have been reported lately (Kaulfuss et al. 2009). The basis for this negative 
correlation was analyzed in this study. However, a direct binding of LPXN to the 
promoter region of CTNND1 was not found. Hence, additional studies including 
chromatin immunoprecipitation (ChIP) have to be conducted to clarify LPXNs influence 
on the CTNND1 promoter. In addition, it is not clear how and in response to which 
stimuli LPXN is transported into the nucleus. Investigation of these questions could 
further help to understand how LPXN acts on p120CTN expression. 
The accumulation of mutations that leads to the deregulation of gene expression profiles 
is known as a hallmark of cancer. Subsequently, this deregulation ends in the disruption 
of signaling networks and molecular processes (Hanahan, Weinberg 2000; 2011). For 
LPXN the effects of its overexpression on PCa cells have been studied, but how 
deregulation of LPXN expression arises and how it is regulated in normal and PCa cells is 
unclear. Reporter gene assays of the promoter region of LPXN could be a first step to 
answer this question. These experiments will identify a region of interest and will lead 
to the identification of putative regulators that could easily be verified in human PCa 
cells. Possibly, these regulators might display putative targets for cancer therapy. 
The generated LPXN knockout mouse model does not display any obvious abnormalities. 
These mice are viable and fertile and do not show any signs of discomfort. However, 
detailed studies on the LPXN knockout mouse are needed. These studies should include 
a confirmation of the absence of LPXN from the corresponding tissues. Proteins of the 
paxillin protein family were hypothesized to have distinct functions (Chen, Kroog 2010). 
However, these results were obtained from in vitro experiments and might not reflect 
the in vivo situation. Thus, if LPXN-/- mice do not show a conspicuous phenotype they 
should be bred with ARA55 knockout mice to see if ARA55 may compensate for the loss 
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of LPXN. In addition, analysis of LPXN expression concerning time and tissue-specificity 
could reveal, which tissues might be affected by a LPXN knockout and could display a 
starting point for further investigations. Since LPXN was originally found to be 
expressed in cells of hematopoietic origin, the analysis of these cells seems to be a 
promising option. Should following investigations require removement of LPXN from a 
specific cell or tissue type, the conditional LPXN knockout model maintains this 
possibility. 
Taken together, LPXN was shown to be involved in a variety of signaling pathways and 
exert specific functions on the actin cytoskeleton to regulate PCa cell migration. In 
addition, LPXN turned out to be dispensable for proper development and represented 
potential to modulate radioresistance of PCa cells.  




Leupaxin is a focal adhesion protein of the paxillin protein family that is overexpressed 
in PCa. Recently, LPXN was shown to interact with the actin-binding protein CaD and to 
modulate its phosphorylation levels of CaD (Hardenberg 2010). In the present study the 
interaction of LPXN and CaD was confirmed. Moreover, LPXN was shown to interact 
with the phosphorylated form of CaD to modulate actin cytoskeletal dynamics during 
migration of PCa cells. To analyze the relevance of this interaction for cell migration, in 
situ proximity ligation assays (PLA) were performed on migrating PCa cells. The 
subcellular interaction pattern of LPXN and CaD showed increased interactions at the 
submembranous compartment, whereas interactions were absent from the leading edge 
of the migrating cell. This leads to the conclusion that CaD is phosphorylated at places 
where actin cytoskeletal structures need to be reassembled. A variety of kinases have 
been reported to phosphorylate CaD, but only a few have already been described to 
regulate the actin affinity of CaD and would therefore display putative candidate kinases. 
A specific inhibitor for the mitogen-activated protein kinase kinase, MEK1, reduced the 
phosphorylation of CaD and identified the extracellular signal-regulated kinase 1/2 
(ERK1/2) to be responsible for LPXN-dependent phosphorylation of CaD during 
migration of PCa cells. In addition, the interaction pattern of LPXN and activated ERK1/2 
were similar to the one observed for LPXN-phospho-CaD interaction, leading to the 
hypothesis that ERK1/2 is recruited to phosphorylate CaD at sites of pre-dynamic actin 
cytoskeletal structures in a LPXN-dependent manner. Consistent with the increased 
LPXN expression in the highly invasive and androgen-independent PC-3 and DU145 cells, 
the proposed mechanism displays an explanation of how LPXN facilitates migration of 
PCa cells. 
In the course of the present study we further analyzed the correlation of the expression 
of LPXN and the cell adhesion molecule β1 integrin, which is known to be involved in the 
acquisition of radioresistance of several cancer entities (Ahmed et al. 2013). The 
resistance to therapeutic drugs and ionizing irradiation is a major obstacle in cancer 
therapy. In our PCa cells LPXN as well as β1 integrin expression were inducible by 
ionizing irradiation. Knockdown of LPXN prevented this irradiation-induced 
upregulation of β1 integrin and resulted in a radio-sensitization of the cells. Likewise, 
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inhibition of β1 integrin using an inhibitory antibody leads to a radio-sensitization of 
PCa cells. However, a simultaneous inhibition of β1 integrin and downregulation of 
LPXN did not result in a synergistic effect, suggesting that LPXN and β1 integrin might 
mediate resistance to ionizing irradiation through the same signaling pathway. To find a 
possible explanation for the LPXN-dependent expression of β1 integrin the activity of 
the specificity protein 1 (SP1), which was shown to drive the expression of several 
integrins, was examined after knockdown and overexpression of LPXN. This assay 
revealed that only overexpression, rather than knockdown of LPXN was activating Sp1. 
This suggests that LPXN might mediate the expression of β1 integrin through SP1. This 
hypothesis is supported by the fact that LPXN knockdown was affecting the activity of 
ERK1/2, which is regulating the DNA-binding activity of SP1.  
Another part of the present study focused on the elucidation of the mechanism behind 
the negative correlation of LPXN and the cell adhesion molecule p120CTN. Because of its 
nuclear localization and coactivation of the androgen receptor, LPXN was suggested to 
have transcriptional activity. To identify LPXN-responsive elements, the p120CTN 
promoter was fragmented. Subsequent luciferase reporter assays identified a LPXN-
responsive region ranging from 200 bp upstream to 100 bp downstream relative to the 
transcriptional start site. Further investigations using EMSA experiments did not 
uncover a LPXN binding site within this region of the p120CTN promoter. This suggests 
that LPXN might regulate p120CTN promoter activity indirectly through association 
with other proteins.  
To investigate the physiologic role of LPXN a conditional knockout mouse was generated. 
Therefore, mouse embryonic stem (mES) cells with a targeted trap of the LPXN gene 
were purchased from the European conditional mouse mutagenesis program (EuCOMM). 
After excision of the resistance/reporter cassette these cells were injected into 
blastocysts but the resulting chimera did not show germ line transmission. Therefore, 
mES cells were subjected to cytogenetic analysis, which did not reveal numerical 
chromosome aberrations. After culturing in RESGRO® medium to remove ES cells that 
already started to differentiate before, mES cells were injected into blastocysts again. 
The resulting chimeras were bred with wild type C57BL/6 to establish a conditional 
LPXN knockout line. To determine the function and developmental importance of LPXN, 
it was deleted very early during development. To this end, LPXNflox/flox mice were bred 
with EIIA-Cre mice, which express the cre-recombinase in the early mouse embryo. 
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LPXN-/- mice did not show any obvious phenotypic abnormalities and were viable and 
fertile, meaning that LPXN is not important for normal development. 
In conclusion, the present study extended the understanding of LPXNs function in the 
progression of PCa. Although it was shown to be dispensable for embryonic 
development, LPXN clearly had a function in the migration of PCa cells. Furthermore, it 
possesses major influence on the radioresistance of PCa cells. Detailed analysis of the 
LPXN knockout mouse will provide a broader view of the processes affect by LPXN and 
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